Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",A1BG,Alpha-1B-glycoprotein,1517,35,3.03 [0.45-20.32],0.2539246208999812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AAMDC,Mth938 domain-containing protein,1458,35,1.41 [0.78-2.55],0.2511664618147198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,1710,44,1.13 [0.71-1.80],0.5924575849075386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,1460,32,1.87 [0.82-4.23],0.1344211756125754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABHD14B,Protein ABHD14B,1695,44,1.40 [0.89-2.19],0.1456866123337402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,1710,44,1.85 [1.31-2.60],0.0004146655237228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABO,Histo-blood group ABO system transferase,1512,35,0.86 [0.68-1.07],0.1731942305218471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,1460,32,1.14 [0.68-1.90],0.6198443713033382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",1660,44,1.21 [0.92-1.59],0.1660776763371609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",1481,36,1.15 [0.75-1.78],0.5197590108052972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",1507,35,0.82 [0.56-1.18],0.2822138943335814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAN,Aggrecan core protein,1703,43,4.63 [1.82-11.79],0.0013212180566001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE,Angiotensin-converting enzyme,1512,35,2.65 [0.82-8.52],0.1029689783062104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE2,Angiotensin-converting enzyme 2,1690,45,0.81 [0.52-1.25],0.3341577367810672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACHE,Acetylcholinesterase,1477,35,2.10 [0.93-4.74],0.0741477254158838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,1500,35,1.10 [0.84-1.44],0.4924926133630422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,1721,43,1.72 [1.10-2.70],0.0185763043529556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,1456,33,0.71 [0.33-1.53],0.375219915252727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,1738,45,2.94 [1.58-5.50],0.0007067436050903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,1736,45,1.73 [1.07-2.81],0.0264565170669906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRBP,Acrosin-binding protein,1503,36,1.36 [0.64-2.90],0.4234124461096582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRV1,Acrosomal protein SP-10,1456,33,1.20 [0.83-1.73],0.330024702137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,1460,32,0.39 [0.11-1.42],0.1549230960969073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",1690,45,3.01 [2.09-4.35],3.883642169040148e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN2,Alpha-actinin-2,1460,32,1.20 [0.73-1.97],0.4672031507211466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN4,Alpha-actinin-4,1682,42,1.64 [0.71-3.81],0.2499187729717219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,1698,44,10.58 [5.81-19.29],1.3039520385345512e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY1,Aminoacylase-1,1721,43,0.61 [0.42-0.89],0.0107928931744416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,1460,32,1.62 [0.99-2.65],0.0569947646895053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACYP1,Acylphosphatase-1,1471,34,1.02 [0.63-1.65],0.9418960241814774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA,Adenosine deaminase,1746,44,1.69 [0.84-3.39],0.1408521947420391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA2,Adenosine deaminase 2,1723,45,2.80 [1.71-4.58],4.425961272235064e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,1456,33,2.84 [1.46-5.54],0.0022131625742824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,1690,45,3.30 [1.46-7.42],0.0039510477843984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,1704,44,4.36 [2.17-8.76],3.4193109374880846e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,1746,44,6.67 [2.76-16.10],2.442680933027753e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,1729,44,4.67 [2.11-10.36],0.0001454217736416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1500,35,4.87 [2.73-8.70],8.721620973697395e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,1456,33,2.85 [1.36-5.99],0.0057053546677795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,1746,45,1.81 [0.62-5.27],0.2776645358974359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,1710,44,3.49 [1.86-6.54],9.464268337068306e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,1690,45,2.65 [1.51-4.63],0.0006470951764508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,1456,33,2.78 [1.41-5.46],0.0030359804689674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,1720,44,1.25 [0.71-2.18],0.4383935432262417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,1512,35,2.02 [1.01-4.06],0.0476251237352425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,1458,35,1.15 [0.32-4.16],0.8270463911570187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,1507,35,1.60 [0.76-3.37],0.2123221070408573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,1660,44,1.13 [0.57-2.23],0.7299680235541611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADD1,Alpha-adducin,1477,35,0.91 [0.57-1.46],0.6909241084635489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,1698,44,6.25 [2.97-13.14],1.3393388652345605e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,1477,35,2.16 [1.09-4.27],0.027031501663398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,1500,35,1.91 [1.15-3.16],0.0119916020396556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,1724,43,9.72 [4.59-20.62],2.997810252968394e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,1742,45,5.69 [3.40-9.50],3.3829593267180926e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,1507,35,3.27 [0.99-10.79],0.0518330149705881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,1710,44,1.19 [0.92-1.53],0.1843268249754682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,1721,43,0.51 [0.20-1.31],0.1642196202814897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,1452,32,0.82 [0.44-1.51],0.5271953991394287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,1477,35,0.65 [0.44-0.96],0.0320047832363653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,1690,45,0.64 [0.47-0.86],0.0030189261618171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADIPOQ,Adiponectin,1517,35,1.36 [0.89-2.08],0.1543199210268213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADM,Pro-adrenomedullin,1739,45,11.58 [5.10-26.29],4.740457569299984e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,1460,32,0.91 [0.54-1.52],0.7218783022737447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFAP1,Actin filament-associated protein 1,1477,35,1.33 [0.94-1.88],0.1088282497462175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFM,Afamin,1517,35,0.34 [0.11-1.00],0.0499369257989242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFP,Alpha-fetoprotein,1697,44,0.55 [0.35-0.86],0.0090635713728417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,1452,32,0.93 [0.65-1.34],0.7042730335451605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,1715,43,3.02 [1.77-5.17],5.380919123650574e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,1648,43,1.78 [1.37-2.32],1.8503105379372253e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR3,Anterior gradient protein 3,1658,44,1.44 [0.93-2.21],0.0990724161031972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRN,Agrin,1724,43,3.58 [2.38-5.36],7.499999731786703e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRP,Agouti-related protein,1746,44,2.59 [1.58-4.26],0.0001666506241963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGT,Angiotensinogen,1512,35,1.04 [0.26-4.19],0.9549042714938156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGXT,Serine--pyruvate aminotransferase,1721,43,0.90 [0.65-1.24],0.5244207463704739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHCY,Adenosylhomocysteinase,1721,43,1.33 [0.91-1.94],0.1445328259015126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,1458,35,2.72 [1.33-5.59],0.0062842906203824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK2,Protein AHNAK2,1458,35,2.75 [1.15-6.55],0.0225337727189686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,1503,36,0.93 [0.56-1.53],0.7767437889488988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,1512,35,0.76 [0.28-2.04],0.5839840050590178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,1724,44,0.87 [0.64-1.18],0.3583795882033415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",1465,33,0.93 [0.61-1.41],0.718975629045086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1,Allograft inflammatory factor 1,1660,44,1.78 [1.17-2.71],0.0075381880632182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,1458,35,1.47 [0.90-2.41],0.1269957488924032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",1706,44,1.28 [1.00-1.63],0.0509564223054255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK1,Adenylate kinase isoenzyme 1,1721,43,0.93 [0.61-1.42],0.7458740117972094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",1493,34,1.20 [0.88-1.63],0.25038676902404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKAP12,A-kinase anchor protein 12,1477,35,2.11 [0.48-9.25],0.3236252405706816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,1660,44,1.38 [1.00-1.90],0.0470094810504498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,1465,33,1.09 [0.75-1.58],0.667886942145304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,1690,45,1.73 [1.22-2.46],0.0021972071148217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,1456,33,1.04 [0.67-1.61],0.8733163764668842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,1660,43,1.13 [0.76-1.67],0.5394122727709846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,1509,36,1.06 [0.83-1.36],0.625271063141839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,1647,44,1.47 [0.94-2.29],0.0876299000135183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALCAM,CD166 antigen,1746,45,13.82 [4.61-41.47],2.7911419599826545e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,1728,44,0.53 [0.33-0.84],0.0072167526923908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",1503,36,1.06 [0.62-1.80],0.8342232896525761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",1716,43,0.96 [0.69-1.33],0.7906143918449888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",1509,36,1.51 [0.84-2.70],0.1664722333299088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALMS1,Alstrom syndrome protein 1,1481,36,1.55 [0.89-2.72],0.1237292650398433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,1456,33,1.20 [0.93-1.54],0.1640961980433155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPP,"Alkaline phosphatase, placental type",1710,44,1.23 [0.96-1.57],0.0997564278444185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBN,Ameloblastin,1682,42,0.54 [0.16-1.85],0.3255921166058754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,1736,45,30.90 [12.07-79.12],8.59196949196572e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,1512,35,0.68 [0.19-2.38],0.5464575217025713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,1660,43,1.53 [1.08-2.16],0.0159052814639539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO1,Amphoterin-induced protein 1,1465,33,0.76 [0.35-1.64],0.4834079024725608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO2,Amphoterin-induced protein 2,1710,44,6.77 [2.13-21.50],0.0011776779717717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMN,Protein amnionless,1682,42,1.64 [0.95-2.83],0.0779697343951256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOT,Angiomotin,1477,35,1.06 [0.49-2.31],0.8859310185036493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOTL2,Angiomotin-like protein 2,1498,34,1.19 [0.72-1.96],0.4922407803981085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMPD3,AMP deaminase 3,1493,34,1.10 [0.70-1.72],0.6759949171553772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,1408,32,1.20 [0.69-2.09],0.5242162688895595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2A,Pancreatic alpha-amylase,1650,45,1.42 [0.86-2.35],0.1735597902592051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2B,Alpha-amylase 2B,1600,43,1.40 [0.84-2.33],0.1920215119951767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANG,Angiogenin,1728,45,3.23 [1.80-5.78],8.348357393823709e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT1,Angiopoietin-1,1710,42,1.28 [0.92-1.79],0.141280321585912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT2,Angiopoietin-2,1739,45,3.95 [2.27-6.90],1.3140056595901534e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,1694,41,3.12 [1.29-7.54],0.0114977012639978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,1717,43,1.49 [0.80-2.76],0.2045802161906748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,1730,45,1.31 [0.65-2.65],0.4527804286342006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,1722,43,3.99 [2.28-6.96],1.2128501497154057e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,1739,45,2.65 [1.57-4.45],0.0002397521130536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANK2,Ankyrin-2,1460,32,0.58 [0.28-1.21],0.1462210226533248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,1456,33,1.32 [0.91-1.92],0.1386698665670348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,1448,34,0.99 [0.57-1.71],0.9655932715773048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,1660,44,1.24 [0.85-1.81],0.2589274649540999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,1458,35,0.40 [0.11-1.41],0.1542410658716516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANPEP,Aminopeptidase N,1730,45,1.33 [0.56-3.14],0.5192106956680693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA1,Annexin A1,1469,35,1.32 [0.80-2.19],0.282083010776363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA10,Annexin A10,1660,43,1.34 [1.01-1.78],0.0425096680789148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA11,Annexin A11,1718,43,1.05 [0.69-1.58],0.8279623623778254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA2,Annexin A2,1440,35,1.54 [1.05-2.27],0.0283309705122696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA3,Annexin A3,1729,44,1.51 [1.06-2.14],0.0218617741686212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA4,Annexin A4,1711,43,1.18 [0.83-1.66],0.3578614331757175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA5,Annexin A5,1653,43,4.70 [2.31-9.56],2.0246506577711608e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],1682,42,0.66 [0.35-1.24],0.1921386407657546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC3,Membrane primary amine oxidase,1733,45,9.06 [4.37-18.78],3.1779011871364795e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,1503,36,1.25 [0.87-1.80],0.2228729433023607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP2B1,AP-2 complex subunit beta,1465,33,1.42 [0.80-2.54],0.2348478277935477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3B1,AP-3 complex subunit beta-1,1500,35,1.45 [0.98-2.14],0.0645166913355211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,1493,34,1.99 [1.15-3.44],0.0133397862568325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,1710,44,2.14 [1.41-3.25],0.0003481390350457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APCS,Serum amyloid P-component,1502,35,0.36 [0.16-0.82],0.0146893657145062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,1735,45,1.72 [1.19-2.48],0.0035448488513313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APLP1,Amyloid-like protein 1,1721,43,0.84 [0.50-1.39],0.4914756990667501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA1,Apolipoprotein A-I,1517,35,0.50 [0.12-2.06],0.3370163884360446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA2,Apolipoprotein A-II,1512,35,2.52 [1.40-4.53],0.001970470601669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA4,Apolipoprotein A-IV,1517,35,3.83 [2.19-6.70],2.581495256578908e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOB,Apolipoprotein B-100,1512,35,0.89 [0.22-3.56],0.8643275550572806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOBR,Apolipoprotein B receptor,1458,35,1.37 [0.61-3.11],0.4492693922884839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOC1,Apolipoprotein C-I,1512,35,0.40 [0.17-0.94],0.034475873395907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOD,Apolipoprotein D,1465,33,0.53 [0.19-1.48],0.2249907053599996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOE,Apolipoprotein E,1517,35,1.12 [0.67-1.87],0.6559427583688398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOF,Apolipoprotein F,1512,35,0.87 [0.45-1.71],0.6904371732604857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOH,Beta-2-glycoprotein 1,1728,44,1.53 [0.76-3.10],0.2343737876905683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOL1,Apolipoprotein L1,1512,35,0.54 [0.29-0.99],0.0462981663785878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOM,Apolipoprotein M,1733,45,0.60 [0.24-1.50],0.2738586669204066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APP,Amyloid-beta precursor protein,1728,44,1.43 [0.97-2.11],0.0691926372800498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APPL2,DCC-interacting protein 13-beta,1477,35,1.05 [0.79-1.39],0.7239289182439171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APRT,Adenine phosphoribosyltransferase,1703,44,0.95 [0.55-1.64],0.8547821957587615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,1481,36,1.28 [0.84-1.94],0.2537914907451192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AREG,Amphiregulin,1710,44,3.07 [2.08-4.55],2.1359158619871724e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARF6,ADP-ribosylation factor 6,1500,35,1.06 [0.79-1.42],0.6922210039338922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARFIP1,Arfaptin-1,1509,36,1.27 [0.83-1.96],0.2687337862699831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG1,Arginase-1,1719,45,0.55 [0.33-0.91],0.0194556734818476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG2,"Arginase-2, mitochondrial",1503,36,1.14 [0.56-2.34],0.7133105568831672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,1660,44,1.24 [0.70-2.20],0.456155867783016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,1660,44,1.47 [1.04-2.07],0.0285217723865524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,1481,36,1.46 [0.81-2.63],0.213014787528856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,1477,35,1.12 [0.77-1.64],0.5482562959012642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,1448,34,1.02 [0.65-1.59],0.9414850413632392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,1493,34,1.40 [0.96-2.04],0.0805793086333634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,1509,36,1.23 [0.90-1.69],0.1918316569820969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,1720,43,1.13 [0.88-1.46],0.3335137556961737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,1452,32,1.10 [0.71-1.72],0.6714796724747204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,1452,32,1.31 [0.59-2.90],0.5004023945197166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,1660,43,0.97 [0.50-1.88],0.9222577550119028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,1460,32,1.56 [1.01-2.41],0.0470017630153418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,1460,32,1.90 [0.91-3.98],0.0885001649977378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,1452,32,0.88 [0.48-1.63],0.6884931676733286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,1682,42,1.09 [0.58-2.03],0.7891010402019677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,1460,32,0.54 [0.19-1.50],0.2350483951819397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSA,Arylsulfatase A,1728,44,1.27 [0.74-2.16],0.3807566896453689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSB,Arylsulfatase B,1710,44,1.40 [0.89-2.18],0.1417384103006378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,1733,45,5.49 [3.42-8.80],1.5253954920331729e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,1452,32,1.40 [0.96-2.04],0.0765452580477707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARTN,Artemin,1682,42,0.99 [0.52-1.87],0.9761043324910412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH1,Acid ceramidase,1504,35,1.48 [0.79-2.77],0.218449359189272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH2,Neutral ceramidase,1704,44,0.82 [0.53-1.27],0.3671100602742376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,1704,44,4.30 [2.58-7.17],2.1332918748400858e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,1512,35,6.43 [2.63-15.72],4.502515633192825e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPN,Asporin,1507,35,2.90 [1.30-6.43],0.009001764133183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,1509,36,1.31 [0.83-2.07],0.2437461264684372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,1458,35,1.17 [0.85-1.62],0.3334126457760142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASS1,Argininosuccinate synthase,1460,32,0.97 [0.65-1.43],0.8609018277252242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,1660,43,1.16 [0.83-1.63],0.3936957229613065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,1448,34,0.45 [0.14-1.44],0.1778794251615676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG16L1,Autophagy-related protein 16-1,1500,35,1.42 [0.98-2.04],0.0611857917997544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG4A,Cysteine protease ATG4A,1660,44,1.18 [0.77-1.81],0.4398007108345034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATOX1,Copper transport protein ATOX1,1720,44,1.52 [1.03-2.24],0.0368028967207993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,1460,32,1.17 [0.57-2.39],0.6673729519290661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,1460,32,1.21 [0.50-2.92],0.6705409003315816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,1460,32,1.21 [0.53-2.76],0.6544656760178298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B4,Protein ATP1B4,1448,34,0.73 [0.31-1.76],0.487631799065777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,1460,32,0.88 [0.49-1.60],0.6839187367263257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",1460,32,0.86 [0.40-1.83],0.6936257200652849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",1724,43,1.30 [1.01-1.67],0.0425281489377504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",1660,43,1.39 [0.84-2.29],0.2042653395762784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6AP2,Renin receptor,1660,44,1.82 [1.13-2.94],0.0142109608736411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,1710,44,1.97 [0.97-3.99],0.0602975206211505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,1654,43,0.92 [0.61-1.40],0.7104999687039426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,1458,35,1.25 [0.82-1.92],0.3057713500736305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,1460,32,0.87 [0.59-1.29],0.4891718871257803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,1500,35,4.01 [2.39-6.73],1.3624658253153126e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRN,"Attractin, Isoform 2",1517,35,1.78 [0.27-11.93],0.5500036315415463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN10,Ataxin-10,1660,43,1.46 [1.01-2.13],0.045771269338754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2,Ataxin-2,1452,32,0.94 [0.67-1.31],0.706704109070585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2L,Ataxin-2-like protein,1509,36,1.13 [0.65-1.98],0.6678608960144092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN3,Ataxin-3,1493,34,1.09 [0.64-1.84],0.7495063290750305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXIN1,Axin-1,1720,43,1.17 [0.89-1.54],0.2565707853810806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,1733,45,5.35 [2.35-12.17],6.423149477843838e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZI2,5-azacytidine-induced protein 2,1509,36,1.81 [1.13-2.90],0.0138616461792075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZU1,Azurocidin,1679,43,1.16 [0.87-1.54],0.3039763395226462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B2M,Beta-2-microglobulin,1517,35,4.17 [2.33-7.46],1.5853549529458912e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,1460,32,0.49 [0.08-3.15],0.4521557243422387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1458,35,6.15 [2.54-14.86],5.47217530364206e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",1724,43,10.57 [5.46-20.44],2.461204946275809e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",1728,44,5.53 [1.85-16.54],0.0022221098080869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,1456,33,0.75 [0.22-2.64],0.6601063260988225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BACH1,Transcription regulator protein BACH1,1720,43,1.11 [0.78-1.59],0.5594010513266221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,1698,44,1.88 [1.05-3.38],0.0334523580541927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,1456,33,1.98 [1.19-3.30],0.0085108380811889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG6,Large proline-rich protein BAG6,1690,45,2.24 [1.17-4.28],0.0147603076506416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,1660,44,1.43 [1.03-1.99],0.0332538822299375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,1660,44,2.76 [1.83-4.16],1.2672640307076042e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,1720,43,1.13 [0.88-1.46],0.3344401699496876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAP18,Chromatin complexes subunit BAP18,1493,34,1.38 [1.01-1.90],0.0432901294480857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,1465,33,0.82 [0.49-1.39],0.4689405704677467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAX,Apoptosis regulator BAX,1658,43,1.42 [1.07-1.88],0.0144291897470928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAM,Basal cell adhesion molecule,1728,44,7.09 [2.61-19.29],0.0001253221993178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAN,Brevican core protein,1704,44,0.94 [0.45-1.96],0.875159672555831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",1507,35,1.32 [0.58-2.99],0.508816162019981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",1452,32,0.39 [0.15-0.99],0.0473221813586642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCHE,Cholinesterase,1487,34,0.99 [0.34-2.87],0.9803925530389584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2,Apoptosis regulator Bcl-2,1500,35,2.08 [1.49-2.89],1.379015766526173e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L1,Bcl-2-like protein 1,1493,34,1.05 [0.76-1.44],0.7800422122094538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",1720,43,6.63 [2.80-15.72],1.7030796999445154e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L15,Bcl-2-like protein 15,1456,33,1.59 [1.11-2.27],0.0119793938474155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,1448,34,0.73 [0.42-1.28],0.275528532843895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,1503,36,0.88 [0.42-1.82],0.7265388568039703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCR,Breakpoint cluster region protein,1720,43,1.12 [0.85-1.49],0.4235571502235244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BDNF,Brain-derived neurotrophic factor,1512,35,1.50 [0.99-2.26],0.0540862522413367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BECN1,Beclin-1,1458,35,1.42 [0.87-2.31],0.1556726656209081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BEX3,Protein BEX3,1448,34,0.87 [0.42-1.81],0.7065093325860416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGLAP,Osteocalcin,1512,35,1.02 [0.75-1.38],0.9095664529134142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGN,Biglycan,1657,44,0.76 [0.59-0.98],0.0337527315172343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,1452,32,0.71 [0.40-1.27],0.2444017172543929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,1460,32,0.85 [0.21-3.49],0.8200922598664865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BID,BH3-interacting domain death agonist,1720,43,1.16 [0.80-1.69],0.4261647681744274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIN2,Bridging integrator 2,1728,44,1.20 [0.90-1.61],0.2186506514268479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,1660,44,1.48 [1.00-2.18],0.050677809202174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLMH,Bleomycin hydrolase,1746,45,1.47 [0.64-3.37],0.3624114541422086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLNK,B-cell linker protein,1456,33,1.22 [0.66-2.25],0.5242373635802438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,1452,32,0.96 [0.60-1.52],0.8497779996205151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,1493,34,1.63 [0.83-3.23],0.1586159721729124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLVRB,Flavin reductase,1728,44,0.83 [0.55-1.25],0.3622698095249487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP10,Bone morphogenetic protein 10,1477,35,15.79 [4.87-51.21],4.263683044436853e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP4,Bone morphogenetic protein 4,1698,44,1.68 [1.08-2.63],0.0218141328864918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP6,Bone morphogenetic protein 6,1689,45,3.13 [1.68-5.84],0.0003356711343236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,1477,35,14.12 [4.38-45.57],9.460943646281067e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,1507,35,0.95 [0.37-2.47],0.9173636792408087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,1456,33,1.86 [1.09-3.17],0.0228138628826264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOC,Brother of CDO,1690,45,11.43 [3.76-34.78],1.7797070208779995e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA1,BolA-like protein 1,1452,32,1.51 [0.97-2.35],0.069904074638233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,1458,35,0.89 [0.49-1.60],0.6958034381111426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFA2,BPI fold-containing family A member 2,1420,35,1.15 [0.87-1.50],0.3252816649186214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB1,BPI fold-containing family B member 1,1723,45,0.91 [0.62-1.33],0.6177763779108487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB2,BPI fold-containing family B member 2,1506,35,1.15 [0.78-1.70],0.4715104218527323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRAP,BRCA1-associated protein,1483,35,1.28 [0.95-1.74],0.1063668306328533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD1,Bromodomain-containing protein 1,1481,36,0.40 [0.11-1.45],0.1647756520141856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD2,Bromodomain-containing protein 2,1452,32,0.33 [0.09-1.16],0.0838622449506513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD3,Bromodomain-containing protein 3,1460,32,1.11 [0.54-2.30],0.7781657149622804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRDT,Bromodomain testis-specific protein,1460,32,1.87 [0.79-4.43],0.1538681830495492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRK1,Protein BRICK1,1660,43,1.72 [1.02-2.93],0.0438244915233929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,1452,32,0.92 [0.36-2.34],0.8613157944430341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,1509,36,1.54 [0.74-3.19],0.2451256681457866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,1743,44,17.36 [8.38-35.98],1.5867854592855105e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSND,Barttin,1448,34,0.71 [0.23-2.17],0.5478732825583765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,1732,44,1.42 [0.69-2.91],0.3360775876097822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST2,Bone marrow stromal antigen 2,1732,44,1.61 [1.13-2.28],0.0080494684915129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTC,Probetacellulin,1660,44,1.47 [1.12-1.91],0.0048844009999831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTD,Biotinidase,1517,35,1.18 [0.27-5.23],0.8264628305583508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTLA,B- and T-lymphocyte attenuator,1448,34,0.97 [0.65-1.45],0.8772338936439616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,1500,36,1.08 [0.56-2.09],0.8095546274114334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,1724,43,11.38 [6.53-19.82],9.294898395865493e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,1720,43,6.78 [3.81-12.05],7.129789704112808e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTNL10,Butyrophilin-like protein 10,1448,34,1.61 [0.86-3.03],0.1396127573752171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C19orf12,Protein C19orf12,1660,43,0.67 [0.45-0.99],0.0455535564166512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,1460,32,1.31 [0.43-4.04],0.6362711691216175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,1735,44,5.57 [1.83-16.96],0.0024865304048736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",1509,36,1.26 [0.84-1.87],0.2629753089501214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QL2,Complement C1q-like protein 2,1456,33,0.85 [0.39-1.85],0.6740274278777746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,1733,45,3.66 [2.32-5.77],2.5215468845840588e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,1477,35,2.86 [1.23-6.62],0.0144367690810283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,1509,36,1.18 [0.45-3.05],0.7392752888464688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,1474,35,2.47 [1.18-5.14],0.0159037646547272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1R,Complement C1r subcomponent,1517,35,0.32 [0.04-2.28],0.2532258231539654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1RL,Complement C1r subcomponent-like protein,1513,35,1.67 [0.34-8.18],0.5263863211313068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1S,Complement C1s subcomponent,1517,35,0.85 [0.22-3.23],0.8109136367651866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2,Complement C2,1733,45,7.01 [2.01-24.49],0.002275326794785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,1654,43,1.76 [0.97-3.20],0.0640940420934748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2orf69,UPF0565 protein C2orf69,1465,33,1.58 [1.06-2.35],0.026109329326872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C3,Complement C3,1436,35,1.01 [0.49-2.10],0.97885430598713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C4BPB,C4b-binding protein beta chain,1720,44,1.91 [1.01-3.62],0.0465530386066634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C5,Complement C5,1517,35,5.89 [1.25-27.68],0.0248141121107508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7,Complement component C7,1479,35,4.35 [1.86-10.16],0.000684746961316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7orf50,Uncharacterized protein C7orf50,1493,34,1.59 [0.71-3.59],0.2602883911861369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C8B,Complement component C8 beta chain,1517,35,0.48 [0.18-1.24],0.1291296051419899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9,Complement component C9,1512,35,0.87 [0.53-1.43],0.5783244450997456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9orf40,Uncharacterized protein C9orf40,1500,35,0.71 [0.47-1.07],0.1010061696247166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA1,Carbonic anhydrase 1,1697,44,0.64 [0.41-0.99],0.0458683572755339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA11,Carbonic anhydrase-related protein 11,1660,44,1.70 [1.10-2.64],0.0169738791989818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,1710,44,4.37 [3.18-6.01],1.0405280923205704e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA13,Carbonic anhydrase 13,1702,42,1.15 [0.88-1.49],0.3051367336729251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,1739,45,4.25 [2.54-7.11],3.772655883306928e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA2,Carbonic anhydrase 2,1722,44,0.80 [0.54-1.17],0.2435892484401833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA3,Carbonic anhydrase 3,1743,45,1.22 [0.83-1.80],0.3163775822681759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,1746,45,14.20 [5.64-35.77],1.8097625686339426e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",1690,45,1.20 [0.96-1.50],0.1149475209368676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA6,Carbonic anhydrase 6,1721,43,0.81 [0.54-1.23],0.3240478369127227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA7,Carbonic anhydrase 7,1481,36,0.37 [0.11-1.22],0.1029796700858825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA8,Carbonic anhydrase-related protein,1456,33,1.10 [0.34-3.53],0.8720678540185974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA9,Carbonic anhydrase 9,1739,45,3.13 [2.24-4.38],2.790288866876798e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CABP2,Calcium-binding protein 2,1465,33,1.15 [0.72-1.86],0.5580730625707764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,1452,32,0.54 [0.16-1.89],0.338870146931526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,1460,32,1.12 [0.66-1.90],0.678866101390883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,1452,32,0.90 [0.50-1.60],0.7160362674311551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,1509,36,1.30 [0.91-1.85],0.1493655343218732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACYBP,Calcyclin-binding protein,1473,34,1.12 [0.82-1.54],0.4702539466995855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CADPS,Calcium-dependent secretion activator 1,1465,33,1.18 [0.58-2.38],0.6529637107082167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB1,Calbindin,1710,44,4.35 [2.61-7.25],1.828377338609326e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB2,Calretinin,1660,43,6.20 [2.65-14.50],2.549663633020835e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCA,Calcitonin,1698,44,1.87 [1.38-2.55],6.686645397707145e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,1493,34,2.16 [1.39-3.36],0.000578037125096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,1732,45,1.15 [0.90-1.48],0.2647051877347743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,1458,35,1.51 [1.02-2.23],0.0373681979360254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,1460,32,0.46 [0.13-1.55],0.2095063988026384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,1660,44,1.99 [1.20-3.30],0.007848615291782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,1465,33,1.25 [0.73-2.15],0.4162094968103211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,1509,36,1.22 [0.92-1.61],0.1772993492392815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,1713,43,21.67 [6.40-73.38],7.693925310730607e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPG,Macrophage-capping protein,1712,45,1.89 [1.37-2.62],0.0001212312827743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPN3,Calpain-3,1503,36,0.81 [0.34-1.91],0.6218768093787632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPS,Calcyphosin,1493,34,1.09 [0.79-1.51],0.5905043397573043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,1660,43,0.92 [0.54-1.57],0.763078978299052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASC3,Protein CASC3,1465,33,1.70 [0.95-3.04],0.0745439362970624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP1,Caspase-1,1660,43,1.15 [0.82-1.62],0.4163980103734551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP10,Caspase-10,1660,43,1.30 [0.90-1.86],0.1593513128214994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP2,Caspase-2,1720,43,1.13 [0.78-1.63],0.5247390346065199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP3,Caspase-3,1746,45,1.21 [0.90-1.63],0.2041666972659673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP4,Caspase-4,1481,36,0.88 [0.71-1.10],0.2519932302938402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP7,Caspase-7,1493,34,1.15 [0.79-1.68],0.4757664819154108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP8,Caspase-8,1733,45,1.46 [1.01-2.11],0.0453467502843065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP9,Caspase-9,1456,33,1.28 [0.82-1.99],0.2783126935811379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASQ2,Calsequestrin-2,1460,32,0.92 [0.41-2.06],0.8367991134195107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAT,Catalase,1491,34,0.71 [0.39-1.30],0.2684633860587052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,1721,43,2.13 [1.61-2.81],9.316613753711134e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN1,Cerebellin-1,1452,32,0.87 [0.55-1.36],0.5384903806511572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN4,Cerebellin-4,1739,45,0.47 [0.23-0.94],0.0327100191734557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBS,Cystathionine beta-synthase,1458,35,0.85 [0.47-1.52],0.5805126710216417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBX2,Chromobox protein homolog 2,1460,32,0.74 [0.26-2.13],0.5802060480079194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,1704,44,1.47 [1.05-2.05],0.0232542114803682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,1493,34,1.24 [0.78-1.96],0.3664542588324905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,1503,36,1.43 [0.78-2.63],0.2480184343413345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,1465,33,1.17 [0.35-3.85],0.8009481646853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,1509,36,1.30 [1.00-1.71],0.0537806001798187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,1721,43,7.44 [3.71-14.90],1.5373213183072582e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,1458,35,1.69 [1.13-2.53],0.0099787332164597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL11,Eotaxin,1746,44,3.10 [1.78-5.38],5.971701943249474e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL13,C-C motif chemokine 13,1742,44,1.55 [1.07-2.26],0.0218522531917455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL14,C-C motif chemokine 14,1728,45,3.32 [2.11-5.22],2.0117600980349893e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL15,C-C motif chemokine 15,1746,45,3.49 [2.30-5.31],5.2129528148563995e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL16,C-C motif chemokine 16,1746,45,2.11 [1.37-3.27],0.0007567079020642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL17,C-C motif chemokine 17,1717,43,1.36 [1.02-1.81],0.0372022607730073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL18,C-C motif chemokine 18,1712,45,1.28 [0.97-1.68],0.0758272456032248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL19,C-C motif chemokine 19,1732,44,1.07 [0.88-1.30],0.4817194678578554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL2,C-C motif chemokine 2,1698,44,1.85 [1.13-3.01],0.0138041236153007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL20,C-C motif chemokine 20,1746,44,1.29 [1.02-1.64],0.0323907102489122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL21,C-C motif chemokine 21,1724,43,1.68 [1.10-2.57],0.0159078694495988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL22,C-C motif chemokine 22,1705,43,1.73 [1.10-2.74],0.0179187140836962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL23,C-C motif chemokine 23,1724,43,2.83 [1.57-5.11],0.0005519291723266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL24,C-C motif chemokine 24,1722,43,1.11 [0.80-1.52],0.5425656154271626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL25,C-C motif chemokine 25,1746,44,1.93 [1.19-3.11],0.0073085324515811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL26,C-C motif chemokine 26,1720,43,1.16 [0.93-1.44],0.1853679016005119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL27,C-C motif chemokine 27,1721,43,1.75 [1.15-2.66],0.0095582328506064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL28,C-C motif chemokine 28,1714,43,1.25 [0.83-1.87],0.2807457947878127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL3,C-C motif chemokine 3,1720,43,1.16 [0.94-1.43],0.175446353425517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL4,C-C motif chemokine 4,1722,43,1.03 [0.67-1.58],0.9063390559962986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL5,C-C motif chemokine 5,1733,45,1.21 [0.95-1.54],0.116830920015035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL7,C-C motif chemokine 7,1720,43,1.42 [0.95-2.13],0.083101360800475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL8,C-C motif chemokine 8,1736,45,2.59 [1.73-3.88],3.53666629772374e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN1,CCN family member 1,1707,44,2.24 [1.48-3.39],0.0001271346885817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN2,CCN family member 2,1717,43,1.97 [1.24-3.13],0.0042276502294609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,1739,45,6.75 [4.13-11.04],2.9069462887123475e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,1739,45,4.83 [3.10-7.54],3.985120387315067e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN5,CCN family member 5,1728,44,4.11 [2.40-7.04],2.510503724873157e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCND2,G1/S-specific cyclin-D2,1481,36,1.27 [0.53-3.02],0.5933770646293093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCNE1,G1/S-specific cyclin-E1,1456,33,0.94 [0.62-1.43],0.7781847104030732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,1704,44,0.76 [0.42-1.35],0.3477575048274444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,1660,44,1.25 [0.72-2.16],0.4258822192785539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD101,Immunoglobulin superfamily member 2,1500,35,1.49 [0.63-3.54],0.3639534625475668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD109,CD109 antigen,1728,44,4.09 [1.91-8.75],0.0002823717523673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,1698,44,5.06 [2.97-8.62],2.458582701762045e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,1746,44,3.08 [2.10-4.51],7.406579694322214e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,1733,45,1.69 [0.99-2.89],0.0553466454339609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164,Sialomucin core protein 24,1728,44,1.95 [1.48-2.58],2.7207382540122563e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,1465,33,0.80 [0.31-2.08],0.6473942267941792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD177,CD177 antigen,1725,44,1.12 [0.89-1.41],0.3449186752365387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,1720,44,1.23 [0.43-3.52],0.697686580622868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2,T-cell surface antigen CD2,1460,32,0.97 [0.36-2.56],0.9448497854338176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200,OX-2 membrane glycoprotein,1720,43,14.28 [6.18-33.00],5.001463979440842e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,1713,43,1.76 [0.82-3.80],0.1498945994134625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD207,C-type lectin domain family 4 member K,1683,44,4.52 [2.64-7.74],4.110703924205374e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD209,CD209 antigen,1726,45,1.70 [0.85-3.40],0.1331360820495163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD22,B-cell receptor CD22,1746,44,2.02 [1.16-3.53],0.0134462759547031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD226,CD226 antigen,1456,33,2.44 [1.21-4.92],0.0123146361669806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD244,Natural killer cell receptor 2B4,1746,44,2.28 [0.96-5.43],0.0632674340857502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD248,Endosialin,1512,35,3.29 [1.58-6.87],0.0014768123180619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,1720,44,5.59 [3.81-8.20],1.4918896698115157e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,1704,44,5.03 [2.72-9.30],2.60900588109738e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD276,CD276 antigen,1717,43,5.61 [3.21-9.80],1.3860635009410056e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,1660,44,3.26 [1.81-5.84],7.534120777963075e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2AP,CD2-associated protein,1721,43,1.23 [0.81-1.86],0.3250793064456743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300A,CMRF35-like molecule 8,1477,35,8.05 [3.50-18.49],8.922565490490816e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300C,CMRF35-like molecule 6,1732,44,7.21 [3.79-13.73],1.756058602668514e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,1733,45,5.65 [3.63-8.79],1.7870504824977925e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LF,CMRF35-like molecule 1,1739,45,2.31 [1.46-3.67],0.0003700286436774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,1728,44,8.22 [4.63-14.59],6.322398611585433e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,1710,44,5.83 [3.67-9.28],9.280981981910173e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD33,Myeloid cell surface antigen CD33,1720,44,1.72 [1.14-2.58],0.0093171932465692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,1726,44,6.53 [2.51-16.96],0.0001172847957915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD36,Platelet glycoprotein 4,1456,33,1.63 [0.89-2.96],0.11211879730804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1710,44,4.87 [2.75-8.61],5.110825117692472e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,1452,32,0.84 [0.26-2.75],0.7750102213956426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,1481,36,0.38 [0.11-1.30],0.1224668301910166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,1456,33,0.89 [0.57-1.41],0.6274825728697941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,1718,43,6.05 [3.25-11.24],1.2513364699598081e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,1720,43,2.60 [1.70-3.97],9.522841854063607e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40LG,CD40 ligand,1746,44,1.18 [0.84-1.66],0.3327618863781736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,1721,45,17.14 [8.69-33.82],2.52286673478486e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD48,CD48 antigen,1722,43,10.42 [4.60-23.62],1.967984361089122e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,1736,45,6.38 [4.19-9.70],4.942270498176312e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,1665,39,13.96 [6.70-29.05],1.837523477381953e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD58,Lymphocyte function-associated antigen 3,1714,43,6.97 [1.45-33.55],0.0154309843487385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,1673,44,8.98 [5.25-15.38],1.2377475582101274e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5L,CD5 antigen-like,1509,35,0.97 [0.51-1.83],0.919330541491042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD6,T-cell differentiation antigen CD6,1743,44,1.36 [0.80-2.31],0.2533229303314707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD63,CD63 antigen,1698,44,1.41 [0.81-2.46],0.2202776739080375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD69,Early activation antigen CD69,1715,43,1.15 [0.85-1.56],0.3743809727710412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD7,T-cell antigen CD7,1451,33,3.61 [1.95-6.70],4.660879120431742e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD70,CD70 antigen,1720,43,2.36 [1.44-3.86],0.0006160267536231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD72,B-cell differentiation antigen CD72,1477,35,2.88 [1.78-4.66],1.7398934170687168e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,1732,44,7.62 [4.35-13.35],1.2736846921058109e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,1746,44,4.46 [3.20-6.22],1.3976452027542634e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,1507,35,3.29 [1.59-6.84],0.0013827200265418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD82,CD82 antigen,1481,36,1.40 [0.96-2.05],0.0776593182846552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD83,CD83 antigen,1720,43,6.96 [3.91-12.41],4.5614390279676685e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD84,SLAM family member 5,1720,43,1.50 [0.67-3.40],0.325801044124775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD86,T-lymphocyte activation antigen CD86,1500,35,2.03 [0.74-5.55],0.1682165619815193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,1732,44,1.56 [0.95-2.56],0.0782130462321646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,1662,42,7.11 [3.96-12.77],4.8994640272633586e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,1728,44,25.46 [8.45-76.67],8.640597286281933e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,1728,44,6.57 [2.53-17.08],0.0001110996220031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDA,Cytidine deaminase,1505,35,1.66 [0.98-2.83],0.0617259760469156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDAN1,Codanin-1,1493,34,0.37 [0.10-1.34],0.1289582717480664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC123,Cell division cycle protein 123 homolog,1448,34,0.92 [0.52-1.64],0.7829024838880798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC25A,M-phase inducer phosphatase 1,1448,34,1.21 [0.54-2.73],0.6436188411653878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,1498,34,1.33 [0.86-2.08],0.201755357217823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC27,Cell division cycle protein 27 homolog,1660,44,1.57 [1.06-2.34],0.0258413445702116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,1720,44,1.39 [1.02-1.89],0.037923712167109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,1500,35,1.22 [0.91-1.64],0.1784169332294145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDCP1,CUB domain-containing protein 1,1704,44,1.63 [1.07-2.47],0.0233262309306089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,1669,42,2.86 [2.09-3.92],5.544705581425573e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH15,Cadherin-15,1726,44,1.37 [1.01-1.84],0.0417077861789031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH17,Cadherin-17,1721,43,2.30 [1.68-3.15],2.0038004115157018e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH2,Cadherin-2,1721,43,2.59 [1.33-5.04],0.0052836297336202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH22,Cadherin-22,1481,36,1.00 [0.31-3.22],0.9971742777888044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH23,Cadherin-23,1493,34,1.16 [0.33-4.12],0.8140337056225082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH3,Cadherin-3,1732,44,5.70 [3.32-9.78],2.8087295188098027e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH4,Cadherin-4,1452,32,0.95 [0.44-2.04],0.898572390653631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH5,Cadherin-5,1746,45,3.58 [1.70-7.51],0.0007700016417035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH6,Cadherin-6,1721,43,2.38 [1.31-4.34],0.0045824081634899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR1,Cadherin-related family member 1,1660,43,1.09 [0.58-2.05],0.7867514166779926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR2,Cadherin-related family member 2,1710,44,0.81 [0.57-1.15],0.23453512971329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR5,Cadherin-related family member 5,1721,43,0.65 [0.33-1.26],0.2030216878068007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK1,Cyclin-dependent kinase 1,1448,34,0.81 [0.31-2.13],0.6655049264589631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,1509,36,1.43 [0.91-2.25],0.1221515835577124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,1452,32,0.48 [0.19-1.24],0.1311966366455197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,1710,44,1.42 [1.11-1.81],0.005238726806488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,1710,44,1.29 [0.95-1.74],0.1078915831137569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,1710,44,5.92 [3.42-10.24],2.1247364914011656e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,1719,43,1.93 [0.72-5.23],0.1937148285931444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDSN,Corneodesmosin,1738,44,3.11 [1.96-4.94],1.516477894000627e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,1719,44,1.53 [0.58-4.05],0.3871976846074919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,1500,35,0.88 [0.60-1.29],0.5051705593453215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,1481,36,1.03 [0.71-1.50],0.8773576338007759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,1500,35,2.06 [0.97-4.38],0.0604105901656761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,1481,36,1.33 [0.65-2.74],0.4387217273976217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,1720,43,1.45 [1.10-1.92],0.0093858664145992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,1660,44,1.18 [0.75-1.87],0.4674853483471941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,1641,43,1.85 [1.23-2.79],0.0030834356709568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,1512,35,3.68 [1.80-7.53],0.0003614220136799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,1690,45,2.49 [1.67-3.73],8.138104277285021e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,1456,33,0.65 [0.21-2.07],0.4670563850220461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,1690,45,1.18 [0.64-2.15],0.5953539813275427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,1512,35,0.90 [0.56-1.43],0.6411346889713987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,1744,45,0.98 [0.65-1.46],0.910468491810698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,1477,35,5.68 [2.15-15.02],0.00046774204068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEMIP2,Cell surface hyaluronidase,1456,33,1.70 [0.85-3.40],0.133766842064137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,1452,32,1.49 [1.02-2.17],0.0368265840604304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPF,Centromere protein F,1481,36,0.80 [0.44-1.47],0.4745345054879281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPJ,Centromere protein J,1481,36,1.01 [0.66-1.55],0.9478569373665734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP112,Centrosomal protein of 112 kDa,1460,32,0.90 [0.43-1.91],0.7852262187851263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP152,Centrosomal protein of 152 kDa,1448,34,1.56 [0.84-2.89],0.1609085849511384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP164,Centrosomal protein of 164 kDa,1682,42,1.35 [1.03-1.77],0.0310910064214488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP170,Centrosomal protein of 170 kDa,1458,35,1.13 [0.76-1.69],0.5457173246315921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP20,Centrosomal protein 20,1660,44,1.31 [0.93-1.83],0.1172672247392042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP290,Centrosomal protein of 290 kDa,1481,36,1.07 [0.57-1.98],0.8390299813844271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP350,Centrosome-associated protein 350,1448,34,0.94 [0.35-2.54],0.9032446048573082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP43,Centrosomal protein 43,1678,44,1.48 [1.04-2.09],0.0288320237299431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP85,Centrosomal protein of 85 kDa,1660,44,1.62 [1.12-2.33],0.0105873572542971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CERT,Ceramide transfer protein,1660,43,1.48 [0.96-2.30],0.0767773422693939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES1,Liver carboxylesterase 1,1722,45,0.90 [0.70-1.16],0.4165258613525138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES2,Cocaine esterase,1710,44,1.28 [0.82-2.00],0.2719950533111914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES3,Carboxylesterase 3,1710,44,0.96 [0.67-1.37],0.8242476299526198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN2,Centrin-2,1660,43,1.58 [1.13-2.22],0.0074082774583578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN3,Centrin-3,1500,35,1.36 [0.95-1.97],0.0969660925424973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFB,Complement factor B,1493,35,1.03 [0.38-2.75],0.9569034067658018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFC1,Cryptic protein,1660,44,1.36 [0.81-2.26],0.2419066322360806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFD,Complement factor D,1517,35,2.51 [0.74-8.54],0.1399816235273722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFH,Complement factor H,1432,34,0.70 [0.18-2.70],0.6054481810082166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR2,Complement factor H-related protein 2,1507,34,1.14 [0.63-2.07],0.6669344223395914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR4,Complement factor H-related protein 4,1513,35,0.94 [0.60-1.46],0.7766390531746643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR5,Complement factor H-related protein 5,1487,34,1.49 [0.70-3.21],0.3033332023626804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFI,Complement factor I,1517,35,0.89 [0.20-3.93],0.8830692837196327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFP,Properdin,1517,35,0.18 [0.06-0.58],0.0040298540343281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,1728,44,1.92 [1.49-2.47],5.142891652468609e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,1512,35,1.25 [0.86-1.81],0.2514721932955098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGN,Cingulin,1465,33,0.78 [0.31-1.97],0.6045928060721788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,1721,43,5.54 [3.53-8.70],1.0162522160456625e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,1660,44,1.07 [0.67-1.70],0.7791937372418863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAD,Chondroadherin,1477,35,0.71 [0.40-1.26],0.2463804384986617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1493,34,3.63 [2.22-5.91],2.510037478709017e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,1503,36,2.08 [1.19-3.65],0.0106049034718719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,1690,45,0.70 [0.30-1.64],0.4129291642695966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGA,Chromogranin-A,1512,35,1.62 [1.30-2.04],2.573246362933598e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,1722,44,4.25 [2.62-6.90],4.605699612086252e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,1681,42,1.70 [1.30-2.23],0.000127846239348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHIT1,Chitotriosidase-1,1736,45,1.27 [1.01-1.59],0.0417562673517449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,1731,45,1.68 [0.76-3.74],0.2003085991887828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,1465,33,1.19 [0.69-2.05],0.5262747012587239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,1704,44,1.28 [0.92-1.80],0.1469541872506751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP6,Charged multivesicular body protein 6,1507,35,1.35 [0.78-2.34],0.2849321951494814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHP1,Calcineurin B homologous protein 1,1452,32,0.96 [0.61-1.53],0.8716679825246807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL1,Chordin-like protein 1,1722,43,15.05 [7.75-29.21],1.1153142164877648e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL2,Chordin-like protein 2,1721,43,1.37 [0.86-2.20],0.1857134025039691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,1465,33,0.44 [0.14-1.33],0.1446183974973075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIAPIN1,Anamorsin,1720,44,1.57 [1.03-2.40],0.0380828857163621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,1512,35,6.08 [3.24-11.41],1.940463410865938e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,1481,36,0.84 [0.37-1.91],0.6778175102138828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,1500,35,1.16 [0.83-1.62],0.374485077409875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIT,Citron Rho-interacting kinase,1465,33,1.48 [0.81-2.71],0.2051742792375862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,1741,44,10.99 [6.33-19.07],1.532011756636602e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKB,Creatine kinase B-type,1512,35,2.56 [1.73-3.78],2.368071429024112e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",1715,43,1.22 [0.79-1.86],0.3691885882835924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLASP1,CLIP-associating protein 1,1448,34,1.00 [0.66-1.53],0.9898397371202932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLC,Galectin-10,1717,43,1.60 [1.14-2.24],0.0063923031218903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,1704,44,4.14 [1.99-8.61],0.0001409353019079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,1722,44,1.33 [0.77-2.32],0.3096302443814672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,1456,33,2.38 [0.65-8.76],0.1907743992653712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,1728,44,11.12 [6.14-20.14],1.8765698905295592e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,1690,45,6.08 [3.79-9.75],7.011447769629513e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,1732,44,1.30 [0.99-1.69],0.0557926443800286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,1465,33,1.02 [0.54-1.91],0.9553125242476356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC3B,Tetranectin,1485,35,0.85 [0.19-3.82],0.8371939942662928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,1720,43,2.28 [1.07-4.87],0.0337575235551418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,1720,43,1.02 [0.58-1.77],0.9551134506850862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,1720,43,2.50 [1.71-3.67],2.4947241396252137e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,1720,43,2.04 [0.91-4.55],0.0828555814227772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,1511,35,0.91 [0.46-1.81],0.784462872020993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,1719,43,8.72 [4.57-16.66],5.415788903018927e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,1660,44,2.21 [1.53-3.19],2.4643644234307063e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,1746,44,2.15 [1.33-3.49],0.0018749317996357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLGN,Calmegin,1465,33,2.67 [1.35-5.27],0.0048289143817841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIC5,Chloride intracellular channel protein 5,1465,33,0.86 [0.29-2.58],0.7882670423393296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLINT1,Clathrin interactor 1,1448,34,1.42 [0.74-2.70],0.291274084227315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,1720,43,1.14 [0.90-1.45],0.2682429034627485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,1739,45,22.37 [10.41-48.09],1.699055866646562e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLNS1A,Methylosome subunit pICln,1465,33,0.68 [0.22-2.04],0.4888636333130974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",1698,44,1.38 [1.06-1.79],0.0163536448483789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPS,Colipase,1724,44,1.32 [0.95-1.84],0.0981078703095735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSPN,Claspin,1654,43,1.19 [0.66-2.17],0.5602842820518996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN1,Calsyntenin-1,1660,43,1.03 [0.60-1.76],0.9180060809380054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN2,Calsyntenin-2,1746,44,1.52 [0.87-2.66],0.1403423313348137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN3,Calsyntenin-3,1493,34,3.20 [1.25-8.17],0.0149942667798122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLTA,Clathrin light chain A,1690,45,1.79 [1.05-3.04],0.0332223448982741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLU,Clusterin,1517,35,1.24 [0.44-3.50],0.687468915335567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLUL1,Clusterin-like protein 1,1716,43,1.26 [0.73-2.19],0.4027995290519381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,1507,35,1.11 [0.79-1.55],0.5545842738009125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMIP,C-Maf-inducing protein,1503,36,1.23 [0.86-1.75],0.2535269196109312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,1733,45,0.88 [0.51-1.52],0.6524367440850889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,1452,32,0.63 [0.26-1.55],0.31680099432671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",1457,35,1.17 [0.79-1.75],0.4312519977124543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY2,Protein canopy homolog 2,1690,45,1.36 [0.99-1.87],0.0578112210804447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY4,Protein canopy homolog 4,1710,44,1.50 [1.05-2.14],0.0265842303819081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNST,Consortin,1721,43,1.07 [0.84-1.35],0.6011205888775029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTF,Ciliary neurotrophic factor,1452,32,0.87 [0.32-2.37],0.7913788102297822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN1,Contactin-1,1746,45,6.36 [2.54-15.92],7.895952366884046e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN2,Contactin-2,1739,45,3.02 [1.74-5.25],8.801965316819653e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN3,Contactin-3,1728,44,0.96 [0.43-2.12],0.9177407957184368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN4,Contactin-4,1728,44,3.01 [0.99-9.19],0.0530869053428357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN5,Contactin-5,1719,44,0.62 [0.30-1.26],0.1851933729082673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,1720,43,2.00 [1.10-3.64],0.0227842611804057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,1465,33,1.11 [0.84-1.45],0.4614814607338653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COCH,Cochlin,1507,35,2.51 [1.64-3.82],2.0361302816876067e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,1512,35,2.08 [0.86-5.04],0.1040744877173847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,1735,45,20.75 [8.98-47.94],1.2749030520686738e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL1A1,Collagen alpha-1(I) chain,1746,45,2.93 [1.09-7.86],0.0333554081192024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,1500,35,2.08 [1.15-3.77],0.0157274011868008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,1465,33,1.32 [0.92-1.89],0.1342382186005487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL2A1,Collagen alpha-1(II) chain,1458,35,1.17 [0.80-1.70],0.416998951293306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL3A1,Collagen alpha-1(III) chain,1512,35,3.36 [1.34-8.46],0.0100004547282762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,1721,43,2.96 [1.90-4.61],1.603211242128478e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,1475,36,0.65 [0.37-1.15],0.1364643421464358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL5A1,Collagen alpha-1(V) chain,1477,35,1.65 [1.17-2.34],0.0047516962505903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,1746,45,6.68 [4.27-10.46],9.602893002631968e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,1720,43,1.97 [1.27-3.06],0.0026197296984048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,1481,36,1.52 [0.94-2.46],0.085800799487326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,1717,43,12.40 [6.44-23.86],4.8611904850712774e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD1,COMM domain-containing protein 1,1458,35,1.52 [0.92-2.50],0.098473322570845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD9,COMM domain-containing protein 9,1503,36,1.10 [0.54-2.24],0.7983970856226346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMP,Cartilage oligomeric matrix protein,1717,45,1.20 [0.56-2.57],0.6348687099434819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMT,Catechol O-methyltransferase,1671,44,1.16 [0.84-1.60],0.3673020273521894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPB2,Coatomer subunit beta',1460,32,1.66 [0.86-3.21],0.1277522942889482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPE,Coatomer subunit epsilon,1660,43,1.33 [0.84-2.09],0.2196984690696512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",1458,35,1.46 [0.80-2.67],0.2170225530075629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO1A,Coronin-1A,1692,44,1.24 [0.95-1.63],0.1182722811242056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO6,Coronin-6,1452,32,1.55 [0.92-2.60],0.0965426709961369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",1710,44,1.76 [1.24-2.48],0.001400742398805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,1507,35,1.53 [0.65-3.61],0.3323194932173983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA1,Carboxypeptidase A1,1746,45,0.82 [0.57-1.19],0.3078000738964871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA2,Carboxypeptidase A2,1724,44,1.24 [0.90-1.72],0.1916930484908582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA4,Carboxypeptidase A4,1447,33,2.23 [1.05-4.72],0.0361648973071693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB1,Carboxypeptidase B,1746,45,0.96 [0.65-1.42],0.8220526957403268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB2,Carboxypeptidase B2,1512,35,0.88 [0.23-3.35],0.8557500505391423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPE,Carboxypeptidase E,1728,45,2.11 [0.97-4.55],0.0580447958192339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPLX2,Complexin-2,1448,34,1.33 [0.58-3.06],0.5024285402724797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPM,Carboxypeptidase M,1722,44,0.95 [0.49-1.87],0.8873715173039288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",1456,33,1.27 [0.39-4.17],0.6960334642439951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,1732,44,1.04 [0.70-1.54],0.8540211277288919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPQ,Carboxypeptidase Q,1511,35,1.41 [0.62-3.18],0.4084739745724101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,1460,32,2.46 [1.38-4.39],0.0023034548196759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,1736,45,2.29 [1.21-4.33],0.0107217552540937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM1,Probable carboxypeptidase X1,1720,44,1.70 [1.18-2.44],0.0042852544904139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,1507,35,6.20 [2.33-16.49],0.0002589324659576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR1,Complement receptor type 1,1507,35,1.83 [0.76-4.41],0.1787223059752919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR2,Complement receptor type 2,1733,45,2.29 [1.34-3.92],0.0023986184682264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,1660,44,1.25 [0.96-1.64],0.1003527913622065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRADD,Death domain-containing protein CRADD,1698,44,1.26 [0.89-1.80],0.1895706878603962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,1448,34,0.88 [0.44-1.77],0.7257978491829136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,1448,34,0.40 [0.09-1.72],0.2170605660644521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREG1,Protein CREG1,1693,43,0.73 [0.39-1.36],0.3149826179075223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,1477,35,4.07 [1.88-8.79],0.0003598858917166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,1722,43,2.39 [1.69-3.39],9.600669144875847e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRH,Corticoliberin,1656,44,0.83 [0.60-1.15],0.2588407827438525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,1717,43,5.68 [2.25-14.34],0.0002335811968666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,1690,45,0.61 [0.36-1.05],0.0749781414762496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,1724,43,19.71 [7.13-54.49],9.176653989024381e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIP2,Cysteine-rich protein 2,1704,44,3.53 [2.33-5.37],3.267536182454722e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,1739,45,1.04 [0.66-1.65],0.8606865079352594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,1493,35,0.54 [0.19-1.54],0.2476519279831702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRKL,Crk-like protein,1719,43,1.28 [0.98-1.66],0.0670690377718325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,1724,43,8.70 [3.28-23.10],1.4058071701556916e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRNN,Cornulin,1666,44,1.59 [1.11-2.28],0.0110829485014273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAC1,Cartilage acidic protein 1,1746,45,0.60 [0.28-1.31],0.2038124102048372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,1704,44,2.48 [1.52-4.06],0.0002920519125029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAP,Cartilage-associated protein,1465,33,0.98 [0.51-1.88],0.9479470381005484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRX,Cone-rod homeobox protein,1690,45,0.88 [0.65-1.20],0.424111805989554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB1,Beta-crystallin B1,1507,35,1.28 [0.81-2.02],0.2895004580288189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB2,Beta-crystallin B2,1493,34,1.10 [0.80-1.52],0.5511575361773493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYGD,Gamma-crystallin D,1493,34,1.07 [0.78-1.48],0.6823007005751086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYM,Ketimine reductase mu-crystallin,1452,32,0.89 [0.55-1.43],0.6341282606740524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,1458,35,1.04 [0.73-1.48],0.8111172841450673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSDE1,Cold shock domain-containing protein E1,1460,32,1.16 [0.91-1.46],0.2311782311197841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,1724,43,15.21 [7.36-31.41],1.9321166009457361e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,1512,35,1.78 [0.87-3.64],0.1162964573880975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,1460,32,1.53 [0.67-3.49],0.3081207367327565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,1704,44,1.47 [1.04-2.08],0.0311473136644015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,1456,33,0.96 [0.45-2.04],0.9194991022956216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3,Granulocyte colony-stimulating factor,1682,42,0.81 [0.44-1.48],0.4901156732540427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,1456,33,1.52 [0.76-3.06],0.2351683478986107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,1512,35,1.11 [0.36-3.43],0.8504256125984428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK1D,Casein kinase I isoform delta,1456,33,1.46 [0.88-2.41],0.1404551529261369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,1509,36,0.93 [0.46-1.89],0.8442219465103655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,1512,35,9.55 [3.94-23.13],5.835902133613482e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,1452,32,0.96 [0.45-2.04],0.9065513285617056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,1460,32,1.03 [0.74-1.43],0.8691991132610402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST1,Cystatin-SN,1317,30,1.25 [0.88-1.77],0.2086815553292028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,1725,45,7.92 [4.57-13.71],1.467192667871796e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST5,Cystatin-D,1688,43,1.31 [0.81-2.13],0.2737093863772535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST6,Cystatin-M,1675,44,2.92 [1.85-4.62],4.465252468492368e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST7,Cystatin-F,1722,43,1.30 [1.06-1.59],0.0112727974493474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSTB,Cystatin-B,1703,44,2.77 [1.63-4.70],0.000158201307933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,1475,36,0.55 [0.27-1.12],0.0995349940211374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTBS,Di-N-acetylchitobiase,1483,34,0.82 [0.37-1.80],0.6203089086413118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTF1,Cardiotrophin-1,1690,45,1.14 [0.84-1.55],0.38387857899058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,1512,35,9.35 [4.00-21.86],2.4791856188001295e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,1512,35,0.87 [0.27-2.79],0.8176066333325815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTNNA1,Catenin alpha-1,1452,32,0.37 [0.09-1.50],0.1630288535712931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRB1,Chymotrypsinogen B,1728,44,0.92 [0.60-1.39],0.6792563826606481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRC,Chymotrypsin-C,1715,43,0.78 [0.54-1.11],0.1707197859762554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,1493,34,0.64 [0.42-0.96],0.0303852736630043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSB,Cathepsin B,1727,45,1.99 [1.25-3.14],0.003391463913401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSC,Dipeptidyl peptidase 1,1715,43,1.14 [0.64-2.06],0.654869891248076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSD,Cathepsin D,1619,39,1.87 [1.06-3.30],0.0312548922965798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSE,Cathepsin E,1477,35,1.92 [1.12-3.27],0.0170829528169502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSF,Cathepsin F,1720,44,1.78 [0.94-3.34],0.0743818495173474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSH,Pro-cathepsin H,1688,45,1.82 [1.26-2.62],0.0015241102240449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSL,Cathepsin L1,1721,43,7.16 [3.08-16.67],4.9660071040353856e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSO,Cathepsin O,1746,44,4.10 [1.95-8.60],0.0001953879494212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSS,Cathepsin S,1355,37,7.12 [2.29-22.11],0.0006850649564667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSV,Cathepsin L2,1734,45,0.52 [0.28-0.96],0.0352151886393584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSZ,Cathepsin Z,1729,45,5.50 [2.74-11.02],1.577445167178097e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,1465,33,0.74 [0.30-1.83],0.5114198891910609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,1491,35,1.28 [0.88-1.87],0.1967494563340645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CX3CL1,Fractalkine,1704,44,5.91 [3.33-10.50],1.363796519950717e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,1720,43,2.34 [1.53-3.57],8.97458172008296e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL1,Growth-regulated alpha protein,1720,43,1.20 [0.94-1.54],0.1362460238464443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL10,C-X-C motif chemokine 10,1724,43,1.22 [0.84-1.79],0.2938396185637169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL11,C-X-C motif chemokine 11,1732,44,1.38 [1.05-1.82],0.0215906066535648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL12,Stromal cell-derived factor 1,1682,42,1.19 [0.62-2.28],0.6099115218151661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL13,C-X-C motif chemokine 13,1732,44,1.67 [1.14-2.44],0.0084342498264596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL14,C-X-C motif chemokine 14,1682,42,1.31 [0.94-1.83],0.1150228063569851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,1745,45,14.93 [6.75-33.04],2.546122506932273e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL17,C-X-C motif chemokine 17,1746,44,1.85 [1.01-3.40],0.0470511682307714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL3,C-X-C motif chemokine 3,1720,43,1.28 [0.96-1.70],0.0962809788745051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL5,C-X-C motif chemokine 5,1719,43,1.34 [1.07-1.69],0.0115026443996472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL6,C-X-C motif chemokine 6,1746,44,1.71 [1.23-2.39],0.0015120838806147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL8,Interleukin-8,1709,44,1.38 [1.09-1.75],0.007661644149727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,1724,43,1.78 [1.34-2.38],8.57903961010071e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5A,Cytochrome b5,1448,34,1.01 [0.64-1.61],0.9547498987490682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,1476,35,1.61 [1.03-2.53],0.0362205584148258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",1460,32,0.87 [0.53-1.43],0.5726934220293662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTH3,Cytohesin-3,1448,34,1.13 [0.77-1.65],0.5308103848311061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTL1,Cytokine-like protein 1,1512,35,2.75 [1.03-7.34],0.0437262793566591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,1477,35,1.14 [0.78-1.66],0.4999352866317859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAB2,Disabled homolog 2,1739,45,1.26 [0.99-1.61],0.0604791065720463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAG1,Dystroglycan,1724,43,2.30 [1.32-4.00],0.0031516569989148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAND5,DAN domain family member 5,1456,33,0.75 [0.47-1.20],0.2314294729828978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPK2,Death-associated protein kinase 2,1456,33,1.52 [0.99-2.33],0.0563431778271886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,1720,43,1.04 [0.84-1.30],0.7095499717649341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",1698,44,1.24 [0.85-1.81],0.2682224785226517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBH,Dopamine beta-hydroxylase,1510,35,0.94 [0.71-1.25],0.677741050943787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBI,Acyl-CoA-binding protein,1718,43,1.57 [1.12-2.19],0.0080178578463272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBN1,Drebrin,1456,33,1.34 [0.76-2.34],0.3145868404136712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBNL,Drebrin-like protein,1724,43,1.31 [0.98-1.76],0.0726823834677244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1720,44,8.35 [4.26-16.36],6.384421645956951e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCC,Netrin receptor DCC,1465,33,0.29 [0.07-1.21],0.0887323133468753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,1448,34,0.80 [0.45-1.42],0.4446592463262228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCLRE1C,Protein artemis,1448,34,1.67 [0.60-4.61],0.3254208992549471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,1690,45,16.42 [6.55-41.14],2.3516824966082566e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTD,Deoxycytidylate deaminase,1477,35,1.04 [0.75-1.45],0.8033980869567139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN1,Dynactin subunit 1,1739,45,1.41 [0.95-2.09],0.0897317862407803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN2,Dynactin subunit 2,1710,44,1.23 [0.94-1.61],0.1310145535076695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN6,Dynactin subunit 6,1660,43,1.08 [0.75-1.55],0.6801252527122483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,1721,43,4.01 [1.96-8.22],0.0001471063039145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D1,DCN1-like protein 1,1452,32,0.72 [0.40-1.30],0.2747989732250499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D2,DCN1-like protein 2,1448,34,1.09 [0.76-1.57],0.6376280731851595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCXR,L-xylulose reductase,1720,44,0.59 [0.38-0.94],0.0252280083013564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,1460,32,0.89 [0.34-2.30],0.8049528946688832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",1710,44,2.86 [1.76-4.64],2.2027160697974663e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,1721,43,1.35 [0.83-2.18],0.2273118671392904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDHD2,Phospholipase DDHD2,1509,36,1.34 [0.84-2.15],0.21836556170937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDI2,Protein DDI1 homolog 2,1477,35,0.65 [0.42-1.00],0.0483696581120866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,1732,44,11.68 [4.44-30.74],6.474461769057925e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDT,D-dopachrome decarboxylase,1512,35,0.92 [0.44-1.91],0.8276327966517179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,1500,35,1.04 [0.58-1.86],0.8978091007201624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,1465,33,0.68 [0.23-2.02],0.491674468937047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,1456,33,0.98 [0.20-4.93],0.9815749573852944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,1456,33,0.65 [0.29-1.48],0.3057896318262844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,1465,33,0.32 [0.15-0.70],0.0041391505469145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,1660,44,1.49 [1.11-2.00],0.0081624023589227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",1720,43,1.24 [0.94-1.64],0.1292321258795277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,1690,43,1.97 [1.40-2.76],8.39691151607792e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,1449,33,1.22 [0.68-2.19],0.4974987828108126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,1452,32,0.49 [0.21-1.12],0.0919518521147867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB116,Beta-defensin 116,1452,32,0.69 [0.37-1.26],0.2220712697196071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB118,Beta-defensin 118,1452,32,1.25 [0.79-1.98],0.3329915655717724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,1694,43,1.19 [1.00-1.43],0.0565868462942031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENND2B,DENN domain-containing protein 2B,1460,32,0.53 [0.18-1.54],0.2451505609200175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENR,Density-regulated protein,1456,33,1.19 [0.71-2.00],0.5108964935369738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,1746,44,1.43 [0.99-2.05],0.0568533968018828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGCR6,Protein DGCR6,1452,32,1.04 [0.48-2.29],0.91454123189305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKA,Diacylglycerol kinase alpha,1456,33,1.63 [0.96-2.79],0.071752025089252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKZ,Diacylglycerol kinase zeta,1682,42,0.83 [0.37-1.84],0.645903019965171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHODH,Dihydroorotate dehydrogenase,1460,32,1.06 [0.47-2.40],0.8820044601157873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHPS,Deoxyhypusine synthase,1503,36,2.21 [1.27-3.84],0.0047905817246431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,1493,34,1.07 [0.55-2.10],0.8328229386974184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",1719,43,1.12 [0.88-1.42],0.341039389049984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,1465,33,0.89 [0.39-2.04],0.7799871738303223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,1477,35,2.20 [0.97-4.98],0.0597959142229417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK1,Dickkopf-related protein 1,1732,44,1.94 [1.23-3.06],0.0040975607908882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK3,Dickkopf-related protein 3,1746,45,10.56 [4.86-22.93],2.559863851694596e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,1702,44,2.51 [1.71-3.66],2.17379812706972e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKKL1,Dickkopf-like protein 1,1710,44,1.10 [0.79-1.53],0.5646538327043729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLG4,Disks large homolog 4,1493,34,1.27 [0.85-1.91],0.2383544436433035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLGAP5,Disks large-associated protein 5,1509,36,0.96 [0.49-1.87],0.9021636811703402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLK1,Protein delta homolog 1,1746,45,2.28 [1.49-3.48],0.0001318782639264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,1720,44,13.09 [7.27-23.57],9.7525380791083e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL4,Delta-like protein 4,1458,35,0.91 [0.58-1.43],0.6886810387096738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMD,Dystrophin,1458,35,1.68 [1.19-2.35],0.002970979994064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,1458,35,0.65 [0.43-0.96],0.0314789791087511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,1448,34,0.56 [0.22-1.46],0.2376303886780178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,1744,44,1.30 [0.94-1.80],0.1192133807159908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,1493,34,0.88 [0.57-1.37],0.5795306896742247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,1710,44,1.40 [1.03-1.91],0.0317440860229751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,1500,35,1.49 [0.99-2.24],0.0581781045623609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,1477,35,0.94 [0.53-1.70],0.8491223168239069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,1462,34,1.15 [0.80-1.67],0.4429673365466074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,1690,45,1.17 [0.76-1.80],0.4749272605916393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,1493,34,1.21 [0.56-2.61],0.625833962977129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,1458,35,1.13 [0.79-1.63],0.4949025430581135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,1500,35,1.01 [0.66-1.53],0.9747708031227168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,1709,43,0.85 [0.32-2.29],0.7483843566040355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNLZ,DNL-type zinc finger protein,1452,32,1.01 [0.66-1.55],0.9594076182255248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM1,Dynamin-1,1500,35,0.97 [0.74-1.27],0.8296698314209909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM3,Dynamin-3,1509,36,2.05 [1.39-3.05],0.0003407544406153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNMBP,Dynamin-binding protein,1704,44,1.63 [1.15-2.31],0.0055812297383302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPEP,Aspartyl aminopeptidase,1493,34,1.50 [0.88-2.56],0.1365680228361782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,1721,43,0.95 [0.57-1.58],0.8484359831292381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,1465,33,0.52 [0.15-1.76],0.2927922761083947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,1452,32,0.95 [0.68-1.31],0.7400466392906759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK1,Docking protein 1,1493,34,1.10 [0.87-1.40],0.435556428445647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK2,Docking protein 2,1721,43,1.16 [0.93-1.43],0.1818683490159227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP1,Dipeptidase 1,1698,44,0.50 [0.32-0.80],0.0037058594911451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP2,Dipeptidase 2,1710,44,1.59 [0.66-3.82],0.3026549093978722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,1720,43,1.27 [0.72-2.26],0.409059114254212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP4,Dipeptidyl peptidase 4,1706,44,1.11 [0.48-2.57],0.8072399066906479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,1710,44,4.00 [2.10-7.64],2.534331247871873e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP7,Dipeptidyl peptidase 2,1708,43,1.14 [0.75-1.75],0.5348540291680604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,1746,45,12.51 [5.23-29.95],1.3984636957025652e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPY30,Protein dpy-30 homolog,1735,45,1.96 [1.48-2.61],3.082980754076216e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRAXIN,Draxin,1704,44,4.38 [2.45-7.84],6.222041487968343e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,1710,44,1.75 [1.13-2.72],0.0124506645547186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,1708,43,3.57 [2.55-5.00],1.4796489306945013e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,1509,36,2.79 [1.30-6.00],0.0086318519995452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG2,Desmoglein-2,1728,44,8.69 [3.85-19.61],1.9705294359940185e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG3,Desmoglein-3,1734,45,4.48 [2.21-9.07],3.0331843783220017e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG4,Desmoglein-4,1700,44,1.85 [1.17-2.94],0.0090355604904219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,1477,35,1.02 [0.72-1.45],0.901492987822566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTNB,Dystrobrevin beta,1501,35,2.27 [1.40-3.67],0.0008138451019419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,1465,33,0.85 [0.47-1.53],0.591100730857133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,1710,44,7.99 [3.98-16.04],5.1916505486803695e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTYMK,Thymidylate kinase,1507,35,1.10 [0.70-1.73],0.6787338639020977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUOX2,Dual oxidase 2,1690,45,1.05 [0.73-1.50],0.7962777253440706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,1503,36,1.09 [0.55-2.13],0.8126961828389336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP29,Dual specificity phosphatase 29,1465,33,0.98 [0.56-1.70],0.9303442701740812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,1660,43,1.10 [0.81-1.48],0.5520073620054158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",1500,35,1.17 [0.87-1.57],0.3116177715827704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DXO,Decapping and exoribonuclease protein,1493,34,1.67 [0.84-3.29],0.1421904888197294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,1503,36,1.60 [0.88-2.93],0.1265095048655891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,1465,33,1.27 [0.89-1.81],0.183292939965144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,1503,36,1.37 [0.71-2.64],0.3446413265818295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,1704,44,1.30 [0.99-1.72],0.0608646220095535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBI3_IL27,Interleukin-27,1736,45,6.23 [3.27-11.88],2.8131362027557693e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECE1,Endothelin-converting enzyme 1,1660,43,1.22 [0.57-2.60],0.6148028478331062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",1507,35,1.01 [0.70-1.46],0.9638521615533244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",1458,35,1.16 [0.84-1.60],0.3572454256661892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,1460,32,1.44 [0.87-2.37],0.1520136104916612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECM1,Extracellular matrix protein 1,1478,35,1.92 [0.99-3.74],0.0544128964243068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,1452,32,0.73 [0.31-1.74],0.4779957611257447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,1739,45,5.66 [3.89-8.24],1.5980951467597126e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,1720,43,1.26 [0.95-1.68],0.1106430021556348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,1503,36,1.11 [0.64-1.93],0.7186658996746931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,1460,32,0.93 [0.31-2.76],0.8965661637118711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDF1,Endothelial differentiation-related factor 1,1509,36,1.48 [1.01-2.16],0.0455732900792587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,1690,45,2.44 [1.24-4.79],0.009831206860992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDN1,Endothelin-1,1458,35,4.79 [2.21-10.39],7.273682479530286e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDNRB,Endothelin receptor type B,1456,33,1.35 [0.68-2.67],0.3882964515685873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EEF1D,Elongation factor 1-delta,1507,35,1.36 [0.98-1.89],0.0669478592589884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,1500,35,4.94 [2.73-8.91],1.2048485030839516e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,1481,36,1.52 [0.67-3.47],0.3149549940204679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,1732,45,7.97 [4.08-15.60],1.3480291414665063e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,1509,36,3.14 [1.98-4.98],1.0948487001109365e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,1726,44,10.90 [6.01-19.79],4.0576957012032366e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,1698,44,11.29 [6.95-18.34],1.1489633353515588e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNB2,Ephrin-B2,1465,33,1.72 [1.25-2.36],0.0008121793973599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGF,Pro-epidermal growth factor,1710,43,1.20 [0.93-1.56],0.1580118132591133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,1660,44,2.89 [1.57-5.32],0.0006277304460741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFLAM,Pikachurin,1500,35,4.23 [2.44-7.35],2.950354500054852e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFR,Epidermal growth factor receptor,1746,45,3.22 [0.67-15.52],0.1448740277862696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGLN1,Egl nine homolog 1,1720,43,1.50 [1.14-1.97],0.0036007704404828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHBP1,EH domain-binding protein 1,1507,35,1.31 [0.87-1.96],0.1971313103618233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHD3,EH domain-containing protein 3,1458,35,1.00 [0.76-1.30],0.9741900705313172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",1493,34,0.75 [0.38-1.46],0.393648618125037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",1495,34,1.29 [0.98-1.69],0.0677829227404225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,1460,32,1.07 [0.65-1.76],0.7986003303364704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,1458,35,0.79 [0.36-1.75],0.5665658383926271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,1704,44,1.24 [0.77-1.99],0.3737596311920576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,1456,33,1.13 [0.78-1.63],0.5211981152501043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,1721,43,1.09 [0.73-1.64],0.6612320123863005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,1746,44,1.28 [0.96-1.70],0.090118248351383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,1509,36,1.24 [0.82-1.87],0.2982828804216123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,1460,32,1.53 [1.06-2.20],0.0231673856886969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,1682,42,0.49 [0.18-1.30],0.1504175870089886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,1509,36,1.23 [0.84-1.78],0.2870326174027451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAVL4,ELAV-like protein 4,1452,32,1.26 [0.91-1.74],0.1647213683393718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELN,Elastin,1507,35,7.93 [3.94-15.93],6.154980202445659e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOA,Elongin-A,1710,44,1.34 [0.96-1.87],0.0826827763084812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOB,Elongin-B,1460,32,2.24 [1.33-3.78],0.0025822788191656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENAH,Protein enabled homolog,1682,42,3.08 [1.90-5.01],5.557444766611572e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,1377,34,1.91 [1.29-2.83],0.0011584040017259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENG,Endoglin,1746,45,9.10 [2.25-36.80],0.0019457241138744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO1,Alpha-enolase,1719,44,1.40 [0.98-2.00],0.0654367005579436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO2,Gamma-enolase,1732,44,1.37 [0.93-2.02],0.1167755410458858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO3,Beta-enolase,1458,35,0.68 [0.40-1.15],0.1482830670881766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOPH1,Enolase-phosphatase E1,1503,36,0.66 [0.28-1.55],0.3370069793507746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,1460,32,1.49 [0.71-3.09],0.2883476523103924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPEP,Glutamyl aminopeptidase,1460,32,0.68 [0.24-1.94],0.4738520500720912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,1746,45,0.95 [0.38-2.35],0.9105447311923844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,1724,43,1.46 [0.73-2.94],0.2891755023378319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,1458,35,2.08 [0.89-4.82],0.0895326965118822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,1663,42,1.24 [0.91-1.68],0.1788442011142548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENSA,Alpha-endosulfine,1503,36,1.17 [0.72-1.89],0.5214193059571552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,1660,44,1.35 [0.83-2.19],0.2237908491840349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,1690,45,1.21 [0.36-4.12],0.7602199017225062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,1690,45,1.65 [0.52-5.27],0.3987419298989721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,1458,35,1.07 [0.70-1.65],0.7519613080644034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EP300,Histone acetyltransferase p300,1456,33,1.91 [0.80-4.53],0.1446086947756403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPB41L5,Band 4.1-like protein 5,1465,33,0.98 [0.57-1.70],0.947722444200962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPCAM,Epithelial cell adhesion molecule,1716,43,1.18 [0.88-1.58],0.2778717530137884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPGN,Epigen,1503,36,0.60 [0.21-1.73],0.3420910758591539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,1721,43,4.77 [2.26-10.08],4.1750068386613536e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA10,Ephrin type-A receptor 10,1660,43,0.88 [0.54-1.43],0.5980095581276803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,1656,44,9.26 [5.82-14.73],6.053414443363797e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,1477,35,8.23 [3.26-20.78],8.127821153383241e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,1746,45,16.40 [9.00-29.90],6.911934719796197e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,1698,44,7.10 [4.01-12.58],1.8965604792410963e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,1690,45,0.99 [0.64-1.53],0.9521616895116384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPN1,Epsin-1,1481,36,0.63 [0.25-1.62],0.3361979393360937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPO,Erythropoietin,1720,43,1.29 [0.95-1.74],0.1032478439704957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPPK1,Epiplakin,1458,35,1.28 [0.89-1.85],0.1812711365284239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,1738,45,3.28 [1.99-5.42],3.490466142943652e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,1720,44,0.72 [0.31-1.64],0.4316349343560082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,1714,43,4.92 [1.28-18.91],0.0204190746840281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,1720,44,6.17 [2.43-15.67],0.0001296062975902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBIN,Erbin,1710,44,1.37 [1.05-1.80],0.020260705949421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERC2,ERC protein 2,1465,33,1.35 [0.91-2.00],0.133113714809835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,1448,34,0.47 [0.14-1.51],0.2019126479185038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EREG,Proepiregulin,1698,44,1.28 [0.96-1.72],0.0959315899232972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERI1,3'-5' exoribonuclease 1,1481,36,1.60 [0.69-3.73],0.2747519655067209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,1456,33,1.88 [0.94-3.76],0.0734598441538664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,1503,36,0.99 [0.41-2.38],0.9789249720558846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,1477,35,0.99 [0.76-1.29],0.9219253732399364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,1707,44,2.31 [0.89-6.01],0.0855646497132391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,1460,32,1.14 [0.55-2.40],0.7201428977125017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,1746,45,8.66 [4.98-15.05],1.938410328320269e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESM1,Endothelial cell-specific molecule 1,1717,43,2.07 [1.04-4.11],0.0373119551120359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESPL1,Separin,1448,34,1.38 [0.83-2.27],0.211873565094327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESR1,Estrogen receptor,1456,33,1.12 [0.62-2.02],0.7127020100523689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESYT2,Extended synaptotagmin-2,1493,34,1.28 [0.89-1.86],0.1881496377439228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI2B,Protein EVI2B,1448,34,1.54 [1.02-2.30],0.0378250684176114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,1456,33,1.33 [0.93-1.88],0.1162790276408731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVPL,Envoplakin,1481,36,2.42 [1.19-4.92],0.0144497444738046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXOSC10,Exosome component 10,1460,32,0.58 [0.26-1.33],0.2011179844546428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXTL1,Exostosin-like 1,1460,32,1.86 [1.04-3.32],0.0361890281683693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EZR,Ezrin,1732,44,3.86 [1.83-8.12],0.0003773593224684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F10,Coagulation factor X,1512,35,0.71 [0.25-2.03],0.5190735513315224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11,Coagulation factor XI,1496,34,1.95 [0.61-6.20],0.2599373968539992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11R,Junctional adhesion molecule A,1728,44,1.97 [1.28-3.03],0.0021178968637303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F12,Coagulation factor XII,1517,35,0.47 [0.24-0.94],0.0320052086180301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F13B,Coagulation factor XIII B chain,1509,35,1.97 [0.59-6.57],0.2703495060556856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2,Prothrombin,1517,35,0.23 [0.04-1.29],0.095347075845326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2R,Proteinase-activated receptor 1,1722,43,2.27 [1.46-3.53],0.0002561812117734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F3,Tissue factor,1726,45,7.55 [3.89-14.63],2.202272876408155e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F7,Coagulation factor VII,1732,45,1.69 [0.75-3.82],0.2050840147264104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F9,Coagulation factor IX,1733,45,1.01 [0.24-4.32],0.9899098833261304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",1717,43,1.61 [1.26-2.04],0.0001143872424138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",1721,43,1.77 [1.38-2.27],7.363221105520875e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",1507,35,2.67 [1.81-3.94],6.717802423930463e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",1746,45,2.82 [2.02-3.94],1.041288621300796e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP5,Fatty acid-binding protein 5,1729,44,1.91 [1.33-2.75],0.0004917500721621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,1686,44,1.89 [1.40-2.55],3.309687588943542e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP9,Fatty acid-binding protein 9,1720,43,1.55 [0.99-2.44],0.0559552923030468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FADD,FAS-associated death domain protein,1721,43,1.25 [0.89-1.75],0.203708333068215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM13A,Protein FAM13A,1500,35,1.17 [0.75-1.84],0.4914913338105099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171A2,Protein FAM171A2,1509,36,1.03 [0.86-1.25],0.7340235007131405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171B,Protein FAM171B,1503,36,1.21 [0.45-3.30],0.7036279452370693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,1458,35,1.25 [0.75-2.07],0.3921821884790903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM20A,Pseudokinase FAM20A,1507,35,0.91 [0.30-2.79],0.8745088694208576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3B,Protein FAM3B,1710,44,3.41 [1.92-6.06],2.938658146918016e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,1721,43,11.26 [6.40-19.79],4.200574492099859e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3D,Protein FAM3D,1500,35,1.62 [1.13-2.31],0.0084275466125305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAP,Prolyl endopeptidase FAP,1746,45,1.24 [0.54-2.83],0.6109463275424067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,1465,33,1.38 [0.92-2.08],0.1148471349314968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,1744,45,2.05 [1.45-2.90],4.382563843884785e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,1746,44,1.13 [0.55-2.29],0.7395057311657891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBLN2,Fibulin-2,1512,35,6.63 [3.30-13.32],1.040396239159153e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBN2,Fibrillin-2,1465,33,0.81 [0.45-1.44],0.4678242245713302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",1721,43,0.94 [0.68-1.31],0.7345571071439412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,1507,35,1.45 [0.96-2.20],0.0793585439201861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,1720,43,1.09 [0.63-1.87],0.7547146028711429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,1509,36,2.01 [0.91-4.45],0.0863203779453693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,1728,44,2.10 [1.65-2.68],2.387852447480406e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,1726,45,1.73 [1.00-3.02],0.0512243752554289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,1660,44,1.12 [0.73-1.72],0.5958284642731764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,1730,44,1.33 [0.78-2.27],0.300404426778404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN1,Ficolin-1,1510,35,0.80 [0.50-1.29],0.3645693683168853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN2,Ficolin-2,1723,45,0.86 [0.47-1.58],0.6250818627763748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL1,Fc receptor-like protein 1,1721,43,2.13 [1.33-3.41],0.0015723586706293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL2,Fc receptor-like protein 2,1733,43,1.94 [1.32-2.85],0.0006913291315313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL3,Fc receptor-like protein 3,1682,42,1.94 [1.31-2.88],0.0009516275432041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL5,Fc receptor-like protein 5,1728,44,1.53 [1.02-2.31],0.0419440568770728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL6,Fc receptor-like protein 6,1720,43,1.31 [0.87-1.96],0.1987740890549119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRLB,Fc receptor-like B,1660,44,1.36 [0.98-1.90],0.0690579635580606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",1460,32,1.41 [0.99-2.00],0.0540427591788295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",1460,32,0.90 [0.49-1.64],0.7249442053132402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FEN1,Flap endonuclease 1,1660,44,1.23 [0.92-1.64],0.1568672293319083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,1660,44,1.30 [0.84-2.02],0.2355404167379792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FETUB,Fetuin-B,1733,45,1.21 [0.52-2.82],0.6534290194713348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGA,Fibrinogen alpha chain,1481,35,2.17 [0.84-5.62],0.1093485383850446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",1509,36,1.38 [0.95-1.99],0.0907564744851059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF12,Fibroblast growth factor 12,1456,33,0.83 [0.34-2.02],0.6878869007923107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF16,Fibroblast growth factor 16,1456,33,0.85 [0.41-1.77],0.6667022440300734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF19,Fibroblast growth factor 19,1724,43,1.24 [0.89-1.71],0.2005761064259725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF2,Fibroblast growth factor 2,1720,43,1.63 [1.16-2.27],0.0043501585976293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF20,Fibroblast growth factor 20,1456,33,0.55 [0.18-1.67],0.2886430630035302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF21,Fibroblast growth factor 21,1736,45,1.29 [1.06-1.57],0.0117574088881524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF23,Fibroblast growth factor 23,1733,45,1.66 [1.31-2.12],3.5790998591732966e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF3,Fibroblast growth factor 3,1456,33,1.93 [0.79-4.73],0.1514895759050271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF5,Fibroblast growth factor 5,1682,42,3.57 [2.22-5.73],1.4867891776617237e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF6,Fibroblast growth factor 6,1456,33,1.82 [1.11-2.97],0.0166921386001573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF7,Fibroblast growth factor 7,1448,34,1.00 [0.64-1.56],0.9880315345394618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF9,Fibroblast growth factor 9,1444,34,1.24 [0.54-2.84],0.6143862004179691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,1720,44,0.57 [0.31-1.04],0.0688774922283219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,1512,35,0.58 [0.31-1.09],0.0903836621139926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,1493,34,1.26 [0.54-2.93],0.5916610629029762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,1720,44,4.41 [2.05-9.50],0.0001496209481451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,1477,35,2.17 [1.25-3.78],0.0061145133923042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGL1,Fibrinogen-like protein 1,1512,35,2.48 [1.59-3.87],6.080947140443453e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGR,Tyrosine-protein kinase Fgr,1660,43,1.22 [0.88-1.69],0.2281006439824767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FH,"Fumarate hydratase, mitochondrial",1452,32,0.90 [0.57-1.43],0.6500012605997358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,1460,32,0.55 [0.24-1.26],0.1561434432181127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,1660,43,1.08 [0.75-1.55],0.6940253470949973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FIS1,Mitochondrial fission 1 protein,1719,43,1.58 [1.14-2.19],0.0058011766644748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,1509,36,1.19 [0.87-1.62],0.2837689644855883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,1728,43,1.23 [0.99-1.53],0.0660707426096011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,1704,44,1.76 [0.94-3.32],0.0785060215714107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,1704,44,1.37 [1.02-1.85],0.0379538174583267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,1654,43,1.52 [1.12-2.08],0.0079456738927971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBPL,FK506-binding protein-like,1500,35,1.32 [0.78-2.24],0.2976746189084245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,1660,44,1.30 [1.04-1.62],0.0231458970670649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1704,44,8.13 [3.77-17.53],9.180335664905089e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,1709,44,5.00 [2.20-11.39],0.0001236273690409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,1660,44,1.39 [0.58-3.35],0.4568037111520724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,1746,44,2.16 [1.00-4.69],0.0510787654309856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,1720,44,2.18 [0.96-4.92],0.0613086667131559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMNL1,Formin-like protein 1,1660,43,1.15 [0.86-1.53],0.3571190817374531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMR1,Synaptic functional regulator FMR1,1660,44,1.51 [0.71-3.19],0.2849651840685808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FN1,Fibronectin,1517,35,0.48 [0.15-1.49],0.2031449823237399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,1493,34,1.59 [0.84-3.00],0.1529606669373109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,1503,36,2.23 [0.95-5.23],0.0666134762062156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,1456,33,0.95 [0.67-1.35],0.7776133792944475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,1715,44,10.80 [6.16-18.94],9.928793939704808e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR2,Folate receptor beta,1732,44,5.97 [2.69-13.26],1.1107297483584026e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR3,Folate receptor gamma,1717,44,0.98 [0.86-1.12],0.7696355450102217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOS,Proto-oncogene c-Fos,1444,34,1.37 [0.54-3.43],0.5057140662015811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOSB,Protein fosB,1660,43,0.78 [0.35-1.72],0.5320671737683593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXJ3,Forkhead box protein J3,1456,33,1.19 [0.63-2.23],0.5936936346950673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO1,Forkhead box protein O1,1720,43,1.23 [0.91-1.67],0.1853226150340559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO3,Forkhead box protein O3,1660,44,1.11 [0.84-1.47],0.4571266489135192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD4B,FERM domain-containing protein 4B,1460,32,1.34 [0.87-2.06],0.1825904700912676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD7,FERM domain-containing protein 7,1465,33,1.26 [0.51-3.07],0.6155698200059321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRZB,Secreted frizzled-related protein 3,1695,44,1.14 [0.43-2.98],0.7951288490735517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSHB,Follitropin subunit beta,1458,35,1.64 [0.93-2.87],0.085635633094051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FST,Follistatin,1722,43,1.04 [0.59-1.81],0.9018396382226992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL1,Follistatin-related protein 1,1458,35,13.70 [4.30-43.64],9.487046109949262e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL3,Follistatin-related protein 3,1714,42,6.60 [3.93-11.08],9.220619598505485e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,1491,33,0.86 [0.62-1.19],0.3679559360032531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,1738,45,1.13 [0.80-1.61],0.4832188475113725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUOM,Fucose mutarotase,1477,35,0.96 [0.61-1.51],0.869292537201403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FURIN,Furin,1720,44,1.10 [0.53-2.29],0.8049861911749877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUS,RNA-binding protein FUS,1654,44,3.06 [2.01-4.67],1.9397765982174885e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",1477,36,1.10 [0.70-1.72],0.6768800683863785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,1732,44,1.89 [1.08-3.30],0.0255096776234548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",1704,44,1.80 [1.17-2.77],0.0071153969377362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXN,"Frataxin, mitochondrial",1739,45,1.45 [1.03-2.05],0.0342588077019718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,1682,42,1.74 [1.20-2.52],0.0032164077486649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FYB1,FYN-binding protein 1,1724,44,1.32 [0.99-1.78],0.0608636184130608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD10,Frizzled-10,1465,33,1.13 [0.66-1.95],0.6567749627299279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD8,Frizzled-8,1452,32,1.86 [1.02-3.39],0.0424746681580977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,1503,36,1.20 [0.70-2.05],0.5057838049587782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,1481,36,0.93 [0.58-1.47],0.7469181305359833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,1452,32,0.78 [0.42-1.46],0.4406427175154173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD1,Glutamate decarboxylase 1,1448,34,0.35 [0.10-1.27],0.1114291039331055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD2,Glutamate decarboxylase 2,1456,33,0.76 [0.30-1.91],0.5551539186998629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,1481,36,0.75 [0.33-1.70],0.4941694649576876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,1458,35,1.18 [0.68-2.05],0.5590983287700863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAGE2A,G antigen 2A,1448,34,0.52 [0.24-1.12],0.0934392682412577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAL,Galanin peptides,1724,43,0.99 [0.65-1.49],0.9449502899343936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,1710,44,1.52 [0.60-3.89],0.3780912753228691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,1739,45,1.23 [0.48-3.18],0.6666711885346985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,1682,42,1.97 [1.12-3.47],0.018114256143616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,1507,35,1.49 [0.52-4.28],0.4619802947992139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,1710,44,1.49 [0.39-5.65],0.5563255951904884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,1460,32,0.71 [0.24-2.07],0.5299797040732589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,1447,33,1.70 [0.50-5.75],0.3935757332771412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,1509,36,0.40 [0.09-1.73],0.2179782619990535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS2,Growth arrest-specific protein 2,1481,36,0.97 [0.53-1.77],0.9152326941994356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS6,Growth arrest-specific protein 6,1739,45,6.37 [2.53-16.08],8.775839060392111e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GASK1A,Golgi-associated kinase 1A,1460,32,0.43 [0.21-0.89],0.0234342383614755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAST,Gastrin,1493,34,1.27 [1.05-1.54],0.0155204230576706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,1448,34,0.37 [0.10-1.39],0.140826688629698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",1458,35,1.24 [0.85-1.81],0.2716544557101473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBA,Lysosomal acid glucosylceramidase,1465,33,1.06 [0.56-1.98],0.8644022656100082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP1,Guanylate-binding protein 1,1490,34,1.54 [0.98-2.42],0.0632187955196506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP2,Guanylate-binding protein 2,1682,42,1.68 [1.16-2.43],0.0055580330788649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP4,Guanylate-binding protein 4,1660,43,1.70 [1.07-2.68],0.0240359375220908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP6,Guanylate-binding protein 6,1460,32,0.73 [0.30-1.79],0.4907021296723285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GC,Vitamin D-binding protein,1517,35,1.36 [0.40-4.62],0.6266951076030833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,1493,34,1.18 [0.88-1.59],0.2782520809943672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCG,Pro-glucagon,1660,44,1.39 [1.13-1.71],0.0017597851406876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,1440,33,1.48 [0.93-2.35],0.1003191482071112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,1460,32,1.05 [0.53-2.11],0.8815723241941309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",1710,44,3.54 [1.74-7.18],0.0004713622233159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,1746,45,3.53 [2.58-4.84],3.72003110040741e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF2,Growth/differentiation factor 2,1721,43,1.81 [0.90-3.65],0.0978844078730781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,1660,43,2.21 [1.21-4.03],0.0098203834731622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GET3,ATPase GET3,1507,35,0.81 [0.42-1.54],0.522580671826389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFAP,Glial fibrillary acidic protein,1658,44,1.71 [1.01-2.89],0.0468836647509992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,1660,44,1.82 [1.26-2.64],0.0015849012762511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,1660,44,0.90 [0.70-1.17],0.4430250947638136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,1736,45,20.21 [10.70-38.19],2.062583952600613e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,1710,44,7.51 [1.98-28.44],0.002994754763787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,1702,44,10.22 [4.83-21.62],1.1817156438352878e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRAL,GDNF family receptor alpha-like,1454,34,0.83 [0.48-1.43],0.4983092402449345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,1660,43,0.99 [0.67-1.46],0.9402486587787672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,1507,35,1.12 [0.72-1.76],0.6102225480726065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,1506,35,1.21 [0.63-2.31],0.5721252077402784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGH,Gamma-glutamyl hydrolase,1705,42,0.68 [0.30-1.53],0.3481449431975013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,1726,44,0.93 [0.58-1.50],0.7778875665767794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,1704,44,6.77 [2.86-16.01],1.3504808482114425e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH1,Somatotropin,1721,43,1.14 [0.99-1.30],0.0637647735601906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH2,Growth hormone variant,1660,44,0.98 [0.82-1.16],0.7733622360400043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHR,Growth hormone receptor,1477,35,0.33 [0.12-0.89],0.0282515789335981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,1660,43,1.15 [0.73-1.83],0.5488822609021565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRL,Appetite-regulating hormone,1721,43,1.34 [0.97-1.84],0.0758480104231753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,1509,36,1.32 [0.56-3.13],0.5238618500040919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,1509,36,1.62 [1.12-2.35],0.0102147404590604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP7,GTPase IMAP family member 7,1477,35,1.87 [0.92-3.79],0.0838171906232538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP8,GTPase IMAP family member 8,1448,34,1.10 [0.59-2.07],0.7606447876919483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIP,Gastric inhibitory polypeptide,1458,35,1.30 [0.67-2.50],0.4343479206176986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,1493,34,3.22 [1.42-7.27],0.0050025347870892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,1500,35,1.08 [0.78-1.49],0.6565250123319364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,1456,33,1.01 [0.45-2.28],0.9804366687466616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,1456,33,1.22 [0.88-1.71],0.235907874298265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GJA8,Gap junction alpha-8 protein,1448,34,0.77 [0.40-1.49],0.4366792403500286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GKN1,Gastrokine-1,1620,42,1.70 [0.70-4.12],0.2430373963620424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLA,Alpha-galactosidase A,1473,34,1.50 [0.66-3.42],0.3316334617376638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLB1,Beta-galactosidase,1704,44,0.81 [0.43-1.53],0.5198308697029865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLI2,Zinc finger protein GLI2,1456,33,0.37 [0.12-1.16],0.088395442506807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLO1,Lactoylglutathione lyase,1690,45,1.33 [0.86-2.07],0.2021780034626067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,1717,43,1.94 [0.90-4.20],0.0906053577438894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,1452,32,1.07 [0.42-2.76],0.8821111237376679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX,Glutaredoxin-1,1708,43,0.92 [0.58-1.47],0.7385594266843839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",1477,35,1.12 [0.79-1.58],0.5349186421019215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,1660,43,0.90 [0.50-1.63],0.7281226379481776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,1503,36,1.26 [0.83-1.90],0.2771847743316145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GM2A,Ganglioside GM2 activator,1481,34,3.87 [2.37-6.32],6.896561655118429e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMFG,Glia maturation factor gamma,1507,35,1.25 [0.81-1.94],0.3161383932582444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR,GMP reductase 1,1746,44,0.80 [0.48-1.36],0.4107053521254661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR2,GMP reductase 2,1477,35,1.01 [0.62-1.63],0.9700078836007726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNAS,Neuroendocrine secretory protein 55,1509,36,1.09 [0.78-1.52],0.6177332466783814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,1660,44,1.43 [0.95-2.15],0.0828807829604884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,1465,33,1.41 [0.92-2.16],0.1157127075401647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNLY,Granulysin,1728,44,1.09 [0.68-1.74],0.7208353059931936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,1458,35,0.72 [0.23-2.20],0.5616505326270527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,1477,35,0.72 [0.32-1.62],0.4261519833364696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLGA3,Golgin subfamily A member 3,1509,36,1.45 [0.98-2.15],0.0609342827541366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLM2,Protein GOLM2,1732,44,7.35 [3.18-16.99],3.07923223378024e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,1720,43,1.22 [0.94-1.59],0.1385454076539292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,1500,35,1.28 [0.67-2.44],0.4617873541238541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",1512,35,0.77 [0.39-1.53],0.4591390948736292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,1721,45,2.87 [1.37-5.99],0.0050252742391757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,1460,32,1.29 [0.78-2.11],0.3167571030840854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,1663,44,1.11 [0.85-1.44],0.4458795424549538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP5,Platelet glycoprotein V,1477,35,1.60 [0.63-4.09],0.3238270469947374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP6,Platelet glycoprotein VI,1724,44,1.32 [0.97-1.79],0.0730971056866565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPA33,Cell surface A33 antigen,1710,44,1.01 [0.82-1.24],0.929057152757028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC1,Glypican-1,1739,45,12.70 [5.62-28.69],9.970482991660794e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC5,Glypican-5,1704,44,1.61 [1.01-2.56],0.0439779003861419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,1503,36,1.18 [0.74-1.90],0.4908809125562663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,1500,35,1.37 [0.81-2.33],0.2437242170958956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPI,Glucose-6-phosphate isomerase,1512,35,1.68 [0.93-3.02],0.0847368491979852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,1500,35,2.14 [1.36-3.37],0.0009442577152167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,1660,43,1.70 [0.97-2.97],0.0641407959630069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,1676,42,6.57 [2.70-16.03],3.464899353126635e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR101,Probable G-protein coupled receptor 101,1452,32,0.49 [0.20-1.23],0.1306681178873787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR158,Probable G-protein coupled receptor 158,1509,36,1.65 [0.93-2.90],0.0846813172795456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR15L,Protein GPR15L,1500,35,1.16 [0.72-1.88],0.5487903292042952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,1690,45,3.77 [2.68-5.31],2.4287326038581283e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,1503,36,1.38 [0.91-2.09],0.127514457094467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRAP2,GRB2-related adapter protein 2,1721,43,1.15 [0.93-1.42],0.1901124037845964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,1507,35,1.19 [0.73-1.94],0.4968246891705176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",1509,36,0.62 [0.23-1.63],0.3314182418644592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",1452,32,0.87 [0.43-1.78],0.7102746706992368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRK5,G protein-coupled receptor kinase 5,1690,45,1.29 [0.95-1.74],0.1048724795944459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRN,Progranulin,1720,44,20.86 [7.45-58.42],7.425809354974839e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRP,Gastrin-releasing peptide,1458,35,1.56 [0.88-2.77],0.127909713778272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",1710,44,1.68 [1.21-2.33],0.0020141470994682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRSF1,G-rich sequence factor 1,1439,34,1.24 [0.86-1.78],0.2470684517043284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSAP,Gamma-secretase-activating protein,1660,44,1.04 [0.76-1.42],0.798923317850314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSN,Gelsolin,1504,35,1.26 [0.26-6.15],0.7735555730322634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSR,"Glutathione reductase, mitochondrial",1504,35,0.99 [0.31-3.19],0.988095459862027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA1,Glutathione S-transferase A1,1717,43,0.64 [0.48-0.87],0.0038407225882337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA3,Glutathione S-transferase A3,1660,44,0.75 [0.55-1.03],0.0778281848835493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,1460,32,1.08 [0.71-1.66],0.710681953683539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTP1,Glutathione S-transferase P,1650,43,1.12 [0.77-1.63],0.5612844963864435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,1493,34,0.99 [0.87-1.14],0.935860722935553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,1481,36,0.75 [0.40-1.42],0.381483919506576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTPBP2,GTP-binding protein 2,1465,33,1.14 [0.77-1.68],0.510394296010197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,1716,44,5.52 [3.37-9.04],1.188809817940242e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,1481,36,1.18 [0.83-1.68],0.3530558043911035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUK1,Guanylate kinase,1460,32,1.56 [0.61-3.97],0.3553387640900013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUSB,Beta-glucuronidase,1738,45,0.89 [0.61-1.31],0.561792575228969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",1690,45,1.19 [0.90-1.57],0.2139427133840558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMA,Granzyme A,1746,44,3.11 [1.53-6.30],0.0016808123365469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMB,Granzyme B,1720,43,0.99 [0.64-1.53],0.978775516733913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMH,Granzyme H,1690,45,1.12 [0.83-1.51],0.4433824078430154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",H2AP,Huntingtin-interacting protein M,1448,34,0.68 [0.27-1.72],0.4134955550767886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",1460,32,1.25 [0.87-1.80],0.2317701208800436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",1733,45,0.78 [0.54-1.14],0.2073253349085505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAO1,Hydroxyacid oxidase 1,1739,45,0.90 [0.73-1.10],0.2855013885081869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",1728,44,1.32 [0.94-1.86],0.112790910955092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,1736,45,2.86 [2.34-3.50],7.886449332812231e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,1728,44,7.05 [4.06-12.24],3.929362738733841e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,1733,45,1.39 [0.98-1.96],0.064893079067174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBQ1,Hemoglobin subunit theta-1,1739,45,0.55 [0.35-0.87],0.0103117778123173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBZ,Hemoglobin subunit zeta,1507,35,0.73 [0.52-1.01],0.0600854699162807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCG22,Protein PBMUCL2,1460,32,0.89 [0.45-1.77],0.7345935360475329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,1746,44,1.61 [0.97-2.67],0.064001446823362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC8,Histone deacetylase 8,1456,33,0.90 [0.47-1.76],0.7651577129349738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC9,Histone deacetylase 9,1452,32,1.21 [0.79-1.84],0.3826432776347124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,1500,35,1.12 [0.53-2.33],0.7716807979760822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGF,Hepatoma-derived growth factor,1736,45,1.12 [0.85-1.49],0.416518778856606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,1493,34,1.74 [1.19-2.55],0.0043668446514897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEBP1,Heme-binding protein 1,1690,45,0.84 [0.47-1.48],0.5398024259952059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEG1,Protein HEG homolog 1,1477,35,4.76 [1.62-13.98],0.0045302048653342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPACAM2,HEPACAM family member 2,1493,34,0.93 [0.44-1.95],0.8436918855687358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPH,Hephaestin,1507,35,20.14 [6.55-61.94],1.615807848935241e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEXIM1,Protein HEXIM1,1720,43,1.26 [0.91-1.75],0.1676004244534224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGF,Hepatocyte growth factor,1746,44,1.72 [0.88-3.39],0.1152086023216564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGFAC,Hepatocyte growth factor activator,1500,34,0.87 [0.30-2.54],0.8034328025154605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,1660,44,1.23 [0.89-1.69],0.2132031009433401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,1493,34,1.69 [1.14-2.51],0.009383275255245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,1456,33,1.52 [1.07-2.15],0.0186812000188829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1,Huntingtin-interacting protein 1,1460,32,0.75 [0.25-2.26],0.6043431336321361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,1493,34,1.53 [1.16-2.01],0.0028018840365709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HJV,Hemojuvelin,1509,36,1.24 [0.66-2.33],0.5122298993290084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HK2,Hexokinase-2,1690,45,0.54 [0.21-1.43],0.2159573454694463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",1509,36,1.93 [0.69-5.39],0.2095365540291831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",1716,43,1.45 [0.73-2.91],0.2900547232285577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1720,43,4.65 [2.80-7.74],3.1648675482037803e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMBS,Porphobilinogen deaminase,1739,45,0.55 [0.30-1.00],0.048516812011119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMCN2,Hemicentin-2,1474,34,2.66 [1.60-4.43],0.0001720693901596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",1458,35,1.12 [0.61-2.07],0.7064717743223504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",1460,32,1.02 [0.52-2.00],0.9499793880884204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMMR,Hyaluronan mediated motility receptor,1446,33,0.61 [0.26-1.43],0.2527039940348004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX1,Heme oxygenase 1,1707,43,0.86 [0.50-1.49],0.5920109713444497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX2,Heme oxygenase 2,1660,43,1.53 [0.99-2.37],0.0575494234763046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,1465,33,1.19 [0.89-1.60],0.2363559229786649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNMT,Histamine N-methyltransferase,1690,43,1.63 [1.02-2.59],0.0406977489228387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,1685,45,1.47 [1.08-1.99],0.014008391213108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,1509,36,1.77 [1.17-2.68],0.0064805467929471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPCAL1,Hippocalcin-like protein 1,1746,44,1.17 [0.82-1.67],0.3871018206716357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,1660,44,0.39 [0.19-0.80],0.0107583273124152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPSE,Heparanase,1500,35,1.30 [0.92-1.84],0.1404631622920834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRAS,GTPase Hras,1479,36,1.10 [0.83-1.45],0.5191397024635354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,1458,35,3.51 [1.98-6.20],1.571682527229782e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRG,Histidine-rich glycoprotein,1509,35,1.00 [0.37-2.72],0.993909819312265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS1BP3,HCLS1-binding protein 3,1458,35,1.22 [0.86-1.74],0.2636504800403935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,1710,44,2.50 [1.30-4.84],0.0062453400426036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,1739,45,2.67 [1.59-4.51],0.0002208167259089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,1456,33,3.16 [1.56-6.39],0.0013656773558084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSBP1,Heat shock factor-binding protein 1,1458,35,1.12 [0.81-1.55],0.5066338942113023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,1720,43,0.74 [0.40-1.34],0.3202923242252062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,1493,34,1.45 [0.92-2.29],0.1124258232896684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,1460,32,1.30 [0.69-2.46],0.4188186434053605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,1458,35,1.65 [0.92-2.95],0.0935321998329516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSP90B1,Endoplasmin,1656,43,0.80 [0.48-1.33],0.3907311037394467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,1721,43,1.59 [1.14-2.24],0.0070951248897606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,1503,36,1.89 [1.25-2.85],0.0025070902949857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB1,Heat shock protein beta-1,1692,43,1.21 [0.80-1.83],0.3749772291579308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB6,Heat shock protein beta-6,1739,45,3.70 [2.35-5.83],1.7587051594733907e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1721,45,6.26 [3.86-10.17],1.174721482686282e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,1452,32,1.04 [0.69-1.57],0.8455742228985594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,1452,32,0.83 [0.34-2.02],0.6781106858046119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",1720,44,1.57 [1.04-2.38],0.0304375220296023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYAL1,Hyaluronidase-1,1711,44,2.13 [0.69-6.60],0.1881358587735179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,1746,45,23.39 [9.51-57.54],6.670555157362558e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICA1,Islet cell autoantigen 1,1682,42,1.28 [0.92-1.78],0.1393104416269149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM1,Intercellular adhesion molecule 1,1726,45,2.16 [0.97-4.84],0.060690146604594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,1746,45,9.34 [4.02-21.66],1.978550881286598e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM3,Intercellular adhesion molecule 3,1746,45,4.36 [2.04-9.34],0.0001487086681736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM4,Intercellular adhesion molecule 4,1720,43,0.94 [0.56-1.57],0.8108007596600952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM5,Intercellular adhesion molecule 5,1721,43,1.28 [0.71-2.30],0.410163509151266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICOSLG,ICOS ligand,1710,44,3.18 [0.84-12.07],0.0893645501726958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,1481,36,1.07 [0.52-2.17],0.8581013246488869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,1660,43,1.36 [0.82-2.24],0.2288663458056727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",1458,35,1.61 [1.08-2.41],0.0195762823094558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDS,Iduronate 2-sulfatase,1746,44,1.03 [0.05-22.98],0.9861214766486358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDUA,Alpha-L-iduronidase,1739,45,1.93 [1.08-3.48],0.0276840569145902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,1455,34,2.03 [0.97-4.27],0.0617281373649427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,1481,36,0.91 [0.47-1.73],0.765146782248666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,1481,36,1.59 [0.82-3.10],0.1688893259359299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,1500,35,1.01 [0.29-3.56],0.9869651086523094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNG,Interferon gamma,1682,42,1.11 [0.87-1.41],0.4066955069706073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,1724,43,24.99 [10.31-60.60],1.0573246903783933e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR2,Interferon gamma receptor 2,1704,44,1.12 [0.69-1.82],0.6519805031338586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL1,Interferon lambda-1,1660,43,1.49 [1.06-2.09],0.0233223457563727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL2,Interferon lambda-2,1452,32,1.16 [0.68-1.97],0.5815907692488629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNLR1,Interferon lambda receptor 1,1720,43,1.55 [0.87-2.76],0.1401270972843669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNW1,Interferon omega-1,1460,32,0.84 [0.29-2.47],0.755367195081949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,1465,33,1.78 [1.04-3.06],0.0360191691760443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,1509,36,1.11 [0.67-1.84],0.6849171549987468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,1452,32,0.49 [0.17-1.41],0.1844414396313491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,1512,35,3.31 [1.07-10.19],0.0373338868878315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,1710,44,28.64 [11.18-73.37],2.7877091692726588e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,1460,32,0.67 [0.27-1.68],0.3903881434756394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,1728,44,2.86 [0.99-8.26],0.051700758679604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,1743,45,1.42 [1.16-1.74],0.0007241559153638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,1744,45,2.54 [1.83-3.51],2.2299621573986112e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,1733,45,1.04 [0.52-2.09],0.9022737652246734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,1700,42,4.00 [2.86-5.60],7.485402437780282e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,1726,45,5.82 [3.69-9.20],4.4149447418326544e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,1746,45,4.82 [2.82-8.25],9.297092088581192e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,1721,43,2.60 [1.50-4.52],0.0007098407302053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFL4,Insulin growth factor-like family member 4,1456,33,0.78 [0.40-1.52],0.4640100257485773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,1460,32,1.24 [0.74-2.07],0.4077666175117158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,1512,35,2.45 [1.17-5.16],0.0178286442537141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLON5,IgLON family member 5,1448,34,0.99 [0.68-1.46],0.9770756438675142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,1458,35,1.01 [0.47-2.15],0.9818120447435128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,1710,44,2.28 [1.37-3.77],0.0013858750490475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,1721,43,8.25 [4.19-16.23],1.0005136119030298e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF9,Protein turtle homolog A,1507,35,0.97 [0.70-1.34],0.8339245479876357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKBKG,NF-kappa-B essential modulator,1720,43,1.19 [0.89-1.59],0.2508498678805679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKZF2,Zinc finger protein Helios,1660,44,0.94 [0.69-1.29],0.7016218158363052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10,Interleukin-10,1682,42,1.58 [1.27-1.97],3.591707711632732e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,1682,42,1.09 [0.74-1.62],0.6569456909957976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,1724,43,11.87 [5.98-23.54],1.4309788288290945e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL11,Interleukin-11,1682,42,1.14 [0.76-1.71],0.5337443083495457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12A_IL12B,Interleukin-12,1710,44,1.95 [1.48-2.58],1.921856688060504e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12B,Interleukin-12 subunit beta,1746,44,2.64 [1.69-4.11],1.9037999684065943e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,1682,42,3.31 [1.85-5.94],5.545012063038114e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,1456,33,1.25 [0.62-2.52],0.5378795492989181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13,Interleukin-13,1682,42,0.36 [0.15-0.85],0.0191512702475543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,1693,44,1.31 [0.44-3.93],0.6318861436878956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,1452,32,0.46 [0.14-1.48],0.1927061355120696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15,Interleukin-15,1720,43,1.96 [1.08-3.56],0.0276242464682529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,1682,42,3.68 [2.29-5.93],7.616419556372631e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL16,Pro-interleukin-16,1746,44,2.06 [1.42-2.99],0.00015080210686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17A,Interleukin-17A,1680,42,1.70 [1.06-2.75],0.0291752536374985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17C,Interleukin-17C,1682,42,2.00 [1.56-2.57],5.4559192144629057e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17D,Interleukin-17D,1682,42,2.97 [1.59-5.57],0.0006621778146947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17F,Interleukin-17F,1682,42,0.99 [0.67-1.46],0.9543358340305576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RA,Interleukin-17 receptor A,1728,44,1.93 [1.05-3.53],0.0339055440476521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RB,Interleukin-17 receptor B,1696,43,1.85 [1.17-2.94],0.0089478125789978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18,Interleukin-18,1714,43,2.23 [1.36-3.63],0.0013431901432673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,1733,45,7.30 [4.16-12.83],4.703325412920425e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,1746,44,3.39 [1.90-6.03],3.322428591479799e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,1686,44,0.97 [0.82-1.14],0.6949120053543385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL19,Interleukin-19,1676,43,1.98 [1.48-2.64],4.569975138391466e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1A,Interleukin-1 alpha,1682,42,1.08 [0.71-1.66],0.7163765189725337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1B,Interleukin-1 beta,1676,42,1.03 [0.67-1.57],0.90877598708593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,1726,44,14.70 [6.73-32.13],1.5910245141277507e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R2,Interleukin-1 receptor type 2,1716,43,2.68 [0.78-9.25],0.1182091004675477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,1728,44,1.23 [0.69-2.20],0.4868160068975927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,1744,45,2.34 [1.39-3.94],0.0014396305669798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,1682,42,1.26 [0.62-2.56],0.5213397945389155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,1713,43,1.57 [1.10-2.24],0.0132524066465228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2,Interleukin-2,1682,42,0.88 [0.37-2.10],0.7739404744586481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20,Interleukin-20,1682,42,0.82 [0.44-1.53],0.5430151655554358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,1682,42,1.63 [1.14-2.33],0.0075141411082172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,1456,33,1.05 [0.52-2.12],0.8984447493223692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL21R,Interleukin-21 receptor,1456,33,0.76 [0.34-1.68],0.4983892339887797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22,Interleukin-22,1503,36,1.35 [0.89-2.04],0.1618290760203609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,1682,42,1.59 [0.99-2.56],0.0551814334401299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL24,Interleukin-24,1682,42,1.99 [1.38-2.88],0.0002418435118768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL25,Interleukin-25,1442,34,1.15 [0.43-3.08],0.7781051247406978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,1722,45,4.69 [2.88-7.65],5.528889199669587e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,1682,42,1.37 [0.74-2.52],0.3162868921554171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,1503,36,1.91 [1.26-2.89],0.0024557866118854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3,Interleukin-3,1448,34,1.21 [0.69-2.12],0.4975997931680359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31,Interleukin-31,1456,33,0.46 [0.19-1.15],0.0962748343617182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,1451,33,2.74 [1.33-5.67],0.0064790129191987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL32,Interleukin-32,1720,43,1.42 [0.95-2.13],0.0895044669560275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL33,Interleukin-33,1682,42,1.67 [0.89-3.17],0.1124055461143662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL34,Interleukin-34,1658,43,1.28 [0.60-2.73],0.5188602815286459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36A,Interleukin-36 alpha,1456,33,0.75 [0.37-1.50],0.4112051119668418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36G,Interleukin-36 gamma,1454,33,0.83 [0.48-1.46],0.5226980099254621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,1682,42,2.15 [0.98-4.74],0.0575898517959231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4,Interleukin-4,1682,42,1.26 [0.86-1.86],0.2346557799209046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,1720,43,4.22 [2.43-7.32],3.161012180979482e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5,Interleukin-5,1682,42,1.05 [0.88-1.26],0.5606421300527207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,1720,43,1.38 [0.90-2.11],0.1383119157653461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6,Interleukin-6,1710,44,1.39 [1.08-1.79],0.0108966379231806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,1722,45,4.88 [2.27-10.51],5.133128311491048e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,1721,43,17.91 [4.51-71.20],4.16239292216067e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7,Interleukin-7,1720,43,0.99 [0.66-1.49],0.9556627884664396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,1728,44,1.33 [0.80-2.23],0.2734919273652223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL9,Interleukin-9,1481,36,0.81 [0.39-1.66],0.5640467068854131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,1659,43,1.33 [0.95-1.88],0.1003393986636185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMMT,MICOS complex subunit MIC60,1503,36,1.68 [1.01-2.78],0.0450314009916979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPA1,Inositol monophosphatase 1,1704,44,1.32 [0.88-1.99],0.183907892143401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPACT,Protein IMPACT,1493,34,1.24 [0.69-2.21],0.4672824817328125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,1452,32,0.91 [0.27-3.08],0.8769933616252785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ING1,Inhibitor of growth protein 1,1654,43,1.24 [0.79-1.94],0.3437618646756749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBB,Inhibin beta B chain,1477,35,2.86 [1.77-4.61],1.7557016149267502e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBC,Inhibin beta C chain,1728,44,1.14 [0.58-2.23],0.7035394175079277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,1710,44,1.79 [1.14-2.80],0.0110636510659667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",1458,35,1.76 [1.06-2.93],0.0302036941829955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1509,36,0.67 [0.26-1.74],0.4117250689087021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",1710,44,1.22 [0.93-1.60],0.1442443416467513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL3,Insulin-like 3,1493,34,0.78 [0.53-1.14],0.1984386943948129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL4,Early placenta insulin-like peptide,1503,36,1.84 [1.28-2.64],0.0009313714532071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL5,Insulin-like peptide INSL5,1500,35,1.23 [0.92-1.63],0.1643943062039486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSR,Insulin receptor,1456,33,5.41 [1.00-29.27],0.0502112052928519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,1698,44,1.56 [1.15-2.10],0.0037851709544247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,1710,44,1.52 [0.97-2.38],0.0671316753046493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",1690,45,1.14 [0.88-1.48],0.315416397479584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,1682,42,1.58 [1.11-2.26],0.0111812679346386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,1720,43,1.09 [0.84-1.42],0.4983875099911862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,1629,42,1.64 [0.80-3.35],0.1739493584601601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM1,Isthmin-1,1720,43,1.58 [0.82-3.05],0.1737397674612441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM2,Isthmin-2,1512,35,0.76 [0.34-1.71],0.5061096782704095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IST1,IST1 homolog,1488,35,1.11 [0.80-1.55],0.5360478623554001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA11,Integrin alpha-11,1720,43,1.12 [0.53-2.39],0.7690452781355996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA2,Integrin alpha-2,1477,35,1.17 [0.47-2.93],0.7419241849636928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA5,Integrin alpha-5,1728,44,3.03 [1.25-7.38],0.0144138755806665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA6,Integrin alpha-6,1720,43,1.08 [0.68-1.74],0.7374472278965254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAL,Integrin alpha-L,1456,33,2.06 [1.02-4.16],0.0427336603276999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAM,Integrin alpha-M,1728,44,2.90 [1.38-6.09],0.0049445965143331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAV,Integrin alpha-V,1739,45,1.95 [0.44-8.69],0.3828952282427914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAX,Integrin alpha-X,1481,36,0.80 [0.41-1.57],0.5234151922317675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1,Integrin beta-1,1728,45,6.78 [2.27-20.21],0.0005993620403227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,1660,44,1.64 [0.89-3.02],0.1163698122836516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,1690,45,1.17 [0.93-1.48],0.1844349190431025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB2,Integrin beta-2,1719,45,6.09 [3.05-12.17],3.195579992600543e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB5,Integrin beta-5,1720,44,2.21 [1.29-3.80],0.0040125602507394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB6,Integrin beta-6,1682,42,16.83 [7.48-37.89],8.987427442049506e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB7,Integrin beta-7,1739,45,2.03 [1.27-3.23],0.0028987545838014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,1512,35,2.08 [1.27-3.40],0.0037322740161715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,1517,35,1.48 [0.34-6.36],0.6001051296039142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,1733,45,5.17 [2.63-10.17],1.9087452271301897e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,1517,35,1.15 [0.35-3.76],0.8171551210115885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,1503,36,1.10 [0.57-2.13],0.7778355493235383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITM2A,Integral membrane protein 2A,1720,43,1.67 [1.10-2.54],0.0156718201410023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,1460,32,0.73 [0.44-1.22],0.2311797397369139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",1458,35,1.33 [0.96-1.85],0.0882792828988534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",1452,32,1.40 [0.84-2.32],0.1981653269773248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",1660,43,1.17 [0.68-2.00],0.5670731577791639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,1448,34,0.91 [0.45-1.86],0.7998148443407753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,1732,44,11.85 [6.72-20.90],1.3175150481357745e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM3,Junctional adhesion molecule C,1477,35,2.09 [1.24-3.52],0.0058138203275378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JCHAIN,Immunoglobulin J chain,1682,42,1.33 [0.84-2.10],0.2249585605162524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,1448,34,0.88 [0.47-1.63],0.6753847437575415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,1500,35,1.14 [0.79-1.64],0.485291983835075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JUN,Transcription factor AP-1,1682,42,1.24 [0.82-1.87],0.3034070045010023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,1710,44,4.86 [2.74-8.61],6.422628309786456e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZN,Kazrin,1500,35,1.11 [0.82-1.49],0.5050128605519348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,1452,32,0.96 [0.52-1.79],0.8999686465799429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,1465,33,1.09 [0.74-1.62],0.658058288171811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNIP4,Kv channel-interacting protein 4,1660,43,0.92 [0.54-1.56],0.7481013601091198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,1471,32,1.62 [1.11-2.36],0.012637346219411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDM3A,Lysine-specific demethylase 3A,1456,33,0.87 [0.56-1.35],0.52141696971155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,1720,44,2.17 [0.75-6.24],0.1518408077822643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KEL,Kell blood group glycoprotein,1660,43,0.97 [0.47-2.00],0.9316459232227028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHDC3L,KH domain-containing protein 3,1448,34,1.13 [0.73-1.75],0.5813682377082761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHK,Ketohexokinase,1458,35,0.96 [0.60-1.53],0.8710025981256796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,1493,34,2.45 [1.37-4.38],0.0024749780206587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,1481,36,0.78 [0.53-1.14],0.193608409013045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,1481,36,0.35 [0.10-1.17],0.0888264344303535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,1503,36,0.94 [0.51-1.70],0.8290119692967854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,1460,32,1.69 [0.75-3.80],0.2015766230287523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF20B,Kinesin-like protein KIF20B,1452,32,0.69 [0.41-1.15],0.1524007254608217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF22,Kinesin-like protein KIF22,1460,32,0.86 [0.65-1.14],0.303492824045731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIFBP,KIF-binding protein,1710,44,1.37 [1.00-1.87],0.0527471483611612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,1503,36,1.05 [0.75-1.48],0.7645162532033754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,1660,44,1.05 [0.76-1.46],0.7513840545391982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,1500,35,0.95 [0.78-1.15],0.5785774157868322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,1660,44,0.93 [0.74-1.16],0.5172551926294789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,1448,34,0.88 [0.55-1.40],0.5889981107249935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,1452,32,0.85 [0.39-1.87],0.6931606948332623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,1660,43,2.49 [1.53-4.04],0.000239824486486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,1733,45,1.58 [0.68-3.71],0.2891002312708635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KITLG,Kit ligand,1721,43,2.54 [1.30-4.96],0.0061590402717053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLB,Beta-klotho,1660,43,1.32 [0.92-1.88],0.1306959573444697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLF4,Krueppel-like factor 4,1452,32,1.02 [0.44-2.34],0.9615616921982636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLHL41,Kelch-like protein 41,1509,36,1.31 [0.82-2.09],0.2531934449819906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK1,Kallikrein-1,1703,42,1.23 [1.01-1.50],0.0413456597039204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK10,Kallikrein-10,1715,44,2.27 [1.43-3.62],0.0005473876248973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,1701,44,4.50 [3.14-6.46],3.1839600157687683e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK12,Kallikrein-12,1660,44,1.05 [0.86-1.29],0.632197748889574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK13,Kallikrein-13,1667,44,1.90 [1.20-3.00],0.0059982210061773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK14,Kallikrein-14,1739,45,1.85 [1.12-3.08],0.0169242600475275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK15,Kallikrein-15,1501,36,1.19 [0.63-2.25],0.5840371944755307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK3,Prostate-specific antigen,1512,35,0.64 [0.43-0.95],0.0283991951959557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK4,Kallikrein-4,1739,45,2.31 [1.69-3.14],1.2155526496629496e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK6,Kallikrein-6,1718,44,7.46 [3.64-15.31],4.272786386614552e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK7,Kallikrein-7,1439,33,0.59 [0.24-1.42],0.2385843639279348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK8,Kallikrein-8,1653,44,3.11 [1.79-5.42],6.139005897560173e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLKB1,Plasma kallikrein,1482,35,1.29 [0.37-4.49],0.6923086029561292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,1746,44,7.32 [4.12-13.01],1.1841466585677122e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,1452,32,0.59 [0.27-1.29],0.1848949457840508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,1746,44,2.22 [1.31-3.77],0.0029593127475833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,1456,33,1.46 [0.93-2.28],0.1009579770009622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,1493,34,3.09 [1.60-5.98],0.0007902519446659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",1607,39,1.04 [0.38-2.84],0.9452245017390326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",1460,32,1.65 [0.81-3.36],0.1700312153605216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",1710,44,1.06 [0.83-1.36],0.6428162441150411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",1716,43,2.31 [1.70-3.15],1.0482406966384373e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",1660,43,1.16 [0.70-1.93],0.5538588542029109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",1460,32,0.97 [0.40-2.38],0.9465264680711188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",1452,32,1.07 [0.83-1.38],0.5966944676388628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,1720,43,1.11 [0.71-1.73],0.6621108230243886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYNU,Kynureninase,1746,44,0.66 [0.40-1.09],0.1054841640240543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L1CAM,Neural cell adhesion molecule L1,1720,44,2.87 [1.24-6.66],0.0137775109051139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,1507,35,1.13 [0.79-1.61],0.5158579648468551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACRT,Extracellular glycoprotein lacritin,1496,36,1.14 [0.55-2.38],0.7223695862532995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACTB2,Endoribonuclease LACTB2,1721,43,1.22 [0.82-1.80],0.3205081369936302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,1710,44,1.98 [1.46-2.68],1.1620801249650012e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1717,43,2.75 [2.01-3.77],2.5689924847685467e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,1704,44,1.37 [1.03-1.82],0.0331026312302019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA1,Laminin subunit alpha-1,1460,32,0.37 [0.12-1.12],0.0792559421159324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA4,Laminin subunit alpha-4,1724,43,6.25 [3.14-12.44],1.731729200644213e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMB1,Laminin subunit beta-1,1458,35,6.44 [2.26-18.36],0.0004856373291702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,1477,35,3.53 [1.27-9.82],0.0157448005588652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,1663,42,0.86 [0.22-3.35],0.8333437401784327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,1743,44,2.58 [1.59-4.17],0.0001144121145807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,1503,36,1.34 [0.61-2.93],0.4673880999840554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAP3,Cytosol aminopeptidase,1682,42,1.43 [0.83-2.46],0.196105687837312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LARP1,La-related protein 1,1503,36,1.27 [0.79-2.03],0.3180232155949302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT,Linker for activation of T-cells family member 1,1746,44,1.42 [0.97-2.07],0.0735134537825419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT2,Linker for activation of T-cells family member 2,1710,44,1.32 [1.08-1.62],0.0069082551119038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,1456,33,1.28 [0.88-1.86],0.1931549695162698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,1698,44,7.93 [5.08-12.38],7.680497804019445e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,1733,45,1.47 [0.94-2.30],0.0878900513650949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBR,Delta(14)-sterol reductase LBR,1732,44,1.44 [1.10-1.88],0.0073392270295795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,1512,35,0.59 [0.18-1.95],0.3884303201309957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN15,Lipocalin-15,1509,36,1.49 [1.14-1.95],0.0040572391588255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,1679,41,3.94 [2.54-6.11],8.770374276369884e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCP1,Plastin-2,1512,35,0.92 [0.46-1.84],0.8190083799370378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLR,Low-density lipoprotein receptor,1725,44,0.89 [0.55-1.44],0.6461928171670122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,1509,36,1.14 [0.84-1.56],0.4023304111803558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,1507,35,1.34 [0.83-2.16],0.2364151293258864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEFTY2,Left-right determination factor 2,1736,45,1.89 [1.21-2.96],0.005430858068655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEG1,Protein LEG1 homolog,1417,35,1.83 [1.20-2.78],0.0047191829109995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,1452,32,0.76 [0.43-1.32],0.325246931113624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,1509,36,1.75 [0.80-3.83],0.1621093731834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEP,Leptin,1721,43,1.16 [0.77-1.75],0.4815513567044551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEPR,Leptin receptor,1721,43,4.94 [2.66-9.19],4.25979063646883e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,1509,36,1.54 [1.00-2.37],0.0518819700082983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,1721,43,4.11 [2.35-7.19],7.061128160469696e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3,Galectin-3,1728,45,5.33 [2.44-11.62],2.6170355942156105e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3BP,Galectin-3-binding protein,1517,35,1.25 [0.49-3.20],0.6372764127441574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,1717,43,2.85 [2.05-3.96],4.78226699444104e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,1727,45,2.22 [1.53-3.23],2.7818795480815344e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS8,Galectin-8,1732,44,1.78 [1.21-2.62],0.0036660646548293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS9,Galectin-9,1720,43,9.39 [4.66-18.91],3.635279920540809e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGMN,Legumain,1724,43,3.81 [1.93-7.52],0.0001158640873066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHB,Lutropin subunit beta,1660,44,0.98 [0.71-1.36],0.9191186141770163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,1715,43,0.71 [0.44-1.14],0.1561442105049869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIF,Leukemia inhibitory factor,1660,43,1.14 [0.76-1.71],0.5222234344669823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,1720,43,12.12 [5.46-26.88],8.31848426942231e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,1728,44,1.65 [0.81-3.38],0.1674922172111562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,1512,35,0.92 [0.75-1.15],0.4713758960690708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,1460,32,0.98 [0.48-1.97],0.9444033062713354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,1721,43,8.65 [3.80-19.69],2.7107126808006065e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,1507,35,0.93 [0.61-1.40],0.7128753782432515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,1746,45,2.01 [0.80-5.08],0.138651219861696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,1742,45,2.40 [1.18-4.88],0.015512344058966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,1682,42,2.98 [1.78-4.99],3.169244884892971e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,1746,45,1.12 [0.75-1.67],0.5731138059490621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIPF,Gastric triacylglycerol lipase,1458,35,0.77 [0.47-1.26],0.3046114805396679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB1,Lamin-B1,1495,35,1.28 [0.88-1.87],0.1963942424935473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB2,Lamin-B2,1493,34,3.07 [1.64-5.72],0.0004230235852034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD1,Leiomodin-1,1509,36,2.38 [1.50-3.76],0.000223503640783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD2,Leiomodin-2,1452,32,0.52 [0.26-1.03],0.0609662643583797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",1458,35,1.42 [1.01-1.99],0.0433267687003683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPA,Apolipoprotein(a),1476,35,1.24 [1.02-1.50],0.0297205364244501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,1710,44,1.21 [0.80-1.84],0.3604968326229455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPL,Lipoprotein lipase,1721,43,1.75 [1.01-3.01],0.0446767539914995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPO,Lactoperoxidase,1666,43,2.45 [1.71-3.50],9.700637244043523e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPP,Lipoma-preferred partner,1460,32,1.10 [0.66-1.83],0.7256397070351068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,1460,32,2.18 [1.40-3.41],0.0005933624801628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,1465,33,1.49 [0.99-2.22],0.0541134256600797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,1517,35,4.79 [1.66-13.85],0.0037841724867658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,1733,45,3.90 [1.96-7.75],0.000106971226924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,1450,33,1.40 [0.50-3.88],0.5223021115833334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,1710,44,2.32 [0.90-6.00],0.0824103690881588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,1721,43,6.78 [4.03-11.41],5.39627788091559e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,1465,33,0.53 [0.18-1.54],0.2396046607696921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2BP,LRP2-binding protein,1465,33,0.94 [0.60-1.48],0.7902921862192457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,1732,44,1.34 [0.89-2.00],0.1620849790071261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,1710,44,2.05 [1.12-3.76],0.0204822214000188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,1500,35,2.71 [1.29-5.68],0.0083828662541882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,1465,33,1.79 [0.97-3.30],0.0627914492536054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,1507,35,1.37 [0.78-2.42],0.2784827749972734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,1503,36,1.52 [0.86-2.69],0.151749615614699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,1682,42,0.76 [0.38-1.51],0.4307977794251281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,1465,33,0.58 [0.22-1.51],0.2654746990806553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,1509,36,2.79 [1.40-5.56],0.0034218924527415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,1660,44,1.16 [0.72-1.85],0.5419608781320031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,1481,36,1.17 [0.86-1.59],0.3133981437262179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,1720,43,2.68 [1.52-4.73],0.0006718889232757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA,Lymphotoxin-alpha,1720,43,1.50 [0.78-2.87],0.2231216813839405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,1739,45,1.32 [0.88-1.98],0.1847122918034016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTB,Lymphotoxin-beta,1503,36,1.38 [0.62-3.04],0.4313560297170992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,1746,45,6.31 [3.85-10.34],2.916206602534586e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,1660,44,1.47 [1.08-1.99],0.0130232346654429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,1712,43,7.37 [4.46-12.19],6.999484881348159e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTO1,Protein LTO1 homolog,1682,42,0.61 [0.30-1.27],0.1872403275401891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LUZP2,Leucine zipper protein 2,1503,36,1.83 [1.11-3.01],0.0175698401509908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LXN,Latexin,1694,44,0.73 [0.48-1.11],0.1356227348195955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,1703,43,2.74 [1.81-4.16],1.844496161931605e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY75,Lymphocyte antigen 75,1720,43,1.75 [0.85-3.61],0.1311108640025606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,1699,42,3.01 [1.32-6.87],0.008702364210039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY96,Lymphocyte antigen 96,1704,44,0.97 [0.48-1.96],0.938180828191412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,1660,44,1.18 [0.79-1.74],0.4163477021667353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYN,Tyrosine-protein kinase Lyn,1710,44,1.58 [1.13-2.22],0.0080668669114435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,1660,43,1.02 [0.68-1.54],0.9133884523388804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,1703,44,2.19 [1.09-4.41],0.0274084499412877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,1660,44,1.81 [1.21-2.69],0.0036317423939923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,1452,32,0.91 [0.63-1.30],0.6001594285788387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,1465,33,1.30 [1.01-1.68],0.0416356210282953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,1517,35,2.42 [0.53-11.01],0.2541196375861828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYZL2,Lysozyme-like protein 2,1448,34,1.25 [0.57-2.73],0.5730294070735686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,1477,35,1.20 [0.78-1.85],0.4041872752278749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,1458,35,1.03 [0.46-2.31],0.9486984003049688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,1696,44,1.64 [1.25-2.17],0.0004159168393499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,1660,44,1.23 [0.67-2.28],0.5045409309394422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAG,Myelin-associated glycoprotein,1465,33,0.64 [0.33-1.26],0.1984643415896972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGEA3,Melanoma-associated antigen 3,1481,36,0.96 [0.67-1.39],0.8400175015976907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGED1,Melanoma-associated antigen D1,1660,44,1.83 [1.22-2.75],0.0035049333076316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,1507,35,6.62 [3.67-11.94],3.5098280346398557e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC4,Apical endosomal glycoprotein,1503,36,1.40 [0.81-2.40],0.2275192486592914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",1458,35,7.48 [2.14-26.10],0.0016057450841232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,1507,35,0.94 [0.55-1.61],0.8209114057113597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",1448,34,1.58 [0.86-2.88],0.13826282658899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,1724,43,1.15 [0.91-1.46],0.2371699777802622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,1720,44,11.91 [5.63-25.20],9.26203344810922e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC4,MANSC domain-containing protein 4,1460,32,1.04 [0.61-1.77],0.8805121579766299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,1452,32,0.41 [0.14-1.19],0.1009994824680723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,1460,32,0.74 [0.36-1.52],0.4125849004959681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2,Microtubule-associated protein 2,1493,34,1.85 [1.13-3.05],0.0147836028318305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,1500,35,1.59 [0.98-2.57],0.061331272638255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,1720,43,1.18 [0.90-1.55],0.2192654551586105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,1660,44,1.17 [0.90-1.52],0.2345560921769903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,1698,44,1.19 [0.93-1.51],0.1614645830100723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,1448,34,1.13 [0.56-2.29],0.7303222811351996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,1720,43,2.00 [1.17-3.41],0.0113164302705303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,1481,36,1.25 [0.85-1.85],0.2622487140991875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,1448,34,1.04 [0.86-1.27],0.6687768142630004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPT,Microtubule-associated protein tau,1660,43,0.82 [0.48-1.39],0.4578253608944663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARCO,Macrophage receptor MARCO,1721,43,2.24 [0.83-6.01],0.1096971716481381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",1473,34,1.17 [0.81-1.69],0.4060458975694937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,1698,44,2.20 [0.73-6.66],0.1619092510844093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN2,Matrilin-2,1719,43,5.06 [2.25-11.36],8.579714150761104e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN3,Matrilin-3,1698,44,1.29 [0.62-2.67],0.492321260523515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,1660,44,1.27 [0.96-1.67],0.093953508313355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAX,Protein max,1660,43,1.30 [1.01-1.67],0.0440280581693715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MB,Myoglobin,1746,45,1.87 [1.32-2.64],0.0004158880086807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MBL2,Mannose-binding protein C,1496,35,0.92 [0.69-1.23],0.5834054251755969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,1733,45,4.39 [2.26-8.56],1.3404182763736385e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",1509,36,0.93 [0.42-2.06],0.8517588725642595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,1456,33,1.16 [0.81-1.64],0.4220116214799009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,1708,43,2.31 [1.34-4.00],0.0026519279548099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,1500,35,1.95 [0.75-5.08],0.171319147189893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,1704,44,1.92 [1.33-2.79],0.0005718586863523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",1503,35,0.89 [0.41-1.93],0.7691865830886121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDK,Midkine,1715,44,2.93 [1.93-4.44],4.1318537926543003e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDM1,Nuclear protein MDM1,1465,33,1.24 [0.46-3.35],0.6679400421866178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",1458,35,1.17 [0.84-1.63],0.3455036301592752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,1660,44,1.57 [1.11-2.22],0.0106886846309307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,1460,32,1.24 [0.72-2.12],0.4363027357745549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,1717,43,2.31 [1.21-4.40],0.0110632983750401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,1460,32,2.49 [1.08-5.76],0.0330248057368678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,1744,45,1.77 [0.53-5.98],0.3563962918256785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MELTF,Melanotransferrin,1507,35,6.45 [2.85-14.60],7.767600800935691e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MENT,Protein MENT,1477,35,0.84 [0.22-3.18],0.8031244106297613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1A,Meprin A subunit alpha,1500,35,1.14 [0.77-1.70],0.5051671387977328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1B,Meprin A subunit beta,1721,43,0.81 [0.65-1.00],0.0500022765791237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,1717,43,1.32 [0.46-3.77],0.6002763438444536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,1746,44,4.25 [2.01-8.98],0.0001462779674042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MESD,LRP chaperone MESD,1728,44,1.19 [0.96-1.47],0.1076497837624269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MET,Hepatocyte growth factor receptor,1727,44,4.77 [1.32-17.24],0.0172748576204256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1,Methionine aminopeptidase 1,1660,43,0.83 [0.32-2.12],0.6923530181472586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",1720,43,1.31 [0.95-1.79],0.0977358937748571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP2,Methionine aminopeptidase 2,1736,45,1.62 [0.98-2.68],0.0599728491348726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,1690,45,1.15 [0.68-1.93],0.6043313602282454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,1465,33,0.66 [0.33-1.32],0.24140662723883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,1477,35,7.70 [3.34-17.72],1.5975922428340456e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,1746,45,4.17 [2.45-7.08],1.3111397767885356e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFGE8,Lactadherin,1728,44,1.85 [1.17-2.92],0.0086454997266672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGLL,Monoglyceride lipase,1722,43,1.34 [0.96-1.86],0.0834926898726268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,1720,43,1.19 [0.94-1.52],0.148399332202122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,1720,44,2.78 [1.53-5.03],0.0007511830339422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICALL2,MICAL-like protein 2,1465,33,1.21 [0.80-1.85],0.3657021487253284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,1720,43,1.07 [0.88-1.31],0.4786339895015919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIF,Macrophage migration inhibitory factor,1725,44,1.24 [0.82-1.86],0.3036959763089897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MILR1,Allergin-1,1682,42,1.89 [1.16-3.06],0.0100471429873221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,1503,36,1.08 [0.81-1.43],0.6182520277463881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINK1,Misshapen-like kinase 1,1493,34,1.16 [0.82-1.65],0.3894033633875509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MITD1,MIT domain-containing protein 1,1704,44,1.26 [0.95-1.67],0.1163941143765876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MKI67,Proliferation marker protein Ki-67,1456,33,0.77 [0.30-2.02],0.6004032257268639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLLT1,Protein ENL,1448,34,0.87 [0.50-1.52],0.6201223453630658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLN,Promotilin,1720,43,1.19 [0.88-1.61],0.2542946474899951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MME,Neprilysin,1710,44,1.19 [0.88-1.60],0.2705909641704821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP1,Interstitial collagenase,1681,42,1.42 [1.04-1.93],0.0270702027120059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP10,Stromelysin-2,1714,43,2.30 [1.64-3.24],1.505468958532612e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP12,Macrophage metalloelastase,1724,45,1.87 [1.27-2.75],0.0014516289770672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP13,Collagenase 3,1660,43,2.03 [0.88-4.71],0.0977524789511877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP15,Matrix metalloproteinase-15,1507,35,0.56 [0.19-1.65],0.2891690873989083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP3,Stromelysin-1,1728,44,1.81 [1.21-2.72],0.004218322075439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,1689,45,4.23 [2.52-7.09],4.754388565002263e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP8,Neutrophil collagenase,1729,44,1.67 [1.22-2.30],0.0013946157941773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP9,Matrix metalloproteinase-9,1726,44,1.34 [0.87-2.08],0.1832379095586313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",1460,32,1.38 [0.75-2.56],0.3030083670229847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MN1,Transcriptional activator MN1,1465,33,1.02 [0.59-1.76],0.9555680464174224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,1481,36,1.52 [0.92-2.53],0.1035309717086725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,1717,43,1.03 [0.81-1.30],0.827679931427142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,1477,35,1.22 [0.77-1.94],0.3920176838466698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,1739,45,4.54 [2.69-7.66],1.4334040637040628e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,1493,34,0.65 [0.18-2.32],0.5083055020130376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,1481,36,0.77 [0.31-1.89],0.5693489569009295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,1448,34,1.20 [0.57-2.56],0.6281291243681493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORN4,MORN repeat-containing protein 4,1448,34,0.69 [0.41-1.17],0.1695969653244855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,1690,45,1.53 [1.14-2.05],0.0050629954434531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPI,Mannose-6-phosphate isomerase,1710,44,1.51 [1.13-2.03],0.0060870695296886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,1722,43,1.32 [0.90-1.95],0.1600928972065308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPO,Myeloperoxidase,1728,44,1.80 [1.15-2.82],0.0106315418830147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,1499,36,0.84 [0.41-1.72],0.6407937676214946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRC1,Macrophage mannose receptor 1,1512,35,4.52 [1.66-12.36],0.0032517873618786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,1465,33,0.88 [0.55-1.41],0.5950578503803663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",1460,32,1.50 [0.92-2.43],0.1020746521098103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",1509,36,0.77 [0.31-1.93],0.5755310118767123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",1660,43,2.03 [0.90-4.59],0.0892710803582411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",1446,33,3.25 [0.93-11.40],0.0655517808404314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",1509,36,1.10 [0.75-1.61],0.6403772014750515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",1456,33,0.40 [0.13-1.19],0.1002589307982531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLN,Mesothelin,1707,44,2.40 [1.60-3.58],2.073611299467777e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLNL,Mesothelin-like protein,1465,33,0.72 [0.26-1.99],0.5312294217815061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,1726,44,2.73 [2.03-3.67],2.923458400200114e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,1732,44,2.09 [1.23-3.56],0.0068225074835661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,1720,44,1.48 [1.03-2.13],0.0355609860072442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MST1,Hepatocyte growth factor-like protein,1486,34,1.31 [0.64-2.68],0.464182077271551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSTN,Growth/differentiation factor 8,1690,45,1.39 [0.87-2.25],0.1719558181063696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTDH,Protein LYRIC,1456,33,1.17 [0.84-1.65],0.357797701949326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",1493,34,0.96 [0.24-3.91],0.955977766661705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,1481,36,1.25 [0.95-1.64],0.1051711554148654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",1500,35,1.06 [0.75-1.50],0.7418501574707337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTPN,Myotrophin,1690,45,0.81 [0.32-2.07],0.6594837110364612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTR,Methionine synthase,1460,32,0.78 [0.41-1.48],0.4420971920654298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS1,Protein MTSS 1,1500,35,1.14 [0.86-1.51],0.358241878413541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS2,Protein MTSS 2,1503,36,1.08 [0.80-1.47],0.6073349431149003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,1481,36,0.87 [0.50-1.52],0.6164516344278611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC13,Mucin-13,1660,43,2.14 [1.49-3.07],3.727134465477768e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC16,Mucin-16,1710,44,0.99 [0.86-1.13],0.8476968248168812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC2,Mucin-2,1512,35,1.24 [0.90-1.72],0.1930836044485899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUCL3,Mucin-like protein 3,1448,34,1.10 [0.53-2.31],0.7911331300083057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MVK,Mevalonate kinase,1682,42,1.33 [1.01-1.74],0.0403479369424411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,1477,35,3.31 [1.24-8.81],0.0167319675501046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",1507,35,1.37 [0.96-1.96],0.0815523114531287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",1458,35,1.01 [0.71-1.43],0.9770060212724871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,1509,36,1.19 [0.79-1.80],0.4141098199916639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYDGF,Myeloid-derived growth factor,1507,35,1.26 [0.93-1.72],0.141003693852763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH4,Myosin-4,1460,32,0.53 [0.19-1.51],0.2352551717592549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH7B,Myosin-7B,1448,34,0.93 [0.42-2.06],0.852053494948374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH9,Myosin-9,1512,35,1.18 [0.89-1.56],0.2425977715330922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",1460,32,1.24 [0.63-2.45],0.5363594531634679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL3,Myosin light chain 3,1458,35,1.17 [0.79-1.74],0.4260077437780301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL4,Myosin light chain 4,1458,35,0.60 [0.31-1.15],0.1217691270587337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL6B,Myosin light chain 6B,1465,33,0.99 [0.69-1.41],0.9368718688323396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",1465,33,1.29 [0.75-2.22],0.3542814174484037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO6,Unconventional myosin-VI,1509,36,1.23 [0.64-2.35],0.5318911345517547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO9B,Unconventional myosin-IXb,1682,42,1.15 [0.80-1.66],0.4424507819786698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOC,Myocilin,1728,44,2.21 [1.26-3.89],0.0059861893541282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM1,Myomesin-1,1452,32,1.05 [0.48-2.28],0.9039660575645536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM2,Myomesin-2,1460,32,1.22 [0.75-1.99],0.4175470293141912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM3,Myomesin-3,1477,35,1.14 [0.83-1.56],0.4336386525501414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,1721,43,2.01 [1.25-3.23],0.0038355974979337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,1660,44,1.39 [0.86-2.24],0.1746529034307951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA10,N-alpha-acetyltransferase 10,1460,32,1.42 [0.72-2.81],0.3168305316097119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA80,N-alpha-acetyltransferase 80,1465,33,1.11 [0.86-1.44],0.4301304559943499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,1699,44,0.87 [0.55-1.38],0.5537775520677803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,1503,36,1.46 [0.96-2.23],0.0765271324719592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NADK,NAD kinase,1721,43,1.40 [0.99-1.98],0.0558700654307982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,1451,33,1.17 [0.67-2.04],0.5842517365823796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,1457,35,1.05 [0.62-1.77],0.8542206435505881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,1477,35,6.04 [1.53-23.79],0.0101231315315728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,1660,44,1.29 [0.91-1.82],0.1522901091421424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,1498,34,0.96 [0.43-2.16],0.9278473376197788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,1493,34,0.92 [0.37-2.32],0.8597635923048256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",1509,36,1.81 [0.91-3.60],0.0932581040264604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,1720,44,19.38 [9.78-38.40],1.990153012141561e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBN,Nibrin,1682,42,1.31 [0.94-1.84],0.1130445251767166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM1,Neural cell adhesion molecule 1,1733,45,1.89 [0.86-4.15],0.1132462642158656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM2,Neural cell adhesion molecule 2,1728,44,2.06 [0.79-5.34],0.1374953703291557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAN,Neurocan core protein,1732,44,0.78 [0.41-1.46],0.4346256468442997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCF2,Neutrophil cytosol factor 2,1717,43,1.16 [0.89-1.52],0.2634160115702682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCK2,Cytoplasmic protein NCK2,1724,43,1.28 [1.00-1.64],0.0532805264367065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCLN,Nicalin,1682,42,0.63 [0.30-1.32],0.2176610877651595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,1720,43,6.90 [3.92-12.15],2.2519793215557888e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1500,35,5.55 [2.79-11.04],9.950434268888431e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,1739,45,5.87 [2.70-12.75],7.816293274444246e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDRG1,Protein NDRG1,1660,43,1.32 [0.99-1.76],0.0582889530673185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,1503,36,0.81 [0.45-1.48],0.4974183824747562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,1454,33,1.52 [0.63-3.69],0.3493190628169131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,1500,35,0.95 [0.67-1.33],0.7518921399407842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",1660,44,1.43 [1.10-1.85],0.0065103770894736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEB,Nebulin,1460,32,1.28 [0.52-3.18],0.5895630089607815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,1460,32,1.19 [0.74-1.92],0.4642525515449862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN1,Nectin-1,1456,33,1.68 [0.73-3.83],0.2197574898817745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,1721,43,11.10 [6.46-19.09],3.159210834216455e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,1720,44,4.56 [3.12-6.65],3.384790775878342e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,1456,33,0.89 [0.42-1.89],0.763338759398728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD9,Enhancer of filamentation 1,1456,33,1.98 [0.98-4.01],0.0586677620334118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,1653,42,4.03 [2.91-5.58],4.954433337243258e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,1481,36,1.20 [0.83-1.73],0.34369918620557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,1720,44,0.40 [0.26-0.64],8.710322032991277e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,1724,43,2.34 [1.10-4.97],0.0264486362654123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NENF,Neudesin,1503,36,1.18 [0.95-1.46],0.1362741719670575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEO1,Neogenin,1509,36,3.56 [2.00-6.34],1.5291503864949987e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEXN,Nexilin,1512,35,1.24 [0.81-1.89],0.3202140816102603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFASC,Neurofascin,1746,44,7.34 [3.56-15.15],6.9462337735851e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,1456,33,1.37 [0.96-1.96],0.0799577351156837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",1720,43,1.15 [0.89-1.50],0.288866990599722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",1682,42,1.31 [0.87-1.96],0.1947554325858563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,1458,35,1.40 [0.93-2.12],0.1089974651189131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFIC,Nuclear factor 1 C-type,1509,36,1.17 [0.56-2.44],0.6670498519167596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,1460,32,1.50 [0.96-2.33],0.0728137471791673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,1481,36,1.23 [0.85-1.79],0.2717001673653029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,1660,44,2.15 [1.46-3.19],0.0001180872826286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",1500,35,1.16 [0.86-1.58],0.3215108124581725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFX1,Transcriptional repressor NF-X1,1460,32,1.25 [0.84-1.87],0.2727282831564845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,1460,32,1.16 [0.61-2.19],0.6581391022915137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGF,Beta-nerve growth factor,1704,44,0.91 [0.10-8.52],0.9362428322920008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,1507,35,3.22 [1.47-7.06],0.0034997056816305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGRN,Neugrin,1493,34,4.23 [1.40-12.74],0.0105046164022608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,1441,33,8.06 [2.96-21.94],4.40936034708857e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID1,Nidogen-1,1730,45,2.68 [1.38-5.19],0.0034679379144847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID2,Nidogen-2,1728,44,1.51 [1.07-2.12],0.0180803012502411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NINJ1,Ninjurin-1,1660,44,1.27 [0.86-1.88],0.2261365578955282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT1,Deaminated glutathione amidase,1458,35,0.74 [0.36-1.53],0.4190611418055534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT2,Omega-amidase NIT2,1502,35,1.06 [0.68-1.66],0.7906888403150953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN1,Neuroligin-1,1465,33,0.98 [0.61-1.57],0.9353895065604568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN2,Neuroligin-2,1452,32,0.58 [0.22-1.52],0.2691720469781457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME1,Nucleoside diphosphate kinase A,1456,33,0.43 [0.08-2.27],0.3196381267655389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME3,Nucleoside diphosphate kinase 3,1719,43,1.94 [0.74-5.07],0.1744710639440772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMI,N-myc-interactor,1494,36,1.32 [0.87-2.00],0.1867367665836885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,1704,44,1.20 [0.92-1.56],0.1713334922173979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,1448,34,0.37 [0.10-1.37],0.1347104976928347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,1509,36,1.33 [0.89-1.99],0.1596829455187455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOMO1,Nodal modulator 1,1728,44,0.81 [0.27-2.39],0.6983741727119972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOP56,Nucleolar protein 56,1460,32,1.21 [0.98-1.49],0.0819790531336759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",1660,43,1.83 [1.26-2.66],0.0014653909092002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS2,"Nitric oxide synthase, inducible",1460,32,0.99 [0.41-2.41],0.9865447249389528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",1660,43,2.01 [1.35-3.00],0.0006098591399374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,1746,45,37.21 [10.03-138.03],6.407864339086272e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,1512,35,6.24 [2.46-15.79],0.000112199358319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,1746,45,2.84 [1.52-5.31],0.0010744571378443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,1496,34,8.12 [4.19-15.77],5.927481723600447e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,1721,43,4.82 [3.24-7.17],7.593201705323336e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS1,Nephrin,1456,33,0.49 [0.18-1.28],0.1441183169354551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS2,Podocin,1456,33,0.97 [0.69-1.38],0.8848304309524485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPL,N-acetylneuraminate lyase,1507,35,0.94 [0.48-1.83],0.8508313145961437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPB,Natriuretic peptides B,1690,45,1.36 [1.14-1.63],0.0006378684591562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPC,C-type natriuretic peptide,1720,43,1.81 [1.27-2.59],0.001174236329414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,1460,32,0.84 [0.29-2.42],0.7498391829625015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTN,Neuroplastin,1660,44,1.11 [0.81-1.52],0.529741544523924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX1,Neuronal pentraxin-1,1728,44,1.26 [0.71-2.24],0.4298726039622497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX2,Neuronal pentraxin-2,1512,35,2.49 [1.04-6.01],0.0416519751121979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTXR,Neuronal pentraxin receptor,1721,43,1.61 [0.89-2.93],0.1165228485224923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPY,Pro-neuropeptide Y,1739,45,2.47 [1.61-3.80],3.612573384444977e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,1721,43,3.84 [1.78-8.29],0.0005994905515263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRGN,Neurogranin,1512,35,1.12 [0.80-1.57],0.5057470481905866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRN1,Neuritin,1509,36,0.99 [0.42-2.31],0.982048870680476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP1,Neuropilin-1,1736,45,6.23 [2.57-15.09],5.1008414207774616e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP2,Neuropilin-2,1728,44,2.58 [1.05-6.32],0.0387818188062608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRTN,Neurturin,1682,42,0.84 [0.49-1.43],0.5168127080331195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRXN3,Neurexin-3,1465,33,0.86 [0.30-2.46],0.7832380842570718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NSFL1C,NSFL1 cofactor p47,1732,44,1.25 [0.84-1.88],0.2715456837723927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",1507,35,1.37 [0.88-2.13],0.1659397339660387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,1493,34,2.09 [1.18-3.70],0.0119898984423634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,1718,43,1.02 [0.75-1.39],0.9108019495850044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5E,5'-nucleotidase,1720,44,1.07 [0.68-1.69],0.7695290404217181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF3,Neurotrophin-3,1720,43,3.10 [1.56-6.15],0.0011898886497908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF4,Neurotrophin-4,1660,44,1.14 [0.59-2.22],0.6989137486851462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,1721,43,6.05 [2.33-15.72],0.0002226583790646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK3,NT-3 growth factor receptor,1732,44,2.73 [0.87-8.58],0.08660808298739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,1721,43,1.55 [1.32-1.82],1.1043879252119645e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUB1,NEDD8 ultimate buster 1,1720,43,1.34 [1.00-1.79],0.0517716401563943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,1503,36,1.04 [0.77-1.40],0.8070272337719461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUCB2,Nucleobindin-2,1736,45,4.96 [2.75-8.91],9.146508155813557e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDC,Nuclear migration protein nudC,1746,44,1.48 [0.96-2.27],0.0756108404902037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,1458,35,0.37 [0.07-2.04],0.2533442521119721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,1460,32,0.78 [0.34-1.76],0.5426483679386717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,1497,35,1.26 [0.89-1.79],0.1914681217849715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],1710,44,0.99 [0.62-1.59],0.965969449744788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,1728,44,1.97 [1.32-2.96],0.0009924719690472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUMB,Protein numb homolog,1456,33,1.19 [0.80-1.76],0.383762795414152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUP50,Nuclear pore complex protein Nup50,1460,32,1.05 [0.45-2.46],0.9023369650683836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPE4,NXPE family member 4,1460,32,0.88 [0.30-2.61],0.8222251289541755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH1,Neurexophilin-1,1660,43,2.20 [1.28-3.77],0.0041269966120142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH3,Neurexophilin-3,1456,33,5.61 [2.05-15.36],0.0007940366308867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OBP2B,Odorant-binding protein 2b,1697,44,0.75 [0.50-1.11],0.1515866784125786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OCLN,Occludin,1509,36,2.70 [1.59-4.58],0.000247270951924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,1658,43,1.27 [0.89-1.83],0.1887574848739487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,1481,36,1.30 [0.89-1.92],0.1795411409296334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGA,Protein O-GlcNAcase,1500,35,1.40 [0.90-2.18],0.1349665242398958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGFR,Opioid growth factor receptor,1710,44,5.19 [2.57-10.49],4.405348193482837e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,1728,44,5.18 [3.26-8.23],3.244424339527701e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,1481,36,1.14 [0.73-1.79],0.5707816917039454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLFM4,Olfactomedin-4,1417,33,1.13 [0.87-1.48],0.3600195951363641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,1712,43,1.54 [1.05-2.25],0.0257060019370348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMD,Osteomodulin,1724,43,1.30 [0.74-2.28],0.3583141998477152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,1710,44,0.93 [0.63-1.37],0.7082065750388546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMP,Olfactory marker protein,1452,32,0.83 [0.38-1.83],0.645904129247507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPHN1,Oligophrenin-1,1493,34,1.16 [0.87-1.55],0.3165101549866731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPLAH,5-oxoprolinase,1458,35,1.20 [0.76-1.87],0.4345772507237071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPTC,Opticin,1710,44,1.81 [1.12-2.90],0.0148493362393921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,1513,35,1.79 [0.41-7.76],0.4370280997444686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,1493,34,0.84 [0.30-2.37],0.7365880728032487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,1719,43,5.74 [2.68-12.30],6.9426058064579385e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSM,Oncostatin-M,1714,43,1.38 [0.95-2.02],0.0918838162372215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,1736,45,5.20 [1.37-19.74],0.0152747835871997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSTN,Osteocrin,1465,33,0.81 [0.30-2.20],0.6859232147005818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTOA,Otoancorin,1452,32,0.96 [0.52-1.76],0.8841801388140189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,1500,35,1.06 [0.62-1.82],0.8343990731458959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD7B,OTU domain-containing protein 7B,1509,36,1.53 [0.96-2.45],0.07257950944187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",1458,35,1.17 [0.77-1.79],0.4654714298659781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXT,Oxytocin-neurophysin 1,1732,44,1.07 [0.89-1.29],0.4725285318040637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",P4HB,Protein disulfide-isomerase,1707,44,3.16 [1.62-6.17],0.0007586816616892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,1460,32,1.24 [0.73-2.12],0.4280714859152817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI2,Protein-arginine deiminase type-2,1682,42,1.48 [1.08-2.03],0.0149156050702224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI4,Protein-arginine deiminase type-4,1658,43,1.04 [0.77-1.41],0.8031666515506546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAEP,Glycodelin,1704,44,1.07 [0.87-1.32],0.5217241507286035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,1509,36,1.09 [0.86-1.38],0.4667873729621306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",1481,36,0.89 [0.45-1.78],0.7422448179766545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,1690,45,1.97 [1.34-2.89],0.0005951124452183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,1458,35,1.43 [0.75-2.72],0.2794670669968254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,1444,34,1.18 [0.67-2.05],0.568216931717411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,1660,43,1.37 [0.95-1.99],0.0961299556520838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALLD,Palladin,1456,33,0.52 [0.16-1.67],0.2734910588242122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM,Paralemmin-1,1491,34,4.95 [2.57-9.51],1.6603842352268252e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM2,Paralemmin-2,1493,34,3.10 [1.77-5.42],7.236156424403724e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM3,Paralemmin-3,1460,32,1.06 [0.70-1.59],0.7849823674298338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,1738,45,6.75 [3.16-14.39],7.979003375763984e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAMR1,Inactive serine protease PAMR1,1728,44,1.76 [0.67-4.58],0.2496886157779971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAPPA,Pappalysin-1,1682,42,0.83 [0.45-1.54],0.5546912235958323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARD3,Partitioning defective 3 homolog,1481,36,1.27 [0.92-1.74],0.1414536522484421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARK7,Parkinson disease protein 7,1728,44,1.44 [0.87-2.38],0.1597441145154052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,1720,43,1.18 [0.83-1.67],0.3539168587910957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAXX,Protein PAXX,1477,35,1.70 [0.93-3.12],0.0874684227039826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,1448,34,0.57 [0.20-1.59],0.2829584445667481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,1660,43,0.75 [0.47-1.21],0.2441953625167437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,1500,35,3.25 [1.38-7.68],0.0071726960779776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCARE,Photoreceptor cilium actin regulator,1452,32,0.67 [0.38-1.18],0.1676787572478046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,1474,35,0.76 [0.43-1.34],0.3388931893982902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBP2,Poly(rC)-binding protein 2,1509,36,1.25 [0.82-1.92],0.3000219021398729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH1,Protocadherin-1,1738,44,3.42 [1.32-8.88],0.0115316665690463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH12,Protocadherin-12,1509,36,1.20 [0.39-3.63],0.7499433642902347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH17,Protocadherin-17,1721,43,3.15 [1.80-5.50],5.5599293803955104e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH7,Protocadherin-7,1500,35,1.86 [1.01-3.43],0.0470950584211961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH9,Protocadherin-9,1500,35,1.96 [0.78-4.91],0.1531520120391929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDHB15,Protocadherin beta-15,1503,36,2.33 [1.25-4.32],0.0073855585008121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCNA,Proliferating cell nuclear antigen,1448,34,1.10 [0.74-1.62],0.6370703064716396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,1503,36,1.04 [0.57-1.90],0.8904255880462331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,1746,45,2.76 [1.50-5.06],0.0010703233622453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,1500,35,1.12 [0.73-1.72],0.6038568115109726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,1507,35,1.17 [0.85-1.63],0.3358231757393872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1,Programmed cell death protein 1,1737,45,3.42 [2.26-5.16],5.5143392065682115e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,1710,44,7.89 [4.01-15.51],2.093504959977361e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD5,Programmed cell death protein 5,1732,44,1.75 [1.14-2.68],0.0105837009815625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD6,Programmed cell death protein 6,1721,43,1.29 [0.80-2.09],0.3015345596516686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCL2,Phosducin-like protein 2,1448,34,1.00 [0.56-1.79],0.992671115173952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",1448,34,0.87 [0.47-1.62],0.6599177575079729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1460,32,0.98 [0.51-1.89],0.95787514846666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",1477,35,1.06 [0.79-1.44],0.6861613692554318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,1746,45,1.43 [0.99-2.05],0.0535701752202288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,1724,43,1.42 [1.02-1.97],0.0377545799706998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFC,Platelet-derived growth factor C,1660,44,1.56 [0.69-3.49],0.2826091299344148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,1721,43,5.54 [2.70-11.38],3.1094624110133414e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,1746,45,1.53 [0.71-3.30],0.2756902309801389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA2,Protein disulfide-isomerase A2,1448,34,0.62 [0.23-1.63],0.3315463749497015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,1477,35,2.72 [0.92-8.03],0.0698959727293691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA4,Protein disulfide-isomerase A4,1512,35,1.23 [0.76-2.00],0.3981668500947132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA5,Protein disulfide-isomerase A5,1448,34,0.98 [0.55-1.73],0.9334849890268042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,1509,36,1.09 [0.84-1.42],0.5282550981744714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,1724,43,1.31 [1.07-1.61],0.0097023602332904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",1660,44,1.21 [0.75-1.94],0.4381699854523898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,1465,33,1.14 [0.68-1.91],0.6152818134131974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,1448,34,0.65 [0.27-1.54],0.3285160034526518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZD2,PDZ domain-containing protein 2,1460,32,1.08 [0.67-1.73],0.7539650971990718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,1456,33,1.12 [0.61-2.06],0.7157013960772433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,1746,45,17.13 [5.90-49.73],1.7637747933340014e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,1728,44,1.44 [0.92-2.25],0.1076660591634974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,1728,44,3.22 [1.58-6.53],0.0012286458950923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,1458,35,0.85 [0.25-2.85],0.7905655087246191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PENK,Proenkephalin-A,1477,35,3.57 [1.98-6.43],2.205115678119675e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEPD,Xaa-Pro dipeptidase,1512,35,0.49 [0.17-1.46],0.2031346744716462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PER3,Period circadian protein homolog 3,1456,33,1.13 [0.85-1.49],0.405347033703749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PF4,Platelet factor 4,1509,35,1.32 [0.95-1.83],0.0972147023224398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN2,Prefoldin subunit 2,1660,43,0.95 [0.57-1.58],0.8361797048236363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN4,Prefoldin subunit 4,1448,34,1.23 [0.71-2.13],0.4658384093076185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN6,Prefoldin subunit 6,1465,33,1.02 [0.57-1.82],0.9468673953092158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",1707,44,1.52 [1.12-2.07],0.0070306592257042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGA4,Pepsin A-4,1512,35,1.94 [1.35-2.79],0.0003811516294164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",1507,35,2.12 [1.51-2.97],1.3534256948824676e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,1746,44,7.49 [4.12-13.62],4.036862357166197e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,1742,45,2.63 [1.70-4.07],1.415678591072122e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,1500,35,2.06 [0.67-6.28],0.2045708527650054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,1460,32,0.81 [0.40-1.65],0.5680292161155418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGM2,Phosphoglucomutase-2,1465,33,0.92 [0.53-1.60],0.7579100417907382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGR,Progesterone receptor,1456,33,0.87 [0.58-1.30],0.4944630944686251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,1509,36,1.11 [0.85-1.46],0.4307122570149676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,1500,35,3.14 [1.97-5.00],1.4775188513451544e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,1448,34,1.03 [0.72-1.48],0.8826512766684032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1704,44,5.22 [2.40-11.36],3.131063742271899e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,1477,35,0.82 [0.41-1.64],0.5734316564359141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI16,Peptidase inhibitor 16,1512,35,15.19 [4.60-50.21],8.17450121653143e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,1706,45,2.66 [1.99-3.56],4.208771521606303e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",1509,36,1.40 [0.95-2.05],0.0858131310771125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,1704,43,2.47 [1.37-4.47],0.0027253480467819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,1720,43,1.34 [0.91-1.98],0.1418849818853139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1728,44,11.59 [6.84-19.66],9.646563980335536e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,1456,33,1.30 [0.78-2.17],0.3190792126876515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,1728,44,4.43 [2.39-8.21],2.308234907122786e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,1721,43,3.70 [2.16-6.35],1.951720410468822e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,1477,35,0.89 [0.56-1.40],0.6085214234324963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PITHD1,PITH domain-containing protein 1,1444,34,1.15 [0.83-1.60],0.4061660237560466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD1,Polycystin-1,1507,35,20.92 [7.46-58.70],7.583640710755818e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD2,Polycystin-2,1460,32,1.51 [0.97-2.36],0.0704975684048311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKLR,Pyruvate kinase PKLR,1719,43,0.60 [0.39-0.92],0.0202345882590658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKN3,Serine/threonine-protein kinase N3,1481,36,1.44 [0.98-2.11],0.0647814615487073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,1704,44,2.33 [1.51-3.62],0.0001520559614844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G15,Phospholipase A2 group XV,1720,44,1.62 [0.67-3.94],0.2860365743026921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G1B,Phospholipase A2,1742,45,1.54 [0.91-2.59],0.1046149369171063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",1719,43,1.31 [0.89-1.93],0.1694066381302119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,1724,43,1.28 [0.95-1.73],0.0980791507466009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,1728,44,0.35 [0.19-0.64],0.0005939832661883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAT,Tissue-type plasminogen activator,1744,45,0.91 [0.57-1.46],0.7029834288352717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAU,Urokinase-type plasminogen activator,1728,44,1.96 [0.86-4.46],0.1088710277170242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,1711,43,12.44 [6.34-24.39],2.1517570042271362e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",1493,34,0.80 [0.44-1.43],0.4481992157126179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",1456,33,0.58 [0.24-1.45],0.2474993624923481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",1493,34,1.06 [0.77-1.47],0.7016290991881069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,1493,34,1.55 [1.01-2.37],0.0431460984367886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLG,Plasminogen,1485,35,0.41 [0.11-1.49],0.1778901792932677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN1,Perilipin-1,1660,43,0.98 [0.47-2.06],0.964002513195661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN3,Perilipin-3,1721,43,2.81 [1.69-4.69],7.612673285690518e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,1721,43,1.13 [0.76-1.66],0.5493488053579513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLSCR3,Phospholipid scramblase 3,1490,33,1.81 [1.07-3.08],0.0280746157995939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLTP,Phospholipid transfer protein,1738,45,1.11 [0.58-2.14],0.7527870151283674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC1,Plexin domain-containing protein 1,1660,44,1.86 [0.89-3.87],0.0976031293692854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,1493,34,2.78 [1.25-6.16],0.0119626619792969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNA4,Plexin-A4,1720,43,1.36 [0.97-1.91],0.0746847243818047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB2,Plexin-B2,1740,45,16.62 [7.82-35.32],2.7074733116345573e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB3,Plexin-B3,1717,43,1.67 [0.99-2.80],0.0548496571489756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,1717,43,1.02 [0.89-1.17],0.7845464928447828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMCH,Pro-MCH,1460,32,0.90 [0.55-1.47],0.671042631122658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMM2,Phosphomannomutase 2,1460,32,1.01 [0.57-1.77],0.982400077267872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMS1,PMS1 protein homolog 1,1465,33,1.17 [0.66-2.06],0.5963537220224427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMVK,Phosphomevalonate kinase,1658,43,1.09 [0.85-1.41],0.4784217484108343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,1512,35,1.17 [0.76-1.81],0.4725364869719671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,1493,34,1.03 [0.72-1.47],0.8804323520750947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,1717,43,1.06 [0.96-1.17],0.2701678615133388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,1458,35,1.06 [0.63-1.78],0.8391749116282823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,1452,32,0.74 [0.31-1.77],0.5035598726273038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",1682,42,1.04 [0.83-1.30],0.7377820467242562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL,Podocalyxin,1710,44,0.47 [0.09-2.50],0.3726150651434798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,1720,44,3.56 [1.63-7.79],0.0014417235211333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POF1B,Protein POF1B,1456,33,1.71 [1.12-2.61],0.0124452787706508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,1456,33,0.57 [0.17-1.97],0.3776906154506586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1710,44,2.43 [1.71-3.45],7.750079014158395e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POMC,Pro-opiomelanocortin,1458,35,0.85 [0.54-1.34],0.4815541665512415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,1512,35,0.53 [0.27-1.04],0.0642606127671595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,1690,45,0.99 [0.49-2.00],0.982127776531626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON3,Serum paraoxonase/lactonase 3,1724,43,0.43 [0.21-0.86],0.0175598760944286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POSTN,Periostin,1512,35,1.35 [0.60-3.07],0.4683250565808222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPBP,Platelet basic protein,1505,35,1.39 [0.94-2.06],0.0942416427354874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,1732,44,1.20 [0.70-2.07],0.5018865348568833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,1730,45,1.24 [0.94-1.63],0.1285311982889816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,1481,36,1.23 [0.83-1.82],0.3014588756728067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",1512,35,1.17 [0.75-1.84],0.4829395490758392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPL,Periplakin,1456,33,2.14 [1.11-4.11],0.0224970012814857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1A,Protein phosphatase 1A,1660,44,1.38 [0.70-2.69],0.3525063819951519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1B,Protein phosphatase 1B,1456,33,0.78 [0.38-1.57],0.4783125931132492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1F,Protein phosphatase 1F,1507,35,1.36 [0.76-2.41],0.2962825563311095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPME1,Protein phosphatase methylesterase 1,1710,44,1.24 [0.79-1.93],0.349774695760728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,1503,36,1.32 [0.91-1.90],0.1382077677008628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,1720,44,1.47 [1.13-1.92],0.0047451830443149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,1481,36,1.08 [0.71-1.63],0.7291655363752807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,1509,36,1.27 [0.87-1.86],0.2221473472515536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,1509,36,1.97 [1.23-3.14],0.0047182193236714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,1721,43,1.46 [1.06-2.00],0.020073065286745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R9B,Neurabin-2,1746,44,1.39 [1.06-1.82],0.0162497372736938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,1500,35,1.16 [0.90-1.49],0.2530729735239477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP3R1,Calcineurin subunit B type 1,1704,44,2.55 [1.44-4.52],0.0013338527845279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,1465,33,0.93 [0.58-1.51],0.7816309327951114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPY,Pancreatic prohormone,1711,41,1.48 [1.15-1.90],0.0019835179395276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PQBP1,Polyglutamine-binding protein 1,1660,44,1.40 [1.01-1.93],0.0408948508806746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,1448,34,0.40 [0.10-1.65],0.2062103028555668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,1512,35,4.13 [1.72-9.93],0.0015060228356998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRC1,Protein regulator of cytokinesis 1,1503,36,0.99 [0.56-1.75],0.9812887549734316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,1736,45,4.03 [2.06-7.88],4.8210208404286105e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX1,Peroxiredoxin-1,1665,43,1.07 [0.80-1.42],0.6641783016644317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX2,Peroxiredoxin-2,1486,35,0.54 [0.31-0.93],0.0258267471717638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",1682,42,1.48 [1.04-2.11],0.0298403485071431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",1746,44,1.08 [0.72-1.63],0.6982105301030769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX6,Peroxiredoxin-6,1739,45,0.95 [0.62-1.46],0.8298191537837115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,1682,42,3.59 [1.85-6.95],0.0001516470042606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRELP,Prolargin,1717,43,18.46 [6.44-52.92],5.8238566941162696e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG2,Bone marrow proteoglycan,1512,35,2.90 [1.74-4.84],4.353847876492409e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG3,Proteoglycan 3,1512,35,1.39 [0.78-2.47],0.2603997281768785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,1682,42,1.61 [1.11-2.36],0.0129545377641865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,1465,33,1.38 [0.58-3.33],0.4682671818130497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,1721,43,1.36 [0.98-1.89],0.0672298249868631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,1491,34,1.27 [0.84-1.92],0.2650336228947654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKCQ,Protein kinase C theta type,1682,42,1.36 [0.80-2.33],0.2524611567433063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,1460,32,1.48 [0.91-2.40],0.1119829544750282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,1477,35,1.00 [0.78-1.29],0.9867612653366704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,1660,44,1.89 [1.34-2.67],0.0003057942901597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRL,Prolactin,1732,44,1.30 [0.97-1.75],0.0769820160414818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRND,Prion-like protein doppel,1493,34,1.31 [0.75-2.29],0.3437945902713748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROC,Vitamin K-dependent protein C,1733,45,1.09 [0.40-2.95],0.8683287153986883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROCR,Endothelial protein C receptor,1460,32,1.48 [0.59-3.66],0.4013608498367648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROK1,Prokineticin-1,1720,43,0.98 [0.63-1.52],0.9411168474372616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROS1,Vitamin K-dependent protein S,1517,35,0.62 [0.18-2.10],0.4396203662074498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR4,Proline-rich protein 4,1469,35,1.69 [1.13-2.53],0.0101616863246875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR5,Proline-rich protein 5,1456,33,0.65 [0.28-1.49],0.3036176081462866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,1458,35,2.92 [1.77-4.80],2.653028692661044e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS2,Trypsin-2,1733,45,1.59 [1.12-2.26],0.0097795271777787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS22,Brain-specific serine protease 4,1456,33,2.72 [1.35-5.49],0.0050977882626429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,1719,43,6.74 [3.55-12.78],5.445971800874192e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS53,Serine protease 53,1493,34,1.29 [0.63-2.64],0.4880989543908958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS8,Prostasin,1711,43,3.49 [1.96-6.21],2.1319533671616315e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,1660,43,1.18 [0.92-1.51],0.1990597047592338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTG,Protogenin,1739,45,11.69 [4.91-27.82],2.7579212098412053e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTN3,Myeloblastin,1685,43,2.12 [1.47-3.06],6.00715800594848e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRUNE2,Protein prune homolog 2,1481,36,0.71 [0.21-2.34],0.5725904746833947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAP,Prosaposin,1506,35,11.12 [4.11-30.13],2.1632059041390664e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,1500,35,2.01 [1.19-3.40],0.0089966003948798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSCA,Prostate stem cell antigen,1500,35,1.10 [0.96-1.26],0.182993866453342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,1704,44,1.49 [1.16-1.91],0.0018116226933808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,1720,43,1.49 [1.15-1.94],0.0026970757426389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMA1,Proteasome subunit alpha type-1,1660,44,0.80 [0.41-1.56],0.5194565246537859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,1448,34,0.51 [0.16-1.63],0.2540517845075662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,1509,36,1.43 [0.80-2.55],0.2269471786491043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,1465,33,1.29 [0.82-2.02],0.2737242638026727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,1710,44,0.80 [0.49-1.31],0.3837612646873941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME1,Proteasome activator complex subunit 1,1703,44,1.20 [0.59-2.48],0.6126583051801533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME2,Proteasome activator complex subunit 2,1694,44,1.13 [0.54-2.40],0.7427209799622001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG3,Proteasome assembly chaperone 3,1720,43,0.74 [0.43-1.28],0.2848792291562971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG4,Proteasome assembly chaperone 4,1456,33,0.86 [0.48-1.53],0.5988309675023062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSPN,Persephin,1720,43,1.26 [0.97-1.64],0.0873006606846599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,1660,44,1.68 [1.17-2.41],0.0051934346493125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,1438,32,1.06 [0.78-1.44],0.7269148014741919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1660,43,3.01 [1.21-7.46],0.017446563824356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,1720,45,5.68 [3.66-8.83],1.178007564988375e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGES2,Prostaglandin E synthase 2,1447,33,1.19 [0.66-2.15],0.5533762460586426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGR1,Prostaglandin reductase 1,1507,35,0.94 [0.67-1.34],0.7482743998786356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH,Parathyroid hormone,1465,33,1.25 [0.89-1.76],0.1955779849705954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,1720,43,1.57 [1.11-2.22],0.0111003309463824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,1660,43,2.71 [1.49-4.93],0.0010732027609321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTN,Pleiotrophin,1690,45,2.21 [1.32-3.70],0.0026932909055109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,1456,33,1.26 [0.66-2.42],0.4834540980441755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,1704,44,1.40 [1.02-1.92],0.0381203284683643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,1722,43,1.19 [0.87-1.64],0.2816597066500657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,1454,33,1.43 [0.71-2.86],0.3130497860604584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,1507,35,3.82 [1.35-10.80],0.0115785035395361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,1512,35,9.64 [2.67-34.85],0.0005494809137046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,1746,45,3.70 [1.56-8.80],0.0030119286702008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,1500,35,1.19 [0.66-2.13],0.5626782575873568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,1500,35,1.53 [0.50-4.71],0.454861702256483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,1716,43,4.45 [1.56-12.72],0.0053153442193624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1696,44,4.20 [2.76-6.37],1.604056124136444e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,1493,34,2.12 [1.08-4.15],0.0291153341198419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,1746,45,13.27 [5.13-34.31],9.582554586841026e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,1507,35,3.70 [1.38-9.93],0.0095583191173147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,1477,35,0.92 [0.54-1.58],0.7645336590319991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,1656,42,0.67 [0.43-1.03],0.0698357494090235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTTG1,Securin,1481,36,0.65 [0.29-1.44],0.2885418507242666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTX3,Pentraxin-related protein PTX3,1720,43,2.07 [1.09-3.95],0.0265753572347008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVALB,Parvalbumin alpha,1731,45,1.08 [0.86-1.35],0.5076272329927182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVR,Poliovirus receptor,1732,44,1.72 [1.00-2.96],0.0505845343252645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXDNL,Peroxidasin-like protein,1503,36,1.41 [0.94-2.12],0.0953281787438542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXN,Paxillin,1660,43,1.76 [1.17-2.66],0.0067225999613061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYDC1,Pyrin domain-containing protein 1,1458,35,1.09 [0.51-2.34],0.8246690401651116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYY,Peptide YY,1460,32,1.65 [1.24-2.20],0.0005820802185195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PZP,Pregnancy zone protein,1517,35,0.57 [0.29-1.11],0.0998224206630467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QDPR,Dihydropteridine reductase,1714,43,1.16 [0.63-2.15],0.635005322321207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,1731,45,24.78 [10.62-57.81],1.1108806439516049e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QSOX1,Sulfhydryl oxidase 1,1483,35,1.78 [1.15-2.75],0.0099409566669464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB10,Ras-related protein Rab-10,1507,35,1.18 [0.67-2.07],0.5745716259140421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,1507,35,1.17 [0.88-1.57],0.2787137427489747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB27B,Ras-related protein Rab-27B,1507,35,1.04 [0.70-1.55],0.8402225211405451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB2B,Ras-related protein Rab-2B,1503,36,0.95 [0.58-1.54],0.8250927654961668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB33A,Ras-related protein Rab-33A,1460,32,1.28 [0.81-2.00],0.2897237160563818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB37,Ras-related protein Rab-37,1682,42,1.17 [0.88-1.55],0.2875473986523363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB39B,Ras-related protein Rab-39B,1460,32,1.25 [0.96-1.62],0.0925797314514931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,1452,32,1.00 [0.54-1.86],0.9995440818568356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB44,Ras-related protein Rab-44,1503,36,1.29 [0.79-2.11],0.3004458343712736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6A,Ras-related protein Rab-6A,1720,43,0.63 [0.36-1.12],0.1139598931027285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6B,Ras-related protein Rab-6B,1660,43,1.00 [0.57-1.76],0.9912873607087652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,1477,35,1.11 [0.74-1.67],0.6088101765904361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,1660,44,1.53 [1.09-2.16],0.0138873690932211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,1682,42,1.16 [0.75-1.80],0.5110417391564932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,1465,33,0.96 [0.52-1.77],0.8903642461966322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,1660,44,1.34 [0.85-2.10],0.208001814374252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,1481,36,1.16 [0.63-2.16],0.6297383401183614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALB,Ras-related protein Ral-B,1456,33,0.51 [0.16-1.63],0.2561070364348203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALY,RNA-binding protein Raly,1503,36,1.55 [0.97-2.48],0.0668545212205483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,1458,35,0.65 [0.35-1.22],0.1831371217842784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,1452,32,0.31 [0.10-0.98],0.0453373810037219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,1660,44,0.85 [0.46-1.56],0.6045372994323586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAP1A,Ras-related protein Rap-1A,1456,33,1.12 [0.76-1.67],0.5610888557084603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,1481,36,1.37 [0.81-2.31],0.2401982062544903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,1660,44,2.35 [1.53-3.62],9.761392587357388e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,1736,45,2.35 [1.66-3.33],1.4547025655169134e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASA1,Ras GTPase-activating protein 1,1660,43,1.02 [0.46-2.24],0.9669787735119486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,1448,34,0.84 [0.36-1.97],0.6952867170484802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASSF2,Ras association domain-containing protein 2,1660,44,1.51 [1.18-1.93],0.0010403782212791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,1509,36,4.36 [2.41-7.89],1.082359553079759e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBKS,Ribokinase,1673,43,0.49 [0.29-0.82],0.0061580446679943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM17,Splicing factor 45,1509,36,1.02 [0.67-1.54],0.941026966812778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM19,Probable RNA-binding protein 19,1460,32,1.26 [0.63-2.52],0.5133740006959074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM25,RNA-binding protein 25,1448,34,1.02 [0.50-2.07],0.9542136948055736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP1,Retinol-binding protein 1,1465,33,1.25 [0.89-1.76],0.1971115108400229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,1710,44,2.01 [1.50-2.70],2.773927554506533e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP5,Retinol-binding protein 5,1710,44,1.55 [1.07-2.23],0.0197763595285438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP7,Retinoid-binding protein 7,1500,35,1.50 [1.02-2.21],0.0397435800754918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,1456,33,1.08 [0.65-1.79],0.7797298773569034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,1458,35,1.23 [0.91-1.66],0.1694621943800694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCC1,Regulator of chromosome condensation,1503,36,0.95 [0.49-1.84],0.8807427541452642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCOR1,REST corepressor 1,1690,45,0.82 [0.38-1.76],0.6113207380506998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,1458,35,3.47 [0.90-13.33],0.0697351384638938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REEP4,Receptor expression-enhancing protein 4,1509,36,1.69 [1.13-2.53],0.0110879646578854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,1721,45,3.24 [2.37-4.42],1.765145223100438e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1B,Lithostathine-1-beta,1746,45,2.54 [1.89-3.42],7.888579142256155e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,1746,45,2.74 [2.07-3.62],1.876592730161761e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,1503,36,1.73 [0.99-3.01],0.0528401583534653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,1719,43,3.12 [2.10-4.64],1.8662363653033933e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELB,Transcription factor RelB,1456,33,0.95 [0.45-2.02],0.8968092220972638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,1728,44,7.46 [4.04-13.78],1.300640893260818e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,1721,43,1.87 [1.52-2.30],3.619151070248359e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,1456,33,1.08 [0.43-2.69],0.8718873837371982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REST,RE1-silencing transcription factor,1448,34,1.30 [0.57-3.01],0.5328220471672798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,1710,44,1.24 [0.64-2.42],0.5297702966400019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RETN,Resistin,1723,43,3.62 [2.31-5.66],1.735100142607603e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",1460,32,0.97 [0.42-2.21],0.938091601172271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RFC4,Replication factor C subunit 4,1503,36,3.40 [1.14-10.12],0.0280646276435329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGCC,Regulator of cell cycle RGCC,1509,36,1.03 [0.69-1.54],0.8775255570422269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,1481,36,0.99 [0.58-1.69],0.9763800649397208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMA,Repulsive guidance molecule A,1732,44,6.55 [3.07-14.01],1.2357803050601524e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,1732,44,10.51 [5.11-21.61],1.5720065381180818e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS10,Regulator of G-protein signaling 10,1509,36,1.20 [0.74-1.92],0.4594580675937639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS8,Regulator of G-protein signaling 8,1682,42,1.25 [0.91-1.71],0.1667248699006055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,1694,43,1.18 [0.93-1.50],0.1616010722276157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,1456,33,0.76 [0.30-1.92],0.5628659093382772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,1477,35,1.18 [0.70-1.99],0.5442655961766559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILP,Rab-interacting lysosomal protein,1733,45,1.08 [0.71-1.65],0.7053412313634666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILPL2,RILP-like protein 2,1507,35,1.10 [0.80-1.52],0.5508152177066186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,1460,32,0.88 [0.50-1.53],0.641168399925859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN1,Prorelaxin H1,1509,36,1.01 [0.60-1.68],0.9806767169480556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN2,Prorelaxin H2,1475,35,1.08 [0.82-1.42],0.6041488949829211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,1512,35,6.22 [3.07-12.60],4.051470815571991e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,1458,35,1.83 [1.31-2.56],0.0004207794798491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE3,Eosinophil cationic protein,1715,43,1.20 [0.98-1.45],0.071407223895315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE4,Ribonuclease 4,1457,33,7.56 [2.70-21.12],0.0001144724783799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE6,Ribonuclease K6,1496,34,3.07 [1.96-4.83],1.1037960617824303e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,1509,36,1.36 [0.81-2.27],0.2432223888858187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,1740,45,16.59 [8.19-33.61],6.477744837668906e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,1458,35,5.62 [3.17-9.97],3.7177983656143286e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,1456,33,1.32 [0.64-2.75],0.4521708475786292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,1456,33,1.34 [0.69-2.59],0.3893469937291465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,1481,36,1.03 [0.63-1.67],0.9182004088520188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,1660,44,1.41 [0.98-2.03],0.066051847448497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,1481,36,1.32 [0.85-2.05],0.2191643616737305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,1458,35,1.11 [0.71-1.73],0.6556296142626099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO1,Roundabout homolog 1,1719,43,2.65 [1.21-5.83],0.0152372649982571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO2,Roundabout homolog 2,1732,44,2.66 [1.00-7.08],0.0499038686019284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO4,Roundabout homolog 4,1458,35,2.87 [0.50-16.44],0.2366432060832404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,1721,43,9.24 [5.11-16.72],1.9574759185112037e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RP2,Protein XRP2,1710,44,1.69 [1.06-2.71],0.0271237559105561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPA2,Replication protein A 32 kDa subunit,1456,33,1.17 [0.46-2.96],0.7480364340954972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,1481,36,1.00 [0.65-1.53],0.9904803848298208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,1465,33,0.52 [0.20-1.36],0.1815454443877546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPL14,60S ribosomal protein L14,1458,35,1.47 [0.72-3.01],0.292312793588962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPS10,40S ribosomal protein S10,1460,32,1.23 [0.62-2.44],0.5443816054477029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRAS,Ras-related protein R-Ras,1465,33,1.19 [0.94-1.50],0.1410822786162904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,1660,44,1.49 [1.07-2.08],0.0180059811354383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,1660,44,2.06 [1.40-3.05],0.0002610638019701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRP15,RRP15-like protein,1452,32,1.00 [0.66-1.53],0.991644255424246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO1,R-spondin-1,1704,44,4.43 [2.28-8.62],1.1399715214738602e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,1739,45,5.76 [3.53-9.41],2.7558970559976838e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTBDN,Retbindin,1710,44,2.65 [1.89-3.72],1.8567312907735643e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTKN2,Rhotekin-2,1460,32,1.41 [0.87-2.30],0.1609626008821601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",1509,36,1.13 [0.81-1.57],0.4679515272983707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4R,Reticulon-4 receptor,1739,45,3.37 [1.75-6.47],0.0002657002436676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RUVBL1,RuvB-like 1,1660,44,1.00 [0.76-1.30],0.9931262886483572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RWDD1,RWD domain-containing protein 1,1732,44,1.44 [0.94-2.19],0.091313793786847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RYR1,Ryanodine receptor 1,1460,32,0.36 [0.12-1.10],0.0732947942405818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A11,Protein S100-A11,1704,43,1.36 [0.91-2.03],0.1357646719475713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A12,Protein S100-A12,1693,44,1.33 [0.94-1.90],0.1111866223978469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A13,Protein S100-A13,1456,33,1.91 [0.84-4.32],0.1221793190131902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A14,Protein S100-A14,1509,36,0.84 [0.44-1.59],0.5866763374699155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A16,Protein S100-A16,1658,43,1.08 [0.71-1.63],0.7260855656890642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A3,Protein S100-A3,1503,36,0.55 [0.19-1.61],0.2723852826447496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A4,Protein S100-A4,1720,44,1.15 [0.72-1.81],0.5628687012635138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100G,Protein S100-G,1509,36,0.63 [0.30-1.31],0.2165703726788122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100P,Protein S100-P,1690,45,1.89 [1.40-2.54],3.2293828559156754e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAA4,Serum amyloid A-4 protein,1517,35,1.19 [0.54-2.65],0.6673775438735476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAFB2,Scaffold attachment factor B2,1509,36,1.40 [0.53-3.72],0.5020779837124085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAG,S-arrestin,1452,32,0.72 [0.33-1.57],0.4137527019140463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,1720,43,1.60 [1.14-2.25],0.0066058109280861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,1481,36,1.37 [1.03-1.81],0.0282347421784386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SARG,Specifically androgen-regulated gene protein,1504,35,1.23 [0.92-1.64],0.1714299052595161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,1460,32,1.47 [0.86-2.51],0.1639942492863197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT1,Diamine acetyltransferase 1,1460,32,1.13 [0.58-2.19],0.7186474617039375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,1481,36,1.03 [0.68-1.56],0.9023071840687782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SATB1,DNA-binding protein SATB1,1509,36,1.02 [0.32-3.22],0.9780765394133852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SBSN,Suprabasin,1511,35,2.45 [1.04-5.80],0.0414381954071619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,1710,44,1.48 [1.09-2.01],0.012229467434806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,1732,44,11.43 [6.15-21.22],1.2388928906038022e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB1,Scavenger receptor class B member 1,1660,43,1.06 [0.64-1.76],0.8083755688855493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,1671,44,6.25 [4.20-9.28],1.2109919522652798e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,1746,45,3.13 [1.83-5.37],3.370840452126462e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,1732,44,10.19 [5.35-19.41],1.700437858512507e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,1730,45,11.04 [5.89-20.71],7.253463404811455e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG3,Secretogranin-3,1719,43,3.32 [1.56-7.07],0.0018572253129608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB1A1,Uteroglobin,1719,43,3.19 [1.95-5.21],3.697577080888153e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB2A2,Mammaglobin-A,1460,32,0.68 [0.17-2.69],0.5826286387036528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,1477,35,2.48 [0.69-8.96],0.1654645126634291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,1722,43,1.57 [1.26-1.97],6.765808289816061e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,1682,42,2.77 [1.76-4.36],1.068955978898452e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCIN,Adseverin,1452,32,0.76 [0.46-1.25],0.2833554574757765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCLY,Selenocysteine lyase,1733,45,0.89 [0.55-1.43],0.623930949380791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,1452,32,0.66 [0.29-1.52],0.3320048121596444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2B,Sodium channel subunit beta-2,1465,33,0.66 [0.17-2.53],0.5477198136995318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,1465,33,0.37 [0.11-1.21],0.10125609698676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3B,Sodium channel subunit beta-3,1452,32,0.42 [0.15-1.13],0.0854912322839437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,1458,35,2.49 [1.61-3.88],4.788221030476743e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCP2,Non-specific lipid-transfer protein,1660,44,1.06 [0.75-1.50],0.725758425560131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,1456,35,1.39 [0.75-2.57],0.2896298683658773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,1507,35,4.71 [2.24-9.87],4.189346075978416e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRIB,Protein scribble homolog,1458,35,1.18 [0.86-1.62],0.2956570503293814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRN1,Secernin-1,1720,43,2.24 [1.47-3.40],0.000170712226797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCT,Secretin,1465,33,1.74 [0.89-3.38],0.1037257499156517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC1,Syndecan-1,1721,43,2.63 [1.64-4.20],5.261919947942007e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC4,Syndecan-4,1721,43,0.99 [0.57-1.72],0.973402845088091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,1503,36,1.17 [0.89-1.54],0.2641114882770781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDHB,Succinate dehydrogenase,1500,35,1.29 [0.86-1.94],0.222543319801044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDK2,Protein sidekick-2,1477,35,1.87 [0.92-3.77],0.081783529227449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEC31A,Protein transport protein Sec31A,1458,35,1.05 [0.69-1.59],0.8353346817630958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,1458,35,2.25 [1.37-3.70],0.0014147448133243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELE,E-selectin,1746,45,2.03 [1.28-3.22],0.0027875930234973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELENOP,Selenoprotein P,1517,35,0.51 [0.12-2.13],0.3563680956007372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELL,L-selectin,1517,35,2.18 [0.68-7.00],0.1899773235761792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELP,P-selectin,1733,45,1.90 [1.23-2.93],0.0036929634251279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,1720,43,1.24 [0.54-2.85],0.6179513374500187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3F,Semaphorin-3F,1721,43,5.39 [2.40-12.12],4.584440828142368e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3G,Semaphorin-3G,1477,35,2.27 [1.30-3.96],0.0040834469509467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4C,Semaphorin-4C,1710,44,1.59 [1.15-2.20],0.0055690717771198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4D,Semaphorin-4D,1732,44,3.51 [1.42-8.69],0.0066315359772451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA6C,Semaphorin-6C,1456,33,2.45 [0.87-6.91],0.0904355159663617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA7A,Semaphorin-7A,1744,45,5.87 [3.06-11.28],1.0447046617916073e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN3,Neuronal-specific septin-3,1509,36,1.09 [0.74-1.58],0.6712654064490678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN7,Septin-7,1481,36,0.76 [0.34-1.70],0.5039960103203461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN8,Septin-8,1488,34,2.37 [1.40-4.03],0.0013976190517915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN9,Septin-9,1710,44,3.42 [1.71-6.84],0.0005184598345479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA1,Alpha-1-antitrypsin,1486,35,16.27 [0.26-1035.04],0.1880296052925936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA11,Serpin A11,1746,45,1.75 [0.94-3.29],0.0797506761677374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA12,Serpin A12,1685,42,0.97 [0.80-1.18],0.7407429144583882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,1510,35,1.99 [0.27-14.76],0.5009513102777318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA4,Kallistatin,1483,35,0.37 [0.12-1.09],0.0721002643709173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA5,Plasma serine protease inhibitor,1490,35,0.83 [0.30-2.25],0.7098668265004957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA6,Corticosteroid-binding globulin,1517,35,1.12 [0.17-7.40],0.9095025536047592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA7,Thyroxine-binding globulin,1517,35,0.58 [0.10-3.30],0.5352961372351471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA9,Serpin A9,1699,44,1.16 [0.81-1.67],0.4236561563751474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,1723,44,1.32 [1.02-1.71],0.0379430388603243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB5,Serpin B5,1690,45,0.98 [0.57-1.69],0.9410410687807422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB6,Serpin B6,1726,44,1.98 [1.28-3.06],0.0021019787338288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB8,Serpin B8,1746,44,1.55 [1.19-2.01],0.0011126410103742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB9,Serpin B9,1704,44,1.19 [0.51-2.76],0.6934128254223104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINC1,Antithrombin-III,1512,35,0.56 [0.09-3.35],0.521829890041626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPIND1,Heparin cofactor 2,1512,35,0.60 [0.22-1.65],0.3220049078444973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,1746,45,1.40 [0.92-2.11],0.1131481078785611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE2,Glia-derived nexin,1507,35,0.99 [0.62-1.59],0.9750299289658776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,1489,35,7.13 [2.27-22.37],0.0007609706036278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF2,Alpha-2-antiplasmin,1478,35,0.73 [0.09-5.96],0.7670417629530302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPING1,Plasma protease C1 inhibitor,1512,35,1.60 [0.31-8.15],0.5699127252495598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINH1,Serpin H1,1481,36,1.20 [0.94-1.52],0.1457594682872284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI1,Neuroserpin,1473,34,0.87 [0.32-2.37],0.7920002887962452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI2,Serpin I2,1500,35,0.78 [0.45-1.36],0.3767075600413464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,1660,43,1.23 [0.83-1.82],0.2946541321455086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,1697,44,0.87 [0.36-2.07],0.7496325843688391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6,Seizure protein 6 homolog,1465,33,1.45 [0.53-3.98],0.4738139288318801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,1720,44,6.65 [3.37-13.14],4.84344824308025e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L2,Seizure 6-like protein 2,1710,44,1.51 [0.61-3.70],0.3708206021067601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SF3B4,Splicing factor 3B subunit 4,1710,44,1.48 [1.05-2.09],0.0246482176327901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,1696,44,3.45 [2.02-5.88],5.819095458941471e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,1477,35,2.17 [1.05-4.50],0.0370173515770841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,1660,44,1.27 [0.91-1.79],0.1643915843375729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,1660,44,1.09 [0.65-1.83],0.7318465870724544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,1721,43,1.17 [0.78-1.76],0.443425094320288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,1486,35,1.72 [1.05-2.81],0.0306222045969294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2B3,SH2B adapter protein 3,1660,44,1.16 [0.89-1.52],0.2779043047321484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,1720,43,1.62 [1.14-2.29],0.0070733037664323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,1452,32,0.96 [0.52-1.76],0.8860143682060848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BP1,SH3 domain-binding protein 1,1500,35,1.23 [0.73-2.08],0.4447564529992256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GL3,Endophilin-A3,1469,36,1.03 [0.71-1.50],0.8801255727614556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GLB2,Endophilin-B2,1493,34,1.23 [0.77-1.98],0.3894377166506898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHBG,Sex hormone-binding globulin,1512,35,1.17 [0.69-2.00],0.5591147213151526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHC1,SHC-transforming protein 1,1448,34,1.22 [0.93-1.60],0.1463990555761234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHD,SH2 domain-containing adapter protein D,1455,32,1.25 [1.00-1.57],0.0497843932157653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHH,Sonic hedgehog protein,1456,33,1.00 [0.49-2.03],0.9988072283463882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHISA5,Protein shisa-5,1512,35,3.56 [2.00-6.32],1.5420750620956462e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",1722,43,1.24 [0.91-1.70],0.1767206965797701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHPK,Sedoheptulokinase,1481,36,1.44 [0.89-2.34],0.1362255928099073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIAE,Sialate O-acetylesterase,1717,44,2.86 [1.69-4.85],9.316698099906128e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC1,Sialoadhesin,1724,43,3.72 [2.20-6.31],9.960671515702326e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,1720,43,5.75 [2.99-11.04],1.510765924704866e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,1660,43,1.08 [0.77-1.52],0.663965737168428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,1728,44,1.27 [0.98-1.66],0.0742384869682626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,1739,45,12.20 [6.40-23.25],3.0092550364953254e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,1721,43,9.26 [3.81-22.51],9.104087874990316e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,1458,35,1.60 [0.87-2.95],0.1309514747720919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,1736,45,2.34 [1.00-5.45],0.0492777375839001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIL1,Nucleotide exchange factor SIL1,1458,35,1.81 [0.91-3.61],0.0910719484768138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,1728,45,3.15 [1.69-5.87],0.0002981742634331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,1714,43,7.15 [4.35-11.75],9.178574756785992e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,1456,33,1.05 [0.72-1.54],0.7926434073302066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,1710,44,1.29 [0.95-1.76],0.0984738903619494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",1660,43,1.06 [0.65-1.74],0.8091050616577085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,1682,42,1.85 [1.14-2.98],0.0120351701468403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,1698,44,1.36 [0.94-1.98],0.1059459121606285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,1724,43,1.37 [1.05-1.78],0.0215690032952243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKIV2L,Helicase SKI2W,1460,32,0.67 [0.24-1.86],0.4381974258126867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLA2,Src-like-adapter 2,1509,36,1.08 [0.80-1.45],0.6166099200834324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,1682,42,1.55 [1.02-2.34],0.0380224412239646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF6,SLAM family member 6,1660,44,2.21 [1.59-3.08],2.66839985404022e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF7,SLAM family member 7,1720,43,1.60 [1.04-2.47],0.0328579352264127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF8,SLAM family member 8,1660,44,1.82 [1.12-2.95],0.0157528083435781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC12A2,Solute carrier family 12 member 2,1460,32,1.09 [0.32-3.69],0.8879091193975802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC13A1,Solute carrier family 13 member 1,1503,36,1.24 [0.87-1.77],0.2314188837639428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC16A1,Monocarboxylate transporter 1,1660,43,1.30 [0.90-1.88],0.1694875125496679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC1A4,Neutral amino acid transporter A,1465,33,1.43 [0.84-2.42],0.184316857102304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,1660,43,1.47 [1.11-1.95],0.0076233927216202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,1448,34,1.45 [0.99-2.14],0.0576960698323108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,1448,34,0.75 [0.33-1.69],0.4925488141383307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,1660,43,3.36 [2.00-5.66],5.1374255478782204e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,1720,43,1.40 [1.01-1.93],0.0421619569821947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC44A4,Choline transporter-like protein 4,1465,33,1.22 [0.83-1.82],0.3141053014913023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC4A1,Band 3 anion transport protein,1512,35,0.74 [0.36-1.53],0.4162734089658119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC51B,Organic solute transporter subunit beta,1460,32,1.28 [0.83-1.96],0.2663741959762418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,1477,35,1.20 [0.83-1.73],0.327273775478421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,1500,35,1.38 [0.90-2.11],0.1384012106933442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",1448,34,1.34 [0.92-1.95],0.1294914386016463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIT2,Slit homolog 2 protein,1660,43,0.80 [0.46-1.39],0.4251592251142041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,1456,33,1.91 [0.71-5.12],0.2005777728371204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,1739,45,3.10 [1.66-5.81],0.000391629059049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,1690,45,3.67 [2.06-6.57],1.126945326929313e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,1481,36,1.06 [0.71-1.58],0.7711740838663677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,1500,35,1.40 [0.99-1.98],0.0579547041931174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,1499,35,1.90 [0.96-3.75],0.0635495513432464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,1660,44,1.48 [1.10-1.98],0.0088852805922538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,1503,36,1.12 [0.74-1.69],0.5930048980460092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,1503,36,1.16 [0.66-2.04],0.6070735490622841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,1710,44,0.98 [0.26-3.63],0.9713347945505708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,1660,43,1.25 [0.90-1.73],0.1857889801854652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,1448,34,1.34 [0.79-2.28],0.2752821149537793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,1500,35,1.48 [1.09-2.02],0.0132186656318346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,1739,45,5.58 [2.62-11.87],8.012481212804605e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,1724,43,5.48 [3.36-8.96],1.1004283021082992e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,1717,44,1.11 [0.67-1.85],0.6802113355908737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,1456,33,1.16 [0.70-1.94],0.5568883852772475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,1721,43,0.82 [0.55-1.24],0.3484867642713773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,1503,36,0.84 [0.51-1.38],0.4888910582185284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMS,Spermine synthase,1452,32,1.18 [0.76-1.84],0.4682724596229288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMTN,Smoothelin,1490,34,1.19 [0.88-1.61],0.2622682710773526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP23,Synaptosomal-associated protein 23,1721,43,1.21 [0.88-1.67],0.2461250283384194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP25,Synaptosomal-associated protein 25,1452,32,1.10 [0.58-2.11],0.7648418848790972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP29,Synaptosomal-associated protein 29,1720,44,1.45 [1.08-1.95],0.0122323725396659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAPIN,SNARE-associated protein Snapin,1509,36,1.01 [0.60-1.72],0.9583585962014718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCA,Alpha-synuclein,1477,35,0.95 [0.73-1.25],0.724514736476273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCG,Gamma-synuclein,1704,44,2.65 [1.80-3.92],9.166765818112684e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",1458,35,1.60 [0.66-3.87],0.2984880618490559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',1493,34,1.52 [1.06-2.19],0.0232592071666751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNU13,NHP2-like protein 1,1460,32,1.15 [0.74-1.81],0.5309133639471871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX15,Sorting nexin-15,1477,35,1.08 [0.60-1.94],0.8015870247311212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX18,Sorting nexin-18,1500,35,1.64 [0.97-2.78],0.0662468000763975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX2,Sorting nexin-2,1503,36,1.27 [0.94-1.73],0.120615898658729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX5,Sorting nexin-5,1458,35,1.48 [0.57-3.84],0.4188994480134431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX9,Sorting nexin-9,1721,43,1.48 [1.04-2.13],0.0317726473588452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],1693,43,1.24 [0.73-2.13],0.4271553907861314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",1728,44,1.31 [0.81-2.14],0.2734935159664413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD3,Extracellular superoxide dismutase,1512,35,1.34 [0.97-1.86],0.0755035537154859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,1509,36,1.22 [0.66-2.28],0.5226543832583568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,1660,44,5.76 [3.49-9.53],8.66528478318213e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORD,Sorbitol dehydrogenase,1729,45,0.61 [0.44-0.84],0.0026764607241427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORT1,Sortilin,1721,43,2.83 [1.45-5.52],0.0023773796955894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOST,Sclerostin,1721,43,2.54 [1.35-4.77],0.0038567938874502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,1465,33,1.04 [0.53-2.06],0.905398568573868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX2,Transcription factor SOX-2,1507,35,0.45 [0.10-1.98],0.2900178090661873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX9,Transcription factor SOX-9,1465,33,1.77 [0.50-6.34],0.3788749645736818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,1509,36,1.92 [1.00-3.69],0.0501878057569934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPAG1,Sperm-associated antigen 1,1509,36,1.09 [0.65-1.83],0.7488440050913086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARC,SPARC,1720,44,1.75 [1.14-2.68],0.0105963149487825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARCL1,SPARC-like protein 1,1721,45,5.14 [2.08-12.67],0.0003787260957226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPART,Spartin,1477,35,1.24 [0.83-1.85],0.2890649090444459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPESP1,Sperm equatorial segment protein 1,1507,35,1.80 [0.66-4.95],0.2514838886902995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,1728,44,2.95 [2.05-4.25],5.3706039791069125e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,1477,35,2.26 [1.24-4.13],0.0076929168157703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,1720,43,2.89 [2.11-3.94],2.8095323693006718e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,1728,44,4.97 [2.52-9.80],3.760310770816256e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,1739,45,1.96 [1.22-3.16],0.0055231845564919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,1460,32,0.39 [0.12-1.28],0.1206159710062262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,1723,44,4.57 [2.18-9.56],5.5027958834702825e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,1724,43,6.56 [3.60-11.95],8.090054255715853e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,1500,35,0.94 [0.76-1.15],0.5427733056324866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPOCK1,Testican-1,1704,44,0.47 [0.18-1.23],0.1229078815579132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON1,Spondin-1,1719,43,4.33 [2.50-7.51],1.7685132094740997e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON2,Spondin-2,1714,43,7.12 [3.79-13.37],1.026405129960444e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPP1,Osteopontin,1744,45,3.12 [1.97-4.93],1.127055014642434e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",1456,33,1.50 [0.75-2.99],0.2510878827114936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRING1,SREBP regulating gene protein,1448,34,1.39 [0.97-1.98],0.0717696685747796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR1B,Cornifin-B,1481,36,0.97 [0.66-1.43],0.8937436643598611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR3,Small proline-rich protein 3,1493,34,1.90 [1.35-2.68],0.0002541636261716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRY2,Protein sprouty homolog 2,1682,42,1.25 [0.97-1.60],0.0803718526097735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",1452,32,0.82 [0.28-2.43],0.7239949457363837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,1493,34,1.60 [0.84-3.05],0.1557329812293684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,1716,44,1.24 [0.98-1.56],0.0699946878130079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,1710,44,1.63 [1.15-2.32],0.0066287322050594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPK2,SRSF protein kinase 2,1720,43,1.45 [1.11-1.89],0.0062953506164337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,1507,35,1.61 [0.69-3.76],0.2735922215935796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSB,Lupus La protein,1660,43,0.96 [0.56-1.62],0.865775093530962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",1456,33,0.80 [0.30-2.18],0.6685154845642868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,1721,43,0.80 [0.66-0.98],0.0336789849170113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,1733,45,1.02 [0.56-1.87],0.9521672948866428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,1448,34,0.36 [0.09-1.35],0.1285278750541928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,1500,35,1.50 [0.87-2.58],0.1491235347605646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST13,Hsc70-interacting protein,1477,35,0.90 [0.51-1.60],0.7199056846917182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",1710,44,1.98 [1.33-2.95],0.0008355714273604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",1746,45,6.45 [3.01-13.82],1.6268734047325595e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",1456,33,0.65 [0.24-1.75],0.3947884646034575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAB2,Stabilin-2,1512,35,2.12 [0.67-6.64],0.1984378720725756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAM,Signal transducing adapter molecule 1,1503,36,2.08 [1.04-4.15],0.0391144101246355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAMBP,STAM-binding protein,1698,44,1.30 [0.87-1.95],0.2060780984243916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT2,Signal transducer and activator of transcription 2,1456,33,1.47 [0.99-2.17],0.0548678964608292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,1710,44,1.15 [0.95-1.39],0.1629118420233929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,1448,34,1.27 [0.86-1.87],0.2218140656830812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC1,Stanniocalcin-1,1732,44,3.71 [2.42-5.69],1.896198492408287e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC2,Stanniocalcin-2,1726,44,8.18 [2.76-24.25],0.0001496803858366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STEAP4,Metalloreductase STEAP4,1452,32,1.15 [0.77-1.71],0.4951794058783545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,1725,44,1.29 [0.87-1.91],0.2031522206636939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK11,Serine/threonine-protein kinase STK11,1690,45,1.33 [0.93-1.90],0.113274115691178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK24,Serine/threonine-protein kinase 24,1660,43,1.39 [0.91-2.12],0.1283135567499336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK4,Serine/threonine-protein kinase 4,1721,43,1.23 [0.90-1.68],0.1871003828132668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",1448,34,1.25 [0.93-1.67],0.133919511312188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX16,Syntaxin-16,1660,44,1.38 [0.97-1.97],0.0737792992835582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX1B,Syntaxin-1B,1465,33,1.42 [0.66-3.09],0.3722558861186963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX3,Syntaxin-3,1493,34,0.83 [0.30-2.28],0.7198527551926694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX4,Syntaxin-4,1710,44,1.55 [1.16-2.07],0.0028044049346614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX5,Syntaxin-5,1456,33,1.14 [0.65-2.02],0.6464872698826516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX6,Syntaxin-6,1660,44,1.35 [0.94-1.94],0.1081301165382795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX7,Syntaxin-7,1456,33,1.41 [0.70-2.84],0.3303180084980076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX8,Syntaxin-8,1720,43,1.49 [0.92-2.42],0.1088171742055608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP1,Syntaxin-binding protein 1,1509,36,1.13 [0.76-1.70],0.5399115827631795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP3,Syntaxin-binding protein 3,1660,44,1.74 [1.07-2.84],0.0269056663542302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,1500,35,1.98 [1.05-3.76],0.0360249024121981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGT1,Protein SGT1 homolog,1660,44,1.31 [0.94-1.83],0.1171802418600439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT1A1,Sulfotransferase 1A1,1732,44,1.07 [0.87-1.32],0.5152096364066274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT2A1,Bile salt sulfotransferase,1720,43,1.01 [0.71-1.45],0.9362221558095088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF1,Formylglycine-generating enzyme,1456,33,0.75 [0.37-1.50],0.408876305485776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,1732,44,1.65 [0.97-2.80],0.0655007663498426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",1509,36,1.35 [0.91-2.00],0.1365137208922013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD1,Sushi domain-containing protein 1,1690,45,1.60 [0.89-2.88],0.1139953384654738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD2,Sushi domain-containing protein 2,1728,44,2.92 [1.32-6.46],0.0083132362506644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,1503,36,1.79 [1.13-2.82],0.0125316981148664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,1470,34,6.68 [3.12-14.32],1.0506782912612e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,1465,33,1.29 [0.84-1.98],0.2461254731157994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SWAP70,Switch-associated protein 70,1500,35,2.09 [1.23-3.54],0.0062833053363492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYAP1,Synapse-associated protein 1,1477,35,0.93 [0.54-1.58],0.7826035328573397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,1452,32,0.69 [0.33-1.41],0.3068000580592362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYT1,Synaptotagmin-1,1493,34,1.61 [0.73-3.56],0.2390248710430315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYTL4,Synaptotagmin-like protein 4,1507,35,1.15 [0.77-1.71],0.4852727059084374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,1481,36,1.22 [0.91-1.64],0.1781779265493493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,1710,44,1.26 [1.00-1.60],0.0485776397231313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,1530,42,6.13 [3.12-12.06],1.454332388660673e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TADA3,Transcriptional adapter 3,1503,36,0.90 [0.41-1.96],0.7915060033089709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,1710,44,4.19 [2.80-6.28],3.9325912680365975e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAGLN3,Transgelin-3,1448,34,1.24 [0.83-1.85],0.28516994068154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TALDO1,Transaldolase,1509,35,1.69 [0.87-3.28],0.1202067477751516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,1682,42,1.42 [0.98-2.06],0.0660707252526993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAP1,Antigen peptide transporter 1,1481,36,1.21 [0.79-1.86],0.3731838625685697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,1660,43,1.43 [1.02-1.99],0.0358963458706929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",1465,33,1.15 [0.78-1.70],0.4746540137737138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",1503,36,1.33 [0.60-2.93],0.4854305818247452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAX1BP1,Tax1-binding protein 1,1493,34,1.96 [1.29-2.98],0.0016789388330072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D17,TBC1 domain family member 17,1660,43,0.83 [0.43-1.59],0.5737512981968174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D23,TBC1 domain family member 23,1710,44,1.29 [0.97-1.72],0.0784801378752703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D5,TBC1 domain family member 5,1720,43,1.15 [0.83-1.58],0.3966392240973447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCA,Tubulin-specific chaperone A,1477,35,1.09 [0.76-1.57],0.6388850117396578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCB,Tubulin-folding cofactor B,1704,44,1.24 [0.94-1.62],0.1251413058489276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCC,Tubulin-specific chaperone C,1704,44,1.30 [0.94-1.80],0.1155537395440653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,1660,44,1.29 [0.94-1.77],0.1112456505901217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBR1,T-box brain protein 1,1465,33,0.72 [0.32-1.64],0.435174236690469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,1703,44,0.91 [0.71-1.18],0.4876708675354634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,1690,45,0.84 [0.56-1.26],0.4033601125176583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN1,Transcobalamin-1,1474,34,1.33 [0.51-3.43],0.5568362847412602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN2,Transcobalamin-2,1744,45,3.01 [1.79-5.07],3.455791435622124e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCOF1,Treacle protein,1507,35,2.04 [1.17-3.53],0.0113782898764517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCP11,T-complex protein 11 homolog,1481,36,0.97 [0.58-1.63],0.9129166229775164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCTN3,Tectonic-3,1507,35,0.69 [0.24-2.03],0.5015883353166486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,1660,43,1.06 [0.88-1.27],0.5456962199181772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",1465,33,1.10 [0.54-2.23],0.7864525493419001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,1503,36,1.17 [0.81-1.67],0.4029009437269778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDRKH,Tudor and KH domain-containing protein,1660,43,1.35 [1.02-1.79],0.0357958888450872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEF,Thyrotroph embryonic factor,1460,32,0.95 [0.42-2.19],0.9112194782856502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEK,Angiopoietin-1 receptor,1720,44,3.15 [1.12-8.85],0.0294451219179571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TERF1,Telomeric repeat-binding factor 1,1456,33,0.45 [0.12-1.64],0.2273388443495988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TET2,Methylcytosine dioxygenase TET2,1479,36,0.66 [0.40-1.10],0.1108133974466142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX101,Testis-expressed protein 101,1465,33,0.60 [0.31-1.15],0.1255565992820074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX33,Testis-expressed protein 33,1481,36,0.78 [0.31-1.97],0.6057455300802075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TF,Serotransferrin,1517,35,0.31 [0.08-1.21],0.0907235958075487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,1452,32,0.83 [0.43-1.60],0.5778955305126585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,1719,44,2.14 [1.71-2.69],4.206878039364618e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF2,Trefoil factor 2,1722,43,3.27 [2.38-4.51],3.667641476370878e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF3,Trefoil factor 3,1718,44,2.40 [1.78-3.24],1.1403678808350847e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI,Tissue factor pathway inhibitor,1728,45,1.55 [0.74-3.26],0.2451860247040738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,1718,44,1.64 [1.23-2.18],0.0006980132028204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFRC,Transferrin receptor protein 1,1734,45,1.81 [0.96-3.43],0.0685405044072244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TG,Thyroglobulin,1503,36,1.33 [1.05-1.67],0.0170149134705283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFA,Protransforming growth factor alpha,1720,43,2.69 [1.73-4.17],1.0995789503750235e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,1743,44,3.29 [1.85-5.85],5.255590873311223e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,1503,36,0.78 [0.43-1.40],0.399951842584012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,1722,45,0.73 [0.29-1.83],0.4995596214834635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,1456,33,2.79 [0.69-11.29],0.1498509044568026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,1720,44,5.04 [3.53-7.19],4.528430022890474e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,1746,45,7.09 [3.60-13.96],1.4440373565210298e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,1717,43,0.87 [0.60-1.25],0.4450146360809759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,1512,35,8.88 [4.05-19.46],5.0244319861163524e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,1444,34,0.84 [0.55-1.30],0.4443098725813532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,1721,43,8.20 [4.61-14.57],7.530933541544866e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS2,Thrombospondin-2,1728,44,1.69 [1.08-2.64],0.0219982399547355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS4,Thrombospondin-4,1730,45,1.81 [1.06-3.11],0.0305722743543956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THOP1,Thimet oligopeptidase,1714,43,0.39 [0.17-0.92],0.0313727412612553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THPO,Thrombopoietin,1690,45,2.47 [1.33-4.62],0.0044432400545464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,1460,32,1.11 [0.81-1.50],0.5242023904237516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,1447,32,1.03 [0.41-2.61],0.945241935203062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THTPA,Thiamine-triphosphatase,1500,36,1.23 [0.86-1.76],0.2577705653231463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,1732,44,6.93 [3.43-13.97],6.440095034787839e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,1665,43,1.18 [0.96-1.45],0.1213100252174684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,1746,45,2.52 [1.13-5.57],0.0231246340212195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",1654,43,1.38 [0.83-2.29],0.2213048839630708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,1481,36,1.87 [0.97-3.58],0.0598560256080497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,1733,45,1.05 [0.60-1.83],0.8691280752179593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,1507,35,1.79 [0.88-3.64],0.1071468317749562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,1493,34,1.11 [0.77-1.60],0.585033222530901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,1706,44,6.38 [3.41-11.94],6.966991960923865e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,1507,35,4.71 [2.24-9.92],4.438497458856704e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,1724,43,1.23 [1.02-1.48],0.0291001659768972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,1728,44,2.58 [1.46-4.55],0.0010829228042882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,1718,43,19.37 [6.83-54.92],2.4925491031369922e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJAP1,Tight junction-associated protein 1,1720,44,1.30 [0.95-1.77],0.0958128040101087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJP3,Tight junction protein ZO-3,1452,32,0.96 [0.43-2.14],0.9145145243899492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TK1,"Thymidine kinase, cytosolic",1481,36,0.96 [0.50-1.87],0.9125590257092864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR1,Toll-like receptor 1,1456,33,2.30 [0.75-7.05],0.144287718246308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR2,Toll-like receptor 2,1481,36,4.26 [1.09-16.68],0.0371785694562369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR3,Toll-like receptor 3,1746,44,1.81 [1.15-2.84],0.0107126561918088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR4,Toll-like receptor 4,1456,33,0.76 [0.22-2.65],0.662961340655142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,1465,33,1.57 [0.97-2.53],0.0669201295873527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,1481,36,0.91 [0.49-1.70],0.76407885658537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,1460,32,0.65 [0.20-2.07],0.4638177533448124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,1460,32,0.89 [0.45-1.78],0.7412098774694703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED8,Protein TMED8,1500,35,1.09 [0.80-1.47],0.5892097731955586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM106A,Transmembrane protein 106A,1503,36,1.25 [0.82-1.90],0.2928828681630964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM132A,Transmembrane protein 132A,1458,35,1.61 [1.04-2.50],0.033506190887184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM25,Transmembrane protein 25,1509,36,1.10 [0.55-2.18],0.7952267534785271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMOD4,Tropomodulin-4,1448,34,0.84 [0.36-1.95],0.688125611594568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,1452,32,1.13 [0.74-1.73],0.569958072803739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,1488,34,2.49 [1.41-4.38],0.0016488728274975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS15,Enteropeptidase,1710,44,1.61 [1.20-2.16],0.0013768300085543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS5,Transmembrane protease serine 5,1693,44,2.71 [1.30-5.68],0.0081261996964091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMSB10,Thymosin beta-10,1728,44,1.96 [1.40-2.74],7.832287342316893e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNC,Tenascin,1733,45,2.31 [1.42-3.76],0.0007841173415542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNF,Tumor necrosis factor,1688,45,2.06 [1.57-2.70],1.7645103070440657e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,1500,35,1.72 [1.12-2.65],0.0139019649634577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,1682,42,1.72 [0.84-3.51],0.1351515730690783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,1477,35,1.10 [0.69-1.77],0.6810544623239709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1704,44,9.86 [5.76-16.87],6.614768016327233e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1704,44,1.73 [1.39-2.17],1.3037277550056678e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,1732,45,1.56 [0.89-2.73],0.1239865440867926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1746,44,4.36 [2.93-6.47],2.9390358235306174e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,1717,43,4.51 [2.40-8.47],2.886088479934036e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1720,44,6.24 [3.95-9.85],3.944598531367746e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,1719,43,5.14 [3.12-8.45],1.1537537330199687e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,1682,42,2.20 [1.39-3.46],0.0007004700706958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1719,43,8.84 [5.36-14.58],1.3202969613657477e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,1477,35,4.49 [2.14-9.43],7.189825753185876e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1739,45,4.36 [3.04-6.26],1.170060167256458e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1728,44,12.48 [7.20-21.62],2.245998788650385e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1728,44,2.01 [1.59-2.53],3.6222644119782478e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1732,44,11.16 [5.45-22.84],4.0454726648966257e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1743,44,5.82 [3.68-9.19],4.3886094092429904e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1704,44,2.17 [1.53-3.08],1.4262566967415469e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,1732,44,2.70 [1.82-4.01],7.403041308784747e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1704,44,4.38 [3.07-6.24],2.777741444260094e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,1746,44,1.18 [0.44-3.13],0.7419556119812583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,1720,43,0.73 [0.47-1.13],0.1573310897266793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,1746,44,2.61 [1.13-6.06],0.0253188210004754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,1724,43,10.42 [5.14-21.15],8.405648206151944e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,1745,45,2.32 [1.05-5.13],0.0375346913609279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,1704,44,1.98 [1.27-3.08],0.0023953824093619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,1512,35,1.76 [0.77-4.00],0.1787195452156023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,1493,34,1.30 [0.92-1.84],0.1352562318292317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNN,Tenascin-N,1512,35,1.77 [0.87-3.61],0.1164664561753251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",1690,45,0.75 [0.58-0.97],0.0311059506521543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNPO1,Transportin-1,1481,36,1.33 [0.56-3.16],0.5155279698309745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNR,Tenascin-R,1704,44,2.81 [1.56-5.06],0.0005670905230655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNXB,Tenascin-X,1728,44,1.01 [0.39-2.59],0.9888764953975198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,1507,35,1.19 [0.80-1.76],0.3920478172452608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1,DNA topoisomerase 1,1500,35,1.20 [0.92-1.57],0.1891125519575781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",1448,34,0.40 [0.16-1.01],0.0533453619169147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP2B,DNA topoisomerase 2-beta,1456,33,1.40 [0.96-2.04],0.0774119081907623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,1458,35,1.47 [0.92-2.35],0.1030398963576681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53,Cellular tumor antigen p53,1660,44,2.48 [1.41-4.34],0.0015395824665518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53BP1,TP53-binding protein 1,1456,33,1.29 [0.89-1.87],0.1707899620443333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,1441,33,0.82 [0.44-1.53],0.5351009492640246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,1690,45,0.30 [0.08-1.11],0.0718958894210605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP73,Tumor protein p73,1465,33,0.75 [0.28-2.05],0.5801291141867453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPBGL,Trophoblast glycoprotein-like,1465,33,0.93 [0.38-2.28],0.8733892655547072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPD52L2,Tumor protein D54,1477,35,1.01 [0.75-1.36],0.9358548052516508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,1507,35,2.10 [0.71-6.21],0.1803004006272174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPM3,Tropomyosin alpha-3 chain,1460,32,0.99 [0.46-2.14],0.9814329378837412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPMT,Thiopurine S-methyltransferase,1660,44,0.79 [0.53-1.17],0.238894670797996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,1704,43,1.87 [1.15-3.04],0.0110660608502141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,1481,36,0.84 [0.53-1.35],0.4726408197410835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,1660,43,1.01 [0.48-2.14],0.976023353317869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPR,Nucleoprotein TPR,1460,32,1.45 [0.93-2.27],0.1048760098420766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,1448,34,1.09 [0.69-1.74],0.7075517980165409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,1740,44,1.32 [0.76-2.31],0.3278016535109438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSD1,Tryptase delta,1509,36,1.73 [0.83-3.62],0.1453072381442202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSG1,Tryptase gamma,1456,33,0.94 [0.26-3.42],0.930669472670914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPT1,Translationally-controlled tumor protein,1682,42,1.07 [0.74-1.54],0.7293670313742604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF2,TNF receptor-associated factor 2,1720,43,1.19 [0.82-1.72],0.3664844776713973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",1456,33,1.59 [0.84-3.02],0.1542616526067195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,1460,32,0.91 [0.41-2.04],0.8168559007789206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,1481,36,1.07 [0.74-1.54],0.719348599501392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREH,Trehalase,1512,35,0.74 [0.50-1.11],0.1459101523634803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,1717,43,1.53 [1.01-2.30],0.0424324215600586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML1,Trem-like transcript 1 protein,1512,35,1.16 [0.66-2.05],0.6034218058153114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML2,Trem-like transcript 2 protein,1728,44,3.78 [2.01-7.09],3.540273410923223e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,1739,45,2.17 [1.47-3.21],0.0001046709221083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,1720,43,1.14 [0.80-1.63],0.4585282420137815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,1475,36,1.33 [0.85-2.09],0.2130921636953759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,1500,35,1.24 [0.92-1.66],0.1577248594575382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM26,Tripartite motif-containing protein 26,1448,34,0.94 [0.51-1.72],0.8426687752523515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,1465,33,1.27 [0.86-1.89],0.2289097975897336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM5,Tripartite motif-containing protein 5,1720,43,1.11 [0.82-1.50],0.4927080056416747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,1503,36,1.15 [0.81-1.62],0.4411767822006008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,1460,32,1.09 [0.62-1.90],0.7676396673602062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC1,Hamartin,1456,33,1.16 [0.77-1.74],0.4772372265584822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC22D1,TSC22 domain family protein 1,1509,36,1.27 [0.81-1.99],0.2942509254821848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSHB,Thyrotropin subunit beta,1721,43,0.73 [0.53-1.02],0.062814548245628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSLP,Thymic stromal lymphopoietin,1690,45,1.05 [0.70-1.57],0.8034310670845906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSNAX,Translin-associated protein X,1460,32,1.07 [0.45-2.51],0.8783701587474492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN1,Tetraspanin-1,1690,45,1.05 [0.67-1.65],0.8335725537529104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN15,Tetraspanin-15,1460,32,0.95 [0.51-1.78],0.8719143129391749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN7,Tetraspanin-7,1452,32,0.74 [0.43-1.28],0.2833442132220454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN8,Tetraspanin-8,1500,35,1.20 [0.89-1.62],0.2344022691515481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,1456,33,1.80 [0.92-3.53],0.0875976543026981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TST,Thiosulfate sulfurtransferase,1659,43,1.48 [1.06-2.07],0.0221565454494797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTF2,Transcription termination factor 2,1465,33,1.25 [0.70-2.25],0.4486149361361538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTN,Titin,1460,32,0.93 [0.56-1.55],0.7842719250494161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTR,Transthyretin,1502,35,0.49 [0.17-1.40],0.1836159079832357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TUBB3,Tubulin beta-3 chain,1452,32,0.58 [0.16-2.08],0.4023167125741957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TWF2,Twinfilin-2,1512,35,1.23 [0.86-1.76],0.2597132916368327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXK,Tyrosine-protein kinase TXK,1481,36,0.67 [0.37-1.21],0.1826845517920364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXLNA,Alpha-taxilin,1704,44,1.35 [1.00-1.83],0.0507923104626279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXN,Thioredoxin,1483,34,1.06 [0.50-2.22],0.8828269305923591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,1720,44,1.24 [0.49-3.16],0.6483913020094902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,1732,44,2.03 [1.42-2.91],0.0001125492916519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,1493,34,1.42 [0.87-2.32],0.1609252015107566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNL1,Thioredoxin-like protein 1,1451,32,0.89 [0.61-1.31],0.5648151465737314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",1728,44,1.47 [0.89-2.43],0.1291154237224795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYMP,Thymidine phosphorylase,1709,43,1.51 [1.03-2.23],0.036764491610296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,1721,43,2.38 [0.92-6.13],0.0731624441698803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",1456,33,1.32 [0.78-2.24],0.2957482264200837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,1710,44,0.56 [0.26-1.21],0.1392683284433972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,1503,36,0.95 [0.31-2.88],0.9301853406701928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,1507,35,1.78 [1.09-2.91],0.0204458414645211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,1456,33,1.02 [0.56-1.85],0.9569924475024212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBQLN3,Ubiquilin-3,1460,32,1.05 [0.63-1.76],0.8414847381247755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBXN1,UBX domain-containing protein 1,1477,35,1.23 [0.80-1.90],0.3503930086671049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,1500,35,1.08 [0.86-1.35],0.529612526937167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,1460,32,1.17 [0.93-1.48],0.1778987461835285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,1460,32,0.66 [0.20-2.19],0.4934948634958935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ULBP2,UL16-binding protein 2,1704,44,5.39 [3.16-9.20],6.92993200314106e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UMOD,Uromodulin,1743,44,0.58 [0.39-0.87],0.0088533620752989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC5D,Netrin receptor UNC5D,1456,33,1.70 [0.54-5.40],0.3665857988798741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC79,Protein unc-79 homolog,1448,34,1.36 [0.84-2.21],0.2125195242956087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNG,Uracil-DNA glycosylase,1503,36,1.75 [0.88-3.50],0.1122864942383821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPB1,Beta-ureidopropionase,1507,35,0.89 [0.66-1.21],0.4553117360216573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3A,Uroplakin-3a,1452,32,0.72 [0.43-1.21],0.2124460267771557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,1479,35,1.27 [0.82-1.96],0.286295980830949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROD,Uroporphyrinogen decarboxylase,1477,35,0.89 [0.55-1.45],0.6462680950265642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROS,Uroporphyrinogen-III synthase,1465,33,1.00 [0.60-1.66],0.993748397812948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USO1,General vesicular transport factor p115,1710,44,1.22 [0.91-1.64],0.1849438540089701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,1503,36,1.51 [0.97-2.33],0.0655001021563152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,1493,34,1.94 [1.09-3.45],0.0246268707705005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,1460,32,1.19 [0.84-1.68],0.3188390978433832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,1690,45,1.38 [1.07-1.77],0.0129735284801745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,1660,44,1.04 [0.61-1.78],0.8721744291724634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,1690,45,1.20 [0.83-1.75],0.3330619739080152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,1456,33,1.17 [0.82-1.68],0.3879907531749588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,1720,43,1.20 [0.88-1.64],0.243905354043959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASN,Vasorin,1701,43,6.60 [2.78-15.68],1.879623864778766e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,1512,35,1.08 [0.71-1.63],0.7225551741441172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,1710,44,4.28 [1.22-14.98],0.0229176606029542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,1452,32,1.20 [0.87-1.66],0.2701991557565965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,1733,45,4.56 [2.16-9.61],6.817834996339139e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAN,Versican core protein,1732,44,2.41 [1.03-5.60],0.0414630087077916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,1448,34,1.03 [0.71-1.49],0.8945907977361331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,1741,44,2.30 [1.57-3.39],2.288489297157211e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,1456,33,3.37 [1.24-9.18],0.0174433582321047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFC,Vascular endothelial growth factor C,1720,44,1.96 [1.22-3.15],0.0051973264933748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,1742,44,5.65 [3.01-10.63],7.649479123873828e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VGF,Neurosecretory protein VGF,1509,36,2.69 [1.36-5.33],0.0045703893114143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIM,Vimentin,1690,45,1.01 [0.81-1.26],0.911938424583716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,1458,35,0.34 [0.09-1.27],0.1081883377482313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIT,Vitrin,1507,35,2.98 [1.31-6.81],0.0095084954742823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,1710,44,1.55 [1.01-2.38],0.0444443295332449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN1,Pantetheinase,1512,35,0.78 [0.52-1.15],0.2090100997686352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,1710,44,1.68 [0.91-3.08],0.095434968802313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,1481,36,0.93 [0.58-1.49],0.757596096732287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,1710,44,1.33 [0.97-1.84],0.0791097561467779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,1503,36,1.09 [0.78-1.51],0.6146241852687666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,1710,44,1.41 [1.03-1.94],0.0308870876030961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,1503,36,1.40 [0.84-2.34],0.1959074001465369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,1460,32,1.46 [0.62-3.45],0.3907330243482604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,1503,36,2.98 [2.09-4.25],1.614061921553037e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,1726,44,5.56 [3.60-8.60],1.2174955051039772e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,1717,43,1.72 [1.19-2.47],0.0036436992108652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSNL1,Visinin-like protein 1,1493,34,0.84 [0.38-1.86],0.6636277052794965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,1660,43,1.25 [0.73-2.14],0.4127737705896009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,1481,36,0.73 [0.30-1.76],0.4842072614043724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,1690,45,1.37 [0.87-2.13],0.1716078805301251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,1732,44,1.24 [0.85-1.80],0.264246031644006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,1660,44,2.08 [1.03-4.18],0.0412089338304815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,1477,35,1.15 [0.68-1.96],0.5979993256238276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,1736,45,2.08 [1.14-3.77],0.0167523370741702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,1448,34,0.86 [0.53-1.41],0.5526664851071476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,1692,44,5.49 [3.23-9.31],2.7766518815076165e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,1509,36,1.38 [0.90-2.11],0.1400655237437478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWF,von Willebrand factor,1746,45,1.68 [1.17-2.42],0.0053456845811668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",1728,44,2.47 [1.28-4.78],0.0072324259903221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,1682,42,1.28 [0.88-1.87],0.1958522007371936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,1690,45,1.22 [0.94-1.58],0.1343278932997481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,1660,43,1.45 [1.07-1.97],0.0166257125702444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASHC3,WASH complex subunit 3,1493,34,1.47 [1.03-2.11],0.0355790224766629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,1456,33,0.99 [0.56-1.75],0.9659381827664608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WDR46,WD repeat-containing protein 46,1503,36,1.43 [0.80-2.56],0.2300511973484986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,1474,36,1.37 [0.93-2.02],0.1113504232423469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,1736,45,1.93 [1.34-2.78],0.0004099108138221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,1639,41,4.64 [3.41-6.30],1.0583073014663557e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",1697,44,0.98 [0.50-1.91],0.956434580109463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",1719,43,4.05 [1.98-8.25],0.0001203378939231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WIF1,Wnt inhibitory factor 1,1739,45,1.57 [0.77-3.20],0.2179001713481039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,1682,42,5.25 [3.03-9.11],3.474346763245475e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,1704,44,1.61 [1.02-2.54],0.0401319869690857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XCL1,Lymphotactin,1739,45,1.34 [0.97-1.86],0.0778524227444335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,1734,45,5.02 [3.20-7.87],1.877466616444057e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,1456,33,1.93 [1.20-3.12],0.0068848152784232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,1720,44,0.68 [0.55-0.85],0.0005048597726954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XRCC4,DNA repair protein XRCC4,1660,43,1.41 [0.68-2.92],0.3521659756709735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,1493,34,5.94 [3.04-11.60],1.7678934287631554e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",1500,35,1.05 [0.84-1.32],0.6448564662799423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YES1,Tyrosine-protein kinase Yes,1710,44,1.28 [1.02-1.61],0.0317183245999832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YJU2,Splicing factor YJU2,1503,36,1.50 [0.61-3.68],0.3742746672324134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,1460,32,0.80 [0.47-1.36],0.4085885490922629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YTHDF3,YTH domain-containing family protein 3,1682,42,1.21 [0.88-1.65],0.2390721291988928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YWHAQ,14-3-3 protein theta,1477,35,1.16 [0.77-1.76],0.4763735362871455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YY1,Transcriptional repressor protein YY1,1456,33,1.35 [0.43-4.20],0.6076318844786881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBP1,Z-DNA-binding protein 1,1456,33,1.82 [1.12-2.98],0.0164593002100018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,1660,44,1.35 [0.97-1.89],0.0737533571416379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,1690,45,1.60 [1.07-2.39],0.0218105915097533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,1460,32,1.17 [0.70-1.95],0.5542968370155958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,1500,35,1.13 [0.79-1.60],0.5024769772312059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,1493,34,1.46 [0.83-2.57],0.1935006559385106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF174,Zinc finger protein 174,1456,33,0.74 [0.24-2.29],0.6075804746922062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF75D,Zinc finger protein 75D,1481,36,1.01 [0.60-1.68],0.9837800370704092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF830,Zinc finger protein 830,1503,36,1.12 [0.79-1.59],0.5408698841156803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRD2,Protein ZNRD2,1500,35,1.35 [0.90-2.01],0.144977122211425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,1503,36,1.29 [0.74-2.25],0.3633237833824334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,1458,35,0.96 [0.85-1.09],0.5602068179391236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,1448,34,0.50 [0.13-1.99],0.3278203690571589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZPR1,Zinc finger protein ZPR1,1452,32,0.64 [0.37-1.10],0.1030153616500339
